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I. INTRODUCTION AND LITERATURE REVIEW 
A. Historical Background 
The ability of higher organisms to defend themselves against foreign 
organisms and objects was recognized as early as 2500 years ago by the 
historian Thucydides (Davis, ^  al., 1973). Thucydides recognized that 
those people who recovered from the "plague" did not suffer from the same 
disease again. This same awareness during the Middle Ages led to active at­
tempts to induce this kind of immunity against smallpox by inoculating well 
persons with material from skin lesions of infected persons. In the late 
eighteenth century, the English physician, Jenner, made the procedure safer 
when he observed that milkmaids who suffered from cowpox were spared during 
smallpox epidemics. He then demonstrated that vaccination with cowpox pre­
vented infection with smallpox. Pasteur in the 19th century extended 
Jenner's work when he found that inoculation of chickens with an old 
avirulent culture of Pasteurella aviseptica failed to cause the chickens to 
become ill. When the chickens were challenged with a young virulent 
culture, they again failed to become ill. Pasteur proceded to apply this 
observation to many other infectious diseases in other domestic animals and 
effectively developed many protective vaccines. 
After the time of Jenner and Pasteur, immunology as an experimental 
science gradually evolved from bacteriology. Even during this early period 
it was apparent that the body had more than one way of expressing specific 
"protective" immunity and there was considerable debate centered around the 
roles of antibodies and phagocytic cells (Metchnikoff, 1905). This concept 
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of two distinctive immunological responses has persisted and recently has 
been placed on a more rational cellular basis. Present experimental 
immunology has termed the bilateral immune system "cell mediated" and 
"humoral" immunity. Cell mediated reactions are commonly defined as 
those immunological reactions transferable by cells and not serum. These 
reactions include manifestations such as allograft rejection, graft versus 
host disease and protective immunity to pathogens. Humoral immunity is 
defined as those immunological responses transferable by serum. Mani­
festations of humoral immunity include allergic responses and antibody-
mediated protective immunity. However, the term humoral immunity is used 
most commonly to indicate the presence of antibody in the serum. 
One of the most significant advances at the cellular level was to 
realize that the two types of responses of the immune system were a result 
of two distinct types of lymphocytes that mediate them. One of the first 
events that led to the discovery of the bilateral nature of the immune 
system was the accidental discovery of Click £t sd. (1956) that chickens 
which had their bursa of Fabricius removed early in life were very poor 
in making specific antibodies upon immunization but could reject allografts. 
Although this information suggested that there might be two parts to the 
immune system, this was not worked out for almost another decade. Part 
of the difficulty lay in the fact that the technique of removing a thymus 
in a very small animal had not yet been mastered. In 1961, Miller 
demonstrated the technique in mice and observed that this neonatal re­
moval of the thymus markedly depressed rejection of skin allografts. Within 
one year Martinez elt al. (1962) accomplished the technique in rabbits with 
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the same conclusion. Warner and Szenberg (1962) found a similar effect 
in the chicken. Warner et al. (1962) then proposed a separation of bursal 
and thymus-dependent lymphoid systems. However, some of the relationships 
proposed were confusing and had to await the development of better model 
systems. 
In 1966, Cooper ^  extended and strengthened this concept when 
they found that bursectomized chickens were agammaglobulinemic and failed 
to produce antibodies after repeated antigen stimulation. These chickens, 
however, were capable of inducing a graft vs host (GVH) reaction. In 
contrast, the thymectomized chickens in the same experiment had low 
lymphocyte counts and could not produce a GVH reaction. The Ig levels, on 
the other hand, were normal and antibody response to most antigens was 
good. 
The absence of a well-characterized bursa-equivalent in mammals made 
the analysis of mammalian lymphoid cells into two functionally distinct 
parts more arduous. Some of the initial experiments by Osoba and Miller 
(1963) indicated that thymectomy of mice shortly after birth greatly re­
duced the amounts of antibody to sheep red blood cells (SRBC) after 
challenge with this antigen. It was found that immunological competence 
could be partially restored to these mice by implantation of thymus grafts 
enclosed in Millipore chambers. This indicated that the thymus secreted 
some factor required for antibody synthesis to SRBC. This concept of 
thymus restoration was more extensively reviewed later by Miller and Osoba 
(1967). 
Evidence for the bilateral immune system in mammals was initially 
4 
established in the mid-1960s. From their work with irradiated mice, 
Claman et (1966) inferred that two different kinds of cells were 
needed to make antibody. The experiment was to transfer spleen cells 
from a donor mouse to a recipient syngeneic mouse which had been lethally 
irradiated. These mice would then make antibody when stimulated by SRBC 
antigen. However, reconstitution with thymus cells alone would not 
function in a similar experiment. When bone marrow cells were added to the 
transferred thymus cells, then antibody was made. This effect of the 
requirement for thymus cells, bone marrow cells and antigen in irradiated 
recipients for antibody production was called "thymus-marrow synergism." 
Claman from this work then postulated that the bone marrow cells make the 
antibody, and that the thymus cells "help." 
The function of mammalian lymphocytes was further clarified when in 
1968, a set of elegant experiments done in Australia by Miller, Mitchell, 
Nossal and associates was published. The first of the series of experi­
ments (Miller and Mitchell, 1968) examined the capacity of the various 
cell types to restore the IgM antibody response of mice to SRBC. The IgM 
antibody of neonatally thymectomized mice was tested by looking for direct 
plaque forming cells (PFC) against SRBC. In the absence of treatment of 
mice with thoracic duct lymphocytes (TDL) or thymus cells, a very small 
response was noted compared to the sham-operated controls. However, mice 
restored with 50 million TDL or thymus cells gave a response equivalent to 
the controls. It was found that only 10 million F1 hybrid cells, TDL or 
thymus cells, were equivalent to syngeneic cells in restorative capacity. 
Tolerized or irradiated cells were incapable of restoring immunocompetence. 
5 
The most Important experiment of this series was to show that PFC were 
cells of the host animal. This was shown using anti H-2 sera (Mitchell 
and Miller, 1968) and using the T^ chromosomal marker (Nossal et al., 
1968). A neonatally thymectomized recipient CBA/1 mouse restored with 
DBA/l X C57BL/6 F1 hybrid or C57BL/6J thymus or TDL cells plus SRBC had 
the spleen PFC reduced by treatment with anti-CBA/1 sera in the presence 
of complement. Anti-C57BL/6 serum did not accomplish the same result. 
Similarly by use of neonatally thymectomized CBA/1 mice possessing the 
T^ chromosomal marker as recipients it was possible to demonstrate that 
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the PFC were of the host rather than the donor origin. These experiments 
conclusively showed that the bone marrow cells (B cells) were the pre­
cursors of the antibody producing cells and that interaction with thymus 
cells or thymus-derived cells was required for full immune competence. 
This concept was then broadened to include other protein antigens in 
addition to SRBC (Chiller et al., 1970; Rajewsky £t , 1969, Katz et al., 
1970; Miller et al., 1971). 
Roitt et (1969) in an analysis of the "two cell" concept cate­
gorized the distinctive properties of these two types of lymphocytes and 
suggested the terminology 2 cell for thymus-derived lymphocytes and cell 
for "bursa equivalent" derived cells. This terminology has now been 
adopted by all immunologists. 
About the same time Miller and his colleagues in Australia worked on 
the requirements of thymus and bone marrow cells for antibody production, 
Mosier (1967) showed that a suspension of spleen cells from a normal mouse 
would make antibody vitro. However, if the glass-adherent cells were 
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first removed from the spleen cells, no antibody was made indicating a 
requirement for the adherent cells. Glass-adherent cells are macrophage 
or macrophage-like cells. The possible function of macrophages has been 
reviewed by Unanue (1972). He found that a small amount of intact antigen 
remains attached to the outside of the macrophage membrane and that this 
antigen is crucial in initiating immunological responses. In support of 
this, Howard £t (1974) found that Ab/H and Ab/L (high and low respond­
ing mice to SRBC) macrophages show divergence in antigen handling which in 
turn regulates bone marrow cell antibody production. In another study, 
Wiener and Bandieri (1974) demonstrated that these same strains of mice 
showed high and low response to two other antigens, keyhole limpet 
hemocyanin (KLH) and Type 3 pneumococcal polysaccharide complexed with 
methylated bovine serum albumin. A third antigen, levan, elicited the 
same IgM response in both strains of mice. The interesting discovery was 
that the first two antigens were handled by the AbH and AbL macrophages in 
a different manner than was levan. Although Ab/L macrophages took up all 
three antigens faster than Ab/H macrophages, the KLH and the Type 3 
pneumococcal polysaccharide were eventually found in greater quantities, 
and persisted longer, in the Ab/H macrophages. No difference was found 
for the third antigen, levan. This, as well as the evidence cited 
previously (Hosier, 1967) suggests that the macrophages may control the B 
cell antibody response in an extrinsic manner. 
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B. Biochemical and Physical Differences Between T Cells and B Cells 
After it was established that the immune response was the result of 
three main cell types, one of the difficulties encountered was to discern 
one cell type from another. Since macrophages are large polymorphic cells, 
they can be easily distinguished from T and B lymphocytes. However, it was 
not until Raff in 1971 found the theta antigen On T cells that the T 
lymphocytes could be distinguished from the B lymphocytes. The antigen on 
T cells has been subdivided into two classes (Vitetta ^  al., 1973). One 
type Thy-1.1 is characterized by anti-sera made in C3H mice to AKR 
thymocytes and the other type, Thy-1.2, is characterized by anti-sera 
made in AKR mice to C3H thymocytes. The Thy-1 complex has been isolated 
by radioiodination of the cell surface followed by disruption of the 
membrane and specific immunoprecipitation of the complex. The complex is 
composed of protein, lipid, and carbohydrate. The antigenicity of the 
Thy-1 complex was abolished by treatment with nonionic detergent, suggesting 
the presence of lipid. The presence of carbohydrate was shown chemically. 
The M. W. of the complex was determined to be 35,000 daltons by SDS gel 
electrophoresis. 
Another set of antigens has been defined for T cells. These include 
antigens of the Ly system. The Ly system (Cantor and Boyse, 1975) of 
subclasses includes three genetic loci each of which can specify two alterna­
tive alleles. All inbred mice express one or the other alternate allele 
on their thymocytes or T cells. These subclasses of Ly antigens are 
associated with different immunological functions and biological characteris­
tics of peripheral T cells in mice. 
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Raff et al. (1971) and Niederhuber and MBller (1972) found the 
antigen, MBLA (mouse specific B lymphocyte antigen) on B cells. B cells 
are also distinguished by the presence of immunoglobulin on their surface 
(Rabellino ^  , 1971). The isotype of this cell surface immunoglobulin 
on B cells has been found to be IgM (Marchalonis et al., 1972). Recently, 
studies by Vitetta and Uhr (1975) have shown that IgD is also present on 
B cells and may be important as a receptor designed to "trigger" antibody 
production. 
Another surface receptor is present on B cells. This receptor is 
capable of binding aggregated Ig (Paraskevas et al., 1972). These receptors 
bind the Fc part of the Ig complex and not the Fab fragment (Paraskevas ^  
al., 1972). This may account for other classes of antibody besides IgM 
and IgD being found on B cells (Vitetta and Uhr, 1975). There are a number 
of other antigens which have been found on T cells, B cells or both. 
These have been reviewed by Greaves ^  (1974) and by Klein ^  (1974) 
and include, among others, TL, GIX, PC-1, MSPCA, H-2 and The H-2 and 
la antigens will be discussed in more detail later. 
Due to the different properties of T and B cells, methods have been 
devised to separate the two cell types. A rapid method of separating T 
and B cells was devised by Julius et (1973). The mixture of cells is 
passed over a nylon wool column. The B cells adhere to the nylon wool and 
the T cells pass through the column. Although this method does not give 
pure T cells, it does greatly enrich the population of T cells. 
Another method (Truffa-Bachi and Wofsy, 1970; Wofsy et_ a^., 1974) 
has been used to separate antigen binding cells by means of affinity 
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chromatography. Large polyacrylamide beads were chemically modified with 
lac (azo-coupled phenyl-3-lactoside). Spleen cells from mice immunized 
with this antigen were assayed for PFC to lac before and after passing the 
cells over the column. It was found that some of the PFC were retained 
by the column. This method can then be used to separate the antigen 
binding cells from the other lymphocytes. B cells have been implicated 
as the antigen binding cells (Brody, 1970). 
Another method in which cells can be sorted or separated is by 
binding appropriate fluorescein labeled antigen or antibody to the cells 
and sorting them automatically by their fluorescence. This automatic 
fluorescent cell sorting machine (Julius et al., 1973) has been a boon to 
immunologists who can afford it ($85,000). 
Nordling al. (1972), taking advantage of the difference in charge 
between T and B lymphocytes in mouse spleen and lymph nodes, have separated 
these cells into two cell fractions; high mobility and low mobility popula­
tions. The separation was accomplished by preparative free flow electro­
phoresis . The high mobility lymphocytes were sensitive to anti 0 serum 
and complement. The low mobility lymphocytes were sensitive to anti-MBLA 
serum and complement. Thus T cells were more negatively charged as shown 
by their high mobility while B cells were less negatively charged as in­
dicated by their low mobility. The separated cells were still viable as 
they were able to perform biological functions. Nordling e^ al. (1972) 
found that the differences in mobility in T and B lymphocytes was due to 
the number of sialic acid groups exposed on the surface of these lympho­
cytes. Treatment with neuraminidase caused all the lymphocytes to move as 
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one very slow fraction. 
Several articles are recommended as reviews of antigen receptors on 
lymphocytes (Warner, 1974; Bach, 1973; Davie and Paul, 1973; Warner and 
Harris, 1973; Jones and Schlossman, 1974; Paul and Benacerraf, 1974). 
It is now widely believed that the initiation of the lymphocyte 
response to antigens requires the binding of antigenic determinants by 
antibody-like molecules on the cell surface (antigen receptors). Burnet 
(1959) hypothesized that there are many cells capable of producing anti­
body, each with its own unique antigen receptor. Stimulation with antigen 
would cause the clonal proliferation of those cells to which antigen had 
bound. Burnet's "clonal selection theory" is generally accepted, although 
some workers (Cunningham and Pilarshi, 1974) still believe that antigen 
may play an-instructive role in the process of differentiation of antibody 
secreting cells. 
To date, it has been easy to demonstrate the presence of immunoglobulin 
molecules on the surface of B cells as antigen receptors, a wide variety 
of direct and indirect methods have been applied to detect these immuno­
globulin receptor molecules on the cellular surface. The evidence from 
these methods of the presence of immunoglobulin on the surface of B lympho­
cytes and macrophages (Huber £t 1969; Unanue and Askonas, 1968) has 
now been unequivocal. The first and the most direct method that has been 
used in evaluation of an antigen binding receptor is to add a labeled anti­
gen to a cell suspension and observe its binding to cells. Using this 
technique, Naor and Sulitzeanu (1967) found that approximately one out of a 
125 
thousand mouse splenic lymphocytes bound labeled antigen, I-BSA. In 
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another experiment, the binding of antigen (flagellin and polymerized 
flagellin) by cells could be inhibited by prior incubation with anti­
immunoglobulin antibodies to the mouse spleen cell suspension (Warner 
et , 1970; Davie and Paul, 1971). 
The most convincing evidence for immunoglobulin on the cell surface 
of lymphocytes has come from the work done by Vitetta and Uhr (1972) and 
Marchalonis e^ al. (1972). The proteins exposed on the cell surface of 
mouse lymphocytes were labeled with radioactive iodide in the presence of 
lactoperoxidase. The iodide binds covalently to the protein through the 
tyrosine moieties. Labeled proteins were found to be immunoglobulins 
through coprecipitation, in the presence of purified mouse IgG, with rabbit 
anti-mouse Ig. The precipitated Immunoglobulin was then dissolved in 
urea and reduced and alkylated. The polypeptide chains were then identi­
fied by disc gel electrophoresis. 
Raff e^ al. (1970) had demonstrated previously that radiolabeled or 
fluorescent arti-immunoglobulin bound to some" lymphocytes but not all. Only 
approximately one-half of mouse spleen lymphocytes bound the anti-immuno-
globulin antibody. It was also demonstrated that immunoglobulin-bearing 
cells were theta negative and not thymus derived. In similar experiments, 
using fluorescent anti-immunoglobulin to crosslink the immunoglobulin 
receptors, Taylor e^ al. (1971) demonstrated that after the crosslinking 
occurred the immunoglobulins môved through the membranes to polarize at 
one end of the cell ("capping"). After a short time, the "capped" immuno-
globulin-complexes were phagocytized by the cell. Another type of migration 
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was also noticed in which the complexes moved in spots on the cell surface. 
This phenomenon was called "patching." The previously described labeling 
experiment done by Vitetta and Uhr (1972) also suggested, as had the 
"capping and patching" experiments, that cell surface immunoglobulins were 
in a state of flux. After the surface immunoglobulins were labeled as 
before with radioactive iodine, the label appeared in the culture medium 
after a short period of time, suggesting a rapid turnover of the immuno­
globulins . 
One problem inherent in detection of immunoglobulin on the cell sur­
face is whether the cell passively absorbs or actively synthesizes the 
immunoglobulins. Numerous control studies (reviewed by Cooper and Eawton, 
1972) have been used to eliminate the contribution of the passively ab­
sorbed immunoglobulin to their surface. Probably the most convincing 
data are those showing paternal allotype molecules on the surface of rabbit 
lymphocytes from heterozygous neonates before the allotype molecules appear 
in the sera (Sell, 1970). 
Thus, to summarize, there is now compelling evidence from studies with 
several species including mice, chickens, and man that the majority of the 
B lymphocytes have readily detectable cell surface immunoglobulin. The 
evidence is of three kinds: 1) the labeling of Ë cells, 2) the general 
failure to label T cells using the same conditions, and 3) the good 
reciprocal correlation between 0 positive and immunoglobulin-positive cells 
in mice. 
The chemical nature of antigen receptors on T cells is one of the most 
controversial questions in current immunology. Attempts to demonstrate 
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immunoglobulin determinants on the surface of T cells have given remark­
ably variable results. Some of the difficulties involved in looking for 
the T cell antigen receptor are the purity of the T cell preparation (B 
cells contain high density Ig) and the small amount of Ig if any on T 
cells. Most of the direct studies have been done with anti-immunoglobulin 
sera. Nossal e^ (1972) using a very sensitive autoradiographic method 
detected IgM on the mouse T cells. However, this same amount of IgM can 
be found bound to the surface of erythrocytes. Lactoperoxidase iodina-
tion of the surface proteins has also shown IgM presence (Marchalonis et 
al., 1972). HMmmerling and Rajewsky (1971) using a hybrid antibody tech­
nique in which labeled anti-0 and labeled anti-IgM antibodies were used 
simultaneously found that mouse cells were double labeled indicating T 
cells possessed IgM. Although still controversial, Feldman et (1974) 
have presented evidence for the presence of immunoglobulin on T cells. 
These researchers found a specific factor characterized as a complex of 
immunoglobulin-like 8S IgM and antigen. This specific factor was derived 
from sensitized T cells and was required for specific T-B cooperation. 
This immunoglobulin was released by T cells and bound to macrophages which 
then triggered B cells to produce antibody. However, to date the bio­
synthesis of this immunoglobulin has not been proven to occur in T cells 
and may actually occur in B cells and be passively absorbed to the T cells. 
Binz and Wigzell (1975) have demonstrated that the antigen-binding 
receptors on T cells and IgG antibodies with the same antigen-binding 
specificity as the T-cell receptors displayed identical idiotypes. This 
was shown using a system where adult hybrid rats between inbred strains 
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were inoculated with T lymphocytes from one parental strain. Such hy­
brid rats produced antibodies directed against idiotypic determinants 
present on IgG alloantibodies, produced in the T donor genotype line and 
specificity for the alloantigens of this parental strain. In order to 
prove identity between the anti-idiotypic antibodies against the B and T-
cell antigen-binding molecules, the antiserum was absorbed with highly 
purified IgG of the relevant alloantibody. This selectively removed the 
anti-idiotypic activities from the anti-serum towards T cells. The ap­
propriate parental T lymphocytes could remove the activity towards the IgG 
alloantibody. Thus, it was concluded that T and B lymphocytes against a 
given antigenic determinant use receptors with antigen-binding areas coded 
for by the same variable gene subset(s). Thus, it is currently believed 
that at least the variable region of a normal Ig molecule is expressed on 
T cells. 
C. The Function of T and B Cells in Antibody Synthesis 
After the discovery of the basic cells of the immune system, one of the 
main thrusts in immunology has been to study the interactions and regulation 
of cells cooperating to give an immune response. All three cells, T and B 
lymphocytes and macrophages, are required to give antibody production of the 
7S type (IgG). B cells alone can produce 19S (IgM) antibody by stimulation 
with certain antigens. These antigens, or polymeric repeating units such as 
dextran, levan, polymerized flagellin, etc., are called T cell independent 
antigens. Humphrey et al. (1964) was the first to discover this type of 
response using pneumococcal polysaccharide Type III as an antigen. 
These antigens elicit only an IgM antibody response. One exception 
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has been found to this, DNP-lys-ficoll (cross linked sucrose). This 
derivative of ficoll stimulates the production of IgG2 in mice (Sharon ^  
al., 1975). It is now believed that there are two components to ficoll— 
one T cell independent and one T cell dependent (unpublished data, W. E. 
Paul, National Institutes of Health, Bethesda, Maryland). This could ex­
plain the IgGg production stimulated by the DNP-ficoll conjugate. 
However, for most protein antigens, T cells are required to produce 
IgG antibody. This appears to be one of the regulatory roles of T cells 
in antibody production. One of the areas in which the influence of T cells 
is particularly apparent is in the genetically controlled responses of 
mice to the synthetic polymer (T,G)-A—L (McDevitt and Benacerraf, 1969). 
Responder and nonresponder mice to this polymer both produce IgM (19S) anti­
body. However, only the responder mice go on to produce IgG (7S) antibody. 
From this information it appears that when T cells participate in an anti­
body response a definite sequence occurs in which the antibody synthesis 
switches from IgM to IgG production. Further aspects of the control of the 
antibody response to (T,G)-A—L will be discussed later. 
Another effect of T cells is to affect the affinity of antibody pro­
duced. Gershon and Paul (1971) found that adult thymectomized, lethally 
irradiated bone-marrow reconstituted mice, receiving different numbers of 
J 
syngeneic T cells, gave different antibody affinities. The antibody af­
finity increased with increasing numbers of T cells. Different numbers of T 
cells were required for different antigens. The difference in numbers of T 
cells required for restoration of antibody probably reflects a difference in 
numbers of cells specific for each antigen. This evidence argues against the 
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possible passive role of the T cell acting only as an antigen "presenter" 
or "concentrator" for the B cells. 
Perhaps the strongest evidence against antigen presentation being the 
only mechanism of T cell help comes from the studies of Katz et (1971) 
on the so-called "allogeneic effect" (reviewed in Katz and Benacerraf, 1972). 
They have shown that a properly timed graft-versus host (GVH) response but 
not HVG response in guinea pigs can enhance the vivo secondary anti-
hapten response of B cells, even to a hapten on a heterologous carrier, 
thus completely overcoming carrier effects and the need for carrier specific 
T cells. Their finding that DNP coupled to a nonimmunogenic carrier, 
(either D-glutamic acid, D lysine copolymer or poly-L-lysine in genetically 
nonresponder strain 13 guinea pigs), gives a good secondary anti-DNP 
response, in the presence of an ongoing GVH reaction, suggests that the 
effect is directly on hapten-reactive B cells. In the absence of a GVH re­
action, the nonimmunogenic DNP conjugates cause DNP-specific tolerance. 
Thus the GVH response appears to turn a toleragenic signal into an immuno­
genic one for primed hapten-reactive B cells. Interestingly, the allogeneic 
effect in guinea pigs is seen only with primed B cells; attempts to enhance 
primary responses by means of a GVH-reaction have been unsuccessful. In 
addition, nonimmunogenic DNP conjugates induce tolerance in unprimed DNP-
reactive B cells even in the presence of a GVH response. The allogeneic 
effect has also been demonstrated in mice (Kreth and Williamson, 1971). 
However, the allogeneic effect in mice, unlike guinea pigs, appears to be able 
to enhance primary as well as secondary responses (Ordal and Grumet, 1972). 
Although the allogeneic effect demonstrates clearly that the need for 
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carrier-specific T helper cells is bypassed, it is not clear how the 
phenomenon is related to T-B cell collaboration in normal animals. How­
ever, it can be concluded from these experiments that T cells recognize 
the carrier function of an antigen and B cells recognize the hapten 
function of an antigen. 
Recently, jji vitro studies by Feldman (1974) have revealed evidence for 
a mechanism of T-B cooperation in the antibody response to hapten protein 
conjugates. Initial experiments using double chamber flasks demonstrated 
that T/B contact was not necessary for cooperation between mouse T and B 
cells. Populations of KLH activated T cells release, in the presence of 
antigen, a specific factor which binds to macrophages, which in turn stimu­
late B cells to synthesize antibody. It was found in the double chamber 
flask experiment that for antibody synthesis to occur the macrophages had 
to be present in the B cell chamber. After absorption of the KLH activated 
T cell supernatant with sepharose beads conjugated with antimouse Ig anti­
body, it was found that this specific factor (IgT) contained Ig determinants. 
Only viable T cells produced this factor. Feldman e^ (1974) proposed 
several functions for this IgT in T-B cell cooperation. After binding to 
macrophages, IgT antigen complexes trigger B cells to produce antibody. By 
occupying the receptors for IgT on macrophages, these complexes induce the 
release of factors necessary for IgG responses and cause antigen competition. 
If IgT complexes act directly with lymphocytes, specific T cell suppression 
(antibody synthesis is inhibited as a result) occurs. Feldman e^ al. (1974) 
also proposed that IgT, as a T cell receptor, is one of the main regulators 
of specific T-B cell interactions, acting to suppress or trigger an immune 
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response. 
In addition to acting as helper cells to B cells in the production of 
antibody, T cells can function as suppressors of B cells and as killer 
cells, as in a GVH reaction. The name "killer" denotes exactly what these 
T cells do. Cantor and Asofsky (1972) have described this activity of T 
cells in GVH disease in mice. T cell-dependent immunosuppression occurs 
in a wide variety of immunological situations. T cell suppression has 
been shown to play an important role in immunological tolerance (Gershon, 
1974). In this case, T cells apparently shut down B cell antibody 
synthesis. Not only do suppressor T cells act on B cells but they may, 
in fact, induce another set of T cells to suppress B cell function (Eardley 
and Gershon, 1975). Transfer of carrier (KLH) primed immune T cells to 
normal mice suppresses the response to a hapten on that carrier (DNP-KLH). 
However, transfer of such T cells to irradiated mice augments the B cell 
response. This augmentation seen in the irradiated mouse can be suppressed 
by the addition of normal T cells to that mouse. Thus, to summarize, T 
cells can help B cells to produce antibody or T cells can suppress or pre­
vent B cells from producing antibody. Also, T cells can function as killer 
cells to kill foreign cells. There is good evidence (Cantor and Boyse, 1975) 
that T cells performing these different functions possess different surface 
antigens. It is not yet clear whether these cell types are irreversibly 
differentiated, or can be converted, one into another. 
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D. The Genetic Control of the Innnune Response 
Another crucial factor of antigen recognition is a series of auto­
somal dominant genes that exert control over the immune response of animals 
to certain sets of antigens. 
It has been recognized for some time that the susceptibility to toxins 
and infectious agents and the ability to develop allergies is influenced 
by hereditary factors. In Table 1 is shown some selected examples of the 
early recognition of hereditary influences on the susceptibility to in­
fectious agents and on the immune response. However, it was not until 1963 
that immune response genes were truly recognized. Kantor et al. (1963) 
described these immune response genes in their study of the immune response 
of guinea pigs to the DNP conjugates of poly-L-lysine (PLL). Levine et al. 
(1963), through breeding experiments, established that this ability to 
respond, characterized by cellular immunity and sustained antibody synthe­
sis to DNP-PLL, was under the control of a dominant autosomal gene. Inbred 
strain 2 guinea pigs are responders, whereas inbred strain 13 guinea pigs 
are uniformly nonresponders (totally or partially deficient in antibody 
synthesis) to this antigen. The F1 hybrids of these strains were found to 
be responders indicating the dominance of the gene. 
Green et al. in 1966 discovered that nonresponder guinea pigs to DNP-
PLL could be made to respond if the DNP-PLL was complexed with a foreign 
albumin such as BSA. However, when DNP-PLL was complexed to guinea pig 
albumin, the nonresponder animals did not respond. Prior tolerization to 
BSA produced a similar result. Green ^  (1968) later concluded that the 
DNP-PLL behaves as a hapten and the foreign albumin as a carrier. 
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Table 1. The early discoveries of relationship of the Immune response 
and hereditary background 
Animal Infectious Agent Reference 
1. Guinea pig 
2. Human 
3. Guinea pigs 
4. Mice 
5. Mice 
6. Mice 
7. Mice 
8. Mice 
Diptheria toxin 
Protein antigens 
Tuberculosis 
Salmonella infection 
Sheep red blood cells 
Egg albumin. Type I 
pheumococcal poly­
saccharide 
Tetanus toxoid 
Sheep red cells 
Smith, 1905, Scheibel^ 
1943 
Cooke and VanderVeer, 
1916 
Wright and Lewis, 1921 
Gorer and Schutze, 1938 
Stern et , 1956 
Fink and Quinn, 1953 
Ipsen, 1959 
Dineen, 1964 
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The carrier also appeared to be the site of initial recognition of 
innnunogenicity. 
In 1965, Pinchuck and Maurer observed a difference in the response of 
mice to synthetic polymers consisting of 2 or 3 L-amino acids. Copolymers 
induced no response but addition of a third amino acid, even in a small 
amount, induced a response. It was found that only about one-half of the 
Swiss Webster mice immunized would give a response to GLA^. However, as 
the mole percent of the alanine of the polymer was increased, there was 
also an increased percentage of responders. These experiments laid the 
groundwork for further experiments with synthetic polymers using inbred 
strains of mice. 
In the same year, McDevitt and Sela (1965) reported that the ability 
of mice to make antibodies to a branched multichain synthetic polypeptide 
antigen (T,G)-A—L (see Figure 1) was genetically controlled by a dominant 
autosomal gene. C57 mice made a good response to this antigen but CBA mice 
responded poorly. If the synthetic polymer (H»G)-A-r-L was used, the re­
verse occurred. F1 hybrids of these two strains respond well to both anti­
gens. McDevitt and Tyan (1968) then attempted tp demonstrate that the 
response of the F1 hybrids could be transferred by the F1 hybrid cells to 
lethally irradiated parental strains. This experiment showed that the 
immune response to this antigen was directly associated with immunocompetent 
cells. However, in the case of the cell transfer experiments the problem 
of graft versus host disease developed and because of this difficulty, 
studies were undertaken at this point with congenic strains (mouse strains 
with identical genetic backgrounds except for one genetic locus). To the 
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Glu po ly -D,L-Ala  Tyr  
o ly lys ine  backbone 
Glu  po ly -D,L-Ala  Tyr  
tyros ine  
Glu  H is  
po ly lys ine  backbone 
H is  Glu  
h i  s t id ine  
Glu  po ly -D,L-Ala  Phe 
o ly lys ine  backbone-
Glu  po ly -D,L-Ala  Phe 
phenyl  a lan i  ne  
Figure 1. Structure of three branched synthetic polypeptide 
antigens: (T,G)-A—L (top), (H,G)-A—L (middle), 
(Phe,G)-A—L (bottom) 
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surprise of the investigators, mice of the same H-2 type always responded 
similarly. This led to intensive analysis of the relationship between 
immune responsiveness and H-2 type. Congenic mice which were identical in 
every respect except H-2 type were then immunized. It was found that the 
immune response to (T,G)-A—L was directly related-to the. H-2 type of the 
mouse strain (McDevitt and Chinitz, 1969; and McDevitt _et , 1969). 
Since the discovery of the first H-2-linked antigen, the number of 
H-2-linked antigens in mice has grown substantially as is shown in Table 2 
(Benacerraf and McDevitt, 1972; McDevitt and Landy, 1972; Benacerraf and 
Dorf, 1974; Klein, 1975 and Hill and Sercarz, 1975). The three types of 
antigens which have been most useful in the identification of H-2-linked I 
genes are 1) synthetic polypeptides with limited structural heterogeneity, 2) 
alloantigens and 3) complex multideterminant antigens administered in low 
doses which causes recognition of only the most antigenic determinants. 
Mice have been used extensively in these studies because of the avail­
ability of inbred and congenic strains and strains with recombinant events 
at the H-2 locus. 
Examination of the H-2 region on chromosome 17 has revealed that it is 
comprised of four regions, two peripheral regions, K and D, and two central 
regions, I and S (Klein and Shreffler, 1971). This is shown on Figure 2. 
The K and D regions contain genes for controlling the histocompatibility 
antigens, S contains the genes for the Ss serum protein and Sip allotype 
traits, and I includes genes controlling immune responses. The precise 
location of subregions in the I region between K and S was made possible by 
recombinations that have occurred in the I region. The recombinations are 
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OS 
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Table 2b. Explanations and definitions of abbreviations of strains 
cited in Table 2a 
Abbreviation Definition 
synthetic branched multichain polypeptide 
poly-L-(Tyr,Glu)-poly-D,L-Ala-Poly-L-Lys 
synthetic branched multichain polypeptide poly-
L(His,Glu)-poly-D,L-Ala-poly-L-Lys 
benzylpenicilloyl (BPO) conjugate of bovine pan­
creatic ribonuclease (RNAse) 
dinitrophenyl (DNP) conjugate of bovine gamma 
globulin 
ovomucoid 
2,4,6-trinitrophenyl (TNP) conjugate of mouse 
serum albumin (MSA) 
random linear copolymer (L-glu^^L-ala^^L-tyr^^)n 
random linear copolymer (L-glu^^L-ala^®L-tyr^)n 
58 38 
random linear copolymer (L-glu L-lys L-phe^)n 
(the superscript is the molecular ratio of 
amino acids in the polymer) 
TG thyroglobulin 
IgA immunoglobulin A myeloma protein of BALB/c origin 
(MOPC 467) 
IgGfyG. ) immunoglobulin G (yG» ) myeloma protein of BALB/c 
origin (MOPC 173) 
IgH(YG-, ) immunoglobulin G (yG-,) myeloma protein of BALB/c 
origin (MOPC 195) 
Thy-1 thymocyte alloantigen-locus 1 (theta) 
H-Y male histocompatibility antigen 
H-2.2 antigen 2 controlled by the H-2 complex 
(T,G)-A~L 
(H,G)-A~L 
BPO^RNAse 
DNP^gBCG 
OM 
TNP-MSA 
^^ 1^0 
GAT^ 
GL«J 
Table 2b. (continued) 
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Abbreviation Definition 
Ea-1 erythrocyte alloantigen locus 1 
(Phe,G)-A—L synthetic branched multichain polypeptide 
poly-L(Phe,Glu)-poly-D,L-Ala-poly-L-Lys 
OA ovalbumin 
BPO-OA benzylpenicilloyl,(BPO) conjugate of oval­
bumin (OA) 
Sip sex-limited protein 
Nase nuclease from Staphylococcus aureus 
n no response 
1 low response 
m moderate response 
1/m borderline response between low and moderate 
®/h borderline response between moderate and high 
not tested 
1/® tested low by one laboratory and moderate by another 
h recipient carries the same allotype as the immunogen 
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tested for by antlsera made In mice which are different only in the I 
region. This technique was reported by Hauptfeld et (1973). Congenic 
mouse strains different only in the I region were reciprocally immunized 
with spleens, lymph nodes and thymus. The antibodies then detected the I-
gene products from the reciprocal strains. This technique is now used to 
"discover" recombinant strains in the I region. From the use of these 
recombinant strains, many of the H-2-linked antigens have been precisely 
mapped as to which genes control the response to these antigens (Shreffler 
and David, 1975). See Figure 2. 
The immunological traits associated with the I-region of the H-2 
complex are 1) genes controlling the serum antibody response to certain 
antigens, 2) genes controlling structures responsible for allogenic mixed 
lymphocyte stimulation and 3) genes controlling expression of la antigens 
on the lymphocyte membrane. 
Lieberman £t (1972) were the first to recognize that the I region 
was subdivided into at least two subregions. The immune response of mice 
to two myeloma proteins is controlled by H-2-linked Ir genes. Mice of H-2 
types a and k are good responders to the IgA protein while mice of H-2 
types b and d are poor responders. The IgG protein elicits a response 
from H-2^ mice but not from H-2^, H-2^ and H-2^ mice. The congenic mouse 
strain BIO.A (essentially a C57BL/10 of H-2^ type) responds well to the 
IgA but not IgG protein. C57BL/10 (H-2^) responds well to IgG and not the 
IgA protein. As a result of genetic recombination in the H-2 complex be­
tween H-2^ and H-2^ type a small series of mice were produced which were 
congenic to the C57BL/10. 
H-2 regions 
i - » 
K , , 1— 1-
lA IB IC 
Ir genes 
( * * 
Ir-(H,G)-A--L Ir-IgG Ir-GLT 
Ir-l-OA Ir-LDH 
Ir-l-BGG Ir-Nase 
Ir-l-OM Ir-GL* 
Ir— (T, G) —A—L 
Ir-IgA 
Ir-RE 
k * 
Ir-GAT 
Ir-GLPro 
Ir-(Phe,G)-A—L 
Figure 2. Map of ^  genes within the H-2 complex 
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Of these, 5 different recombinant strains were tested; four were good 
responders to one class of myeloma protein and poor responders to the 
other. In each case the gene appeared associated with the "K" end of 
the H-2 complex. However, of the five strains, one, B.lOA 4R, was a good 
responder to both IgA and IgG myeloma proteins. This suggested that a 
crossover event had occurred in the formation of the H-2 complex. The 
event took place somewhere between the genes controlling the response 
to IgA and IgG. This gave strong evidence then that there were two genes, 
one that controlled the IgA response and another that controlled the IgG 
response. The two loci or subregions of the I region were called Ir-IA 
and Ir-IB according to the nomenclature of Klein let al. (1974). In this 
early work the number of recombinant strains produced in this experiment 
was quite small, so it was implied that many more loci might exist. 
During the past few years, a great deal of effort has been put into 
establishing recombinant strains of mice within the H-2 region. An 
abbreviated list of the H-2 type of some of these strains, as well as the 
normal nonrecombinant strains used in the studies described herein is 
shown in Table 3. 
Good evidence for a subregion, I-C, in the I region has been reported 
(David e^ al., 1975b). This subregion has been located-between Ir-IB and S. 
The I-C region was identified serologically by the production of antiserum 
to the antigen la.7. Specifically, (BlOxHTI)Fl mice were immunized with 
B10.A(5R) cells. It is clear from Table 3 that only if an I^C region 
existed would antibody synthesis be elicited. Very recent evidence, from 
two laboratories, has shown that Ir genes are located in the I-C region 
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Table 3. Map of H-2 region for several different H-2 types* 
Strain H-2 Type 
K 
H-2 Region 
Ir-IA Ir-IB S D 
BIO.A.A, a k k k d d d 
C57B46, BIO b b b b b b b 
BALB/c d d d d d d d 
C3H/He, CBA/1 k k k k k k k 
DBA/1 q q q q q q q 
SJL s s s s s s s 
HTH h k k k d d d 
HTI i b b b b b d 
BIO.A (2R) h2 k k k d d b 
BIO.A (4R) h4 k k b b b b 
BIO.A (SE) ±5 b b b d d d 
complete list of all recombinant strains as of 1974, is found in 
Klein, 1975 (pp. 210-211). 
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(Dorf , 1975; Merryman and Maurer, 1975). One of the IT genes is 
involved in controlling the response to the synthetic polypeptide GLd 
(Dorf eit , 1975) and the other is involved in controlling the response 
to GLT (Merryman and Maurer, 1975). As more cross-over mice became avail­
able, more subregions of the I region probably will be identified. It is 
estimated by Shreffler and David (1975) that there are perhaps 20-30 loci 
in the I region. 
Whether la antigens (the group of cell surface proteins whose ex­
pression is regulated by genes mapping in the I region) are expressed on 
T cells or B cells or both is controversial. It has been reported that 
la antigens are found on macrophages (HMmmerling et al., 1974). The 
technique of identifying these proteins with antisera from congenic strains 
is similar to the technique previously described for the identification of 
the I-C subregion. At least ten different la antigens have been described, 
and more will undoubtedly be found as more recombinant strains become 
available. Hauptfeld ^  (1973) originally found these la antigens on 
spleen cells and lymph node cells of B cell origin. Biochemical characteri­
zation of these cellular antigens included examination of SDS-polyacrylamide 
gel electrophoresis after radiolabeling, solubilization with NP-40 and 
precipitation with anti-la sera. These membrane-associated proteins have 
a M.W. of about 30,000 daltons, under reducing conditions (McDevitt et al., 
1974). The la antigens were found to be 100 percent of the total labeled 
proteins and differ from H-2 antigens with respect to size, composition 
and serological reactivity (Cullen et al., 1974). 
Recently, the expression of la antigens has also been shown to be on 
T cells (Delovitch e^ al., 1975; David ^  , 1975a). Howevep, before la 
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antigens were demonstrated on T cells, the T cells were activated allo-
geneically. David et al., (1975e) screened several antlsera to different 
la specificities and found that there was a wide variation in the ex­
pression of the la antigen on T cells. The relationship of the ^  antigens 
to the Ir gene products is still not clear. 
Expression of H-2-linked Ir genes is one of great significance. 
McDevitt and Benacerraf (1969) have hypothesized that the H-2-linked Ir 
gene products were expressed on T cells. Evidence pointing to this fact 
was that a relevant Ir gene was required for cellular immunity. Animals 
which were unable to respond because of the carrier function could be made 
to respond by coupling the antigen to methylated bovine serum albumin. T 
cells recognize the carrier function of an antigen and B cells recognize 
the hapten. 
An even stronger argument in favor of the expression in mice of Ir 
genes on T cells is the finding that the genetically controlled difference 
in the IgG antibody response between high and low responder strains 
immunized with (T,G)-A—L is lost in irradiated thymectomized mice restored 
with syngeneic bone marrow. Both responders and nonresponders produce IgM 
antibody similar to the normal nonresponder (Grumet et , 1971). Another 
line of evidence came from tetraparental mice produced from responder and 
nonresponder parental strains. Some of these tetraparental mice behaved 
as responders and some of these responders produced antibodies of non­
responder allotype (McDevitt and Landy, 1972; McDevitt et al., 1974). 
Although the expression of Ir gene products on T cells has been 
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controversial, evidence in the past few years has accumulated that in 
some cases it is expressed on the B cells. Mozes (1974) using the syn­
thetic polypeptide (T,G)-A—L demonstrated that the low response of 
C3H/HeJ mice was expressed only in the B cells, whereas the genetic de­
fect in the response of SJL mice was reflected in both T and B cells. In 
the polymer (T,G)-A—L, A—L is considered to be the carrier and (T,G) 
the determinant or hapten (See Figure 1). The C3H/HeJ response to the 
(T,G)-A—L was "determinant" specific since this strain of mouse could 
respond to other determinants attached to the A—L backbone; however, the 
SJL mice could not respond to any determinant attached to A—L and thus 
had a carrier defect as well. It was suggested that a determinant 
specific genetic defect is expressed on B cells and an inability to 
recognize or react with the carrier part of the antigen in a T cell defect. 
Dorf e^ al. (1975) have suggested that this effect may be explained by the 
fact that two genes may be involved in Dr gene control of the antibody 
response to this polymer. 
Many questions remain in the Ir gene puzzle. One of the most important 
unanswered questions is the relationship of the l£ gene product(s) to the 
la antigens. To date no good correlation has been found (Shreffler and 
David, 1975). Contributing to this problem is the fact that approximately 
only ten la antigen specificities have been defined (Klein, 1975). When 
more of these antigens are identified, correlations may be found. Another 
important question in the puzzle lies in defining the mechanism of non-
response to the H-2-llnked antigens. Essentially, the question is where is 
the defect and how does the Ir gene product(s) regulate or act in the 
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immune system to cguse expression of response or nonresponse. 
Although a large body of experimental data exists, the mechanism of 
genetic control of the immune response to H-2-linked antigens remains un­
known. However, the possible mechanisms have been narrowed down sub­
stantially. It is clear in the response to (T,G)-A—L that low responsive­
ness is not caused by a nonspecific defect completely unrelated to anti­
body synthesis. The argument used to support this explanation is that the 
low-responding mice can produce antibody to (T,G)-A—L coupled to an immuno­
genic molecule (methylated BSA). Cross tolerance with self-antigens has 
been suggested as a possible basis for nonresponse. However, F1 hybrids of 
responder and nonresponder strains act as responder. Since the F1 hybrids 
possess both sets of antigenic determinants of parental strains, cross 
tolerance does not seem possible as a mechanism of nonresponse to (TCG)-A—L. 
Also, antisera against low responder cells do not bind (TCG)-A—1 (McDevitt 
and Tyan, 1968). 
This leaves two possibilities for the explanation of low responsiveness: 
either the low responding strains are defective in genetic coding for anti­
bodies or a defective antigen-recognition system exists. Since the regions 
coding for antibody chains segregate independently of the H-2 region 
(Herzenberg et al., 1968), the first possibility seems unlikely. The second 
hypothesis, a defective antigen-recognition system seems more likely. This 
defect could involve macrophages, B cells or T cells. All of these cell 
types have receptors for antigen binding on their membranes. Almost all the 
available data show that low response or nonresponse is due to a T cell de­
fect. However, there is no direct proof that the Ir-1 genes are expressed 
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only on T cells. (la antigens are expressed mainly on B cells.) The 
nothing-wrong-with-B-cells evidence comes from experiments in which the 
antigen if coupled to an immunogenic carrier such as MBSA, can induce the 
B cells to respond (McDevitt, 1968). The antibody produced has the same 
specificity in responder and nonresponders. Another experiment using 
tetraparental mice (Freed et , 1973) has shown that low responder B 
cells can produce antibody. In this case T cells of high responder animals 
are Implicated as providing "help" for the low responder B cells. It is 
hypothesized that the low responder T cells remain defective in the tetra­
parental animals. 
Katz e^ (1975) have done experiments with F1 hybrid mice which are 
in conflict with McDevitt's work with tetraparental mice. They have found 
that T and B cells must be of the same H-2 type in order to cooperate 
(produce antibody). In the previously cited work, the high responder and 
low responder cells in the tetraparental mice were of different H-2 types. 
Evidence for T cell defects has been shown by experiments in which 
thymectomy abolishes reactivity of high responder animals (Grumet et al., 
1971). 
Ir-1 gene action can be envisioned as follows. Ir-1 loci code for 
receptors on T cells making them capable of recognizing the carrier portion 
of the antigen while B cells are capable of recognizing only the hapten 
portion. The T cells, with the antigen bound to them react with the B 
cells directly or through macrophage or through soluble factors and stimu­
late them to proliferate and produce antibody. The major thrust of the 
work reported in this thesis was to further elucidate the mechanism of Ir 
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gene action. 
E. The Immune Response of Allophenic Mice 
The use of tetraparental mice as a model system has been recognized 
as a unique approach to explore the control of immune response genes to 
the H-2-linked antigens (McDevitt et al., 1974; Warner et al., 1973b). 
Although tetraparental mice were first produced for studies in developmental 
biology, they have proved to be of tremendous value to immunologists for 
the following reasons: two cell types can be combined in the same animal 
without a graft vs. host reaction since the cells are combined at the 
embryonic state, and cell-types of responder and nonresponder strains can 
coexist in the same environment ^  vivo. 
The technique for production of allophenic or tetraparental mice was 
first performed by Tarkowski (1961) and popularized by Mintz (1962). Mouse 
embryos are collected from superovulated females on the third day after 
mating. The zona pollucida is digested from the embryos and the embryos 
mechanically pushed together, placed at 37°C under a CO^ atmosphere and 
incubated overnight. The embryos are then surgically transferred to an in­
cubator female and allowed to proceed through gestation. Criteria used for 
the production of tetraparental mice will be discussed later. A mouse is 
described as "tetraparental" or "allophenic" if it comes from a known fused 
embryo. It is known that coat color phenotype is not a good indicator of 
chimaerism of many of the internal organs of an allophenic mouse (Wegmann, 
1973). Therefore, it was hypothesized in these studies that coat color may 
not be a good indicator of the lymphocyte population. Since lymphocytes 
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are the antibody producing cells, it is Imperative in any study of the 
immune response of allophenic mice, to know the contribution of each 
parental cell type to the total lymphocyte population. Since techniques 
for the direct determination of the lymphocyte composition were not avail­
able in this laboratory at the time that these experiments were undertaken, 
an alternative method was sought. It was hypothesized in the present study 
that perhaps a good indicator of the composition of the lymphocyte popula­
tion may be the composition of the types of hemoglobin from the red blood 
cells. 
Evidence exists which indicates that red blood cells and small 
lymphocytes arise from the same embryonic cells in guinea pigs. The in 
vivo autoradiographic studies of Osmond and Everett (1964) suggested that 
the committed stem cell or transitional cell in the bone marrow compartment 
is the precursor to the bone marrow small lymphocytes. Yoshida and Osmond 
(1971) presented conclusive evidence that the transitional cells separated 
on a density gradient gave rise by division vitro to the small lympho­
cytes. Rosse (1973) found that transitional cells from the bone marrow 
compartment give rise to erythrocytes. It was found that guinea pigs with 
suppressed erythropoiesis gave an increase in the small lymphocyte pro­
duction. Stimulation of erythropoiesis then resulted in a decrease in the 
production of the small lymphocytes. Also during early stimulation of 
erythropoiesis minimum amounts of hemoglobin, as demonstrated by benzidine 
staining and ^^Fe incorporation, were found in transitional cells. These 
experiments then indicate that the transitional cell compartment of bone 
marrow contains the precursor cell to bone marrow small lymphocytes and 
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erythrocytes. It has been demonstrated that the precursors to both the 
erythrocytes and the small lymphocytes belong to a pool of cells with 
identical morphological characteristics. This then suggests that these 
committed stem cells must have arisen from the same precommitted stem cell. 
Assuming then that the red blood cells are of the same composition 
as the lymphocytes in the allophenic mice, an indirect approach is to look 
at the hemoglobin produced. Hemoglobins from inbred strains of mice gave 
two distinctly different patterns during electrophoresis on paper (Ranney 
and Gluecksohn-Waelsch, 1955). One pattern shows a homogeneous or "single" 
electrophoretic component and the other pattern is heterogeneous or 
"diffuse." Resolution in starch gel is greater than on paper, and several 
investigators have used starch gel electrophoresis to confirm and to extend 
these observations to other strains of mice (Popp, 1963; Russell and 
Gerald, 1958). In 1962, Hutton £t , studied the electrophoretic 
differences found in the hemoglobins of mice and hypothesized that these 
differences were due to changes in the g-chains. The conclusions of Hutton 
and colleagues were confirmed when Oilman (1972) reported the partial se­
quence of the 3 chains of the hemoglobin. The inbred strains of mice which 
have diffuse hemoglobin apparently have an adult g-chain doublet. The two 
3 chains are produced in unequal amounts. The doublet was called Hbb^ 
(diffuse) and strains which possess the 3 chain singlet are called Hbb® 
(single). Morton (1962) discovered a third allele at the 3 chain locus of 
mice, Hbb^, with the p hemolysate bearing resemblance to the d hemolysate. 
The diffuse hemoglobin posseses two structurally different 3 chains; 3 
is produced as about 20 percent of the total and g ^ is produced 
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as 80% of the total, g ^ differs from 3^ in 3 known amino acids, 
positions 13, 20 and 22. A possible difference also exists at position 
139. 0 ^  differs from g ^ in 9 amino acid positions, 9, 16, 20, 
22, 23, 58, 73, 76, and 77. Hbb^ is a variant of the Hbb^ allele since 
Hbb ^ is identical to Hbb ^ However, Hbb ^  differs from 
Hbb ^ in 2 positions (Oilman, 1974) . A small diagram Illustrates 
the number of changes in amino acids from g® of these chains. 
d maj 
11 
p min 
With the Information that inbred strains of mice possess different forms 
of hemoglobin, strains of mice were chosen that had two types of hemoglobin, 
diffuse and single. Since some difficulty is encountered in scanning and 
quantitating starch gels, the use of polyacrylamide slab gels was in­
vestigated. Nakamichi and Raymond (1963) had demonstrated that poly­
acrylamide gels were effective in separating and quantitating pathological 
human hemoglobins. Using this information and exploring the use of 
polyacrylamide gels, it was found that the polyacrylamide slab gels were 
very suitable for scanning and quantitation of the hemoglobin. A pattern 
similar to the one on the starch slab gels was obtained (Oilman, 1974). 
Each inbred strain was characterized as to the type of hemoglobin it 
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possessed. A method then was designed to calculate the contribution of 
each type of hemoglobin in a mixture of hemoglobin from two of the inbred 
strains. The contribution of the hemoglobin from each inbred strain could 
then be determined for the tetraparental mice. 
The tetraparental mice were produced according to the following 
criteria: coat color, H-2 type, response or nonresponse to a particular 
antigen, Hb type, and the allotype of the IgGl produced in the sera. On 
Table 4 is shown the mouse strains used to produce tetraparentals with the 
above parameters. Mice were engineered from these inbred strains so that 
they were different in each of these parameters. 
In order to do meaningful studies with the tetraparental mice, it was 
necessary to carefully characterize the response to the H-2-linked antigens 
of each inbred strain that was used In producing the tetraparental mice. 
The first polymer used, the synthetic polymer dinitrophenyl-poly-
glu^^,lys^®,ala^(DNP-GLA^) was chosen on the basis of the restricted number 
of determinants it would present to the host and the fact that it is an H-2-
linked antigen (personal communication, ?. H. îlaurer and C. F. Merryaan, 
Jefferson Medical College, Philadelphia, Pa.). DNA-GLA^ elicits the type 
of response in which a gap qualitative exists between responder and 
nonresponder mice. This Is an advantage missing from the (G,G)A—L 
system in which there is a continuous range of responses. Mice were 
immunized with DNP-GLA^ in complete Fruend's adjuvant. The Immunization 
schedule and bleeding followed the normal procedure with Freund's 
adjuvant. The tetraparental mice were immunized in the same manner. In­
bred mice Immunized with DNP-GLA^ were challenged further with dinitrophenyl 
47 
bovine serum albumin (DNP-BSA) to see if a response could be induced in 
the mice which had not given a response to DNP-GLA^. All inbred strains 
of mice give a good response to DNP-BSA. Another boosting antigen DNP-
lys-levan was used. Levan is a T cell independent antigen as previously 
described. If the nonresponder mice to DNP-GLA^ gave anti DNP-antibody to 
this antigen after prior immunization with the DNP-GLA^, this would give 
more evidence that the ability to respond or not to respond is related to 
the T cell inability to recognize the antigen. 
Vaz and Levine (1970) described the H-2-link.ed immune response gene 
controlling the response of mice to low dose (1 pg) EGG or DNP-BGG. 
McDevitt ^  al. (1974) have shown the response to DNP-BGG to be located at 
the j[r gene locus Ir-IB. Others (Klein, 1975; Benacerraf and Katz, 1975) 
have placed ^  gene control of low dose BGG in the Ir-IA subregion. The 
immunization schedule followed by Levine involved three intraperitoneal in­
jections of 1 yg of antigen in 1 mg of Al(OH)g gel adjuvant on days 1, 28, 
and 56. Primary, secondary, and tertiary bleedings were then made on days 
8, 35, and 63. Since most other H-2 linked gene controlled antigens 
(Benacerraf and McDevitt, 1972) have been administered in Freund's adjuvant 
followed by an i.p. injection in saline, it was of interest to compare the 
effect of adjuvant on the ability of the inbred strains of mice to respond 
to DNP-BGG. The response to DNP-BGG was compared using complete Freund's 
adjuvant as well as the Al(OH)g gel adjuvant. A comparison was also made 
between the low dose and high dose of DNP-BGG in Al(OH)g gel adjuvant. 
A comparative study was made of the relative affinity of the antibody 
produced among the individual strains. Determination of affinity is a way 
Table 4. Parameters used in producing tetraparental mice 
Inbred Strain Coat H-2 Type Hemo- Response to Response to IgGl 
Color globin DNP-GLA^ 1 yg DNP-BGG Allotype 
A/J albino a/a d/d* Rb R e 
SJL/J albino s/s s/s^ N.R. R b 
A/JxSJL/J 
F1 hybrid 
albino a/s d/s N.D.d R e/b 
BALB/cJ albino d/d d/d R R a 
C3H/HeJ agouti k/k d/d R R a 
CBA/J agouti k/k d/d N.D. R a 
CBA/JxDBA/H-T6J 
F1 hybrid 
agouti k/k d/d N.D. R a 
C57/BL/6J black b/b s/s N.R.® L.R.f b 
DBA/IJ gray q/q d/d N.R. N.R. c 
^Diffuse Hbb^. 
^Responder. 
^Single Hbb®. 
^Hot done. 
^Nonresponder. 
^Low responder. 
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of assessing the binding characteristics of receptors on precursors of 
antibody producing cells (Siskind and Benacerraf, 1969). A difference in 
serum antibody affinity in different mouse strains is a reflection in the 
difference in the population of antibody producing cells. Determination 
of average intrinsic association constants (K^) is very difficult to do 
with mouse sera for the following reasons. 1). The exact amount of serum 
anti-DNP antibody is difficult to determine due to the small amount of 
serum available; 2) there is considerable heterogeneity in the population 
of the serum antibody; 3) calculations require precise values for the 
total concentration of antigen binding sites in the serum; 4) extrapolation 
to infinite ligand concentration to obtain the number of sites has con­
siderable uncertainty in heterogeneous populations. An alternative approach 
which obtains relative affinity values has been demonstrated by Paul and 
Elfenbein (1975). This approach is based upon the capacity of antibodies 
to bind increasing dilutions of antigen. This approach was first suggested 
by Farr (1958). Five different ligand concentrations were used and the 
relative affinity of the antibody was determined using the method of Paul 
and Elfenbein (1975). It is important to point out that the empirical 
relationship to determine affinities yields relative affinities and not 
average intrinsic association constants. 
Grumet ejt al. (1971) found that nonresponding strains to (T,G)-A—L 
do not produce IgG type antibody. With this in mind, the type of antibody 
produced in the mice challenged with DNP-BGG was assayed. The tetraparental 
mice were tested in a similar fashion as the control strains. Thus a 
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study of the amount, affinity, and isotype of antibody produced by inbred 
strains and tetraparental mice in response to DNP-BGG, was determined in 
the present work. 
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II. EXPERIMENTAL METHODS AND PROCEDURES 
A. Preparation of Tetraparental (Allophenic) Mice 
Tetraparental mice were produced by a combination of the methods of 
Mintz (1971), Whitten (personal communication), and Wegmann (personal 
communication). All inbred strains of mice were obtained from the Jackson 
Labs, Bar Harbor, Maine. The CFl mice were obtained from the Carworth Labs, 
Portage, Michigan. The mice were kept in a day-night cycled room with the 
light period from 7:00 a.m. to 9:00 p.m. The temperature was maintained at 
68° - 75° and food and water were ^  libidum. Female mice of the different 
inbred strains (> 6 weeks old) received doses of PMS (Organon) and HCG 
(Nutritional Biochemical,(ICN) Cleveland, Ohio) to stimulate superovulation. 
(See Table 5.) A seasonal variation was noted in the success of super-
ovulation. During the spring and early summer superovulation was not as 
successful as the rest of the year. The 8-cell embryos were collected by 
flushing culture medium through the oviduct of each uterine horn using a 
blunted 30 gauge needle. Embryos of each strain were kept separate under an 
atmosphere of 5% CO^, 5% 0^, 90% N^. After all the embryos had been 
collected for all the strains, the embryos were treated with a 0.5% solution 
of pronase until the zona pellucida disappeared (approximately 8-12 minutes). 
After pronase treatment, the embryos were washed with the culture medium 
three times. Individual embryos of one strain were then placed in droplets 
of culture medium which contained 0.01% of a stock PHA P (Difco) solution. 
One embryo of another strain was then placed with each of the above embryos 
and mechanically bumped into the other embryo. The touching embryos were 
allowed to remain so for 1 minute at 25°C. The fused embryos were washed 
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Table 5. Usual dose of superovxilatlng hormones used for the various inbred 
mouse strains 
Mouse Strain I.U.* of PMS^ I.U. of HCG^ 
A/J 5.0 10.0 
SJL/J 5.0 2.5 
C3H/HeJ 5.0 5.0 
CBA/J 5.0 5.0 
C57BL/6J 5.0 10.0 
DBA/IJ 5.0 10.0 
BALB/cJ 5.0 2.5 
^I.U. = International units. 
^PMS = Pregnant mare serum. 
^^HCG = Human chorionic gonadotropin. 
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once in culture medium and then placed in a microdrop of culture medium 
under paraffin oil (Fisher; 125/135 viscosity) which had been previously 
equilibrated with culture medium without BSA present. Embryos were also 
fused by mechanically bumping them into each other and allowing the touching 
embryos to incubate for 1-2 hours at 37°C under an atmosphere of 5% CO^ , 
5% Og and 90% N^ . After this incubation the embryos were rebumped. PHA P 
was not used in this procedure. (See Table 6 for the components of the 
culture medium, pronase, and PHA P.) The culture plates containing the 
embryos were then placed in a desiccator which was equilibrated with an 
atmosphere of 5% CO^ , 5% Og and 90% for 15 minutes. The embryos were 
incubated overnight at 37°C + 0.2°C. Often this incubation was continued 
until late in the afternoon of the next day or even until the following 
morning of the second day before surgical transfer to another mouse. 
Fusion of two embryos was determined visibly by the increase in size. 
Embryos which were in excess from one mouse strain over another mouse 
strain were treated in the same manner as those which were fused and used 
as control single or unfused embryos. 
The fused and single blastocysts were transferred to CFl pseudopregnant 
foster females that had been mated three days previously with vasectomized 
males. The vasectomized males were prepared by the method of Rafferty (1970) • 
One half inch segment of each of the two vas deferens was removed. The 
tetraparental mice were born 17 days later. If they were not born on the 
calculated due date, they were delivered by Caesarian section and given to 
a female (usually CFl females were used) with a nursing litter that was born 
that day or the previous night. The following types of allophenic mice were 
54 
Table 6. Components of culture medium, pronase, PHA P 
Medium components No. grams/Jl 
Culture Medium 
NaCl 5.140 
KCl 0.356 
KH^ PO^  0.162 
MggSO^  0.294 
NaHCOg 2.106 
Na Pyruvate 0.036 
Glucose 1.000 
Penicillin G, Ksalt 1585 I.U./mg 0.075 
Streptomyocin SO^  750 I.U./mg 0.050 
Ca lactate • 5H2O 0.527 
Na lactate, D-L 60% syrup (Sigma) 3.680 ml/£ 
1% Phenol red 1.000 ml/A 
BSA (crystalline (Sigma)) 3 g 
Sterilize by positive filtration; store at 4°C. The medium is 
stable for one month. 
Pronase 
100 mg pronase (Calbiochem) 
20 mg PVP (polyvinylpyrrolidone) 
20 ml culture medium without BSA 
Dissolve pronase and PVP in culture medium and let stand for 1 hour, 
then filter. Freeze (-20°C) in aliquots. Pronase is stable for 
several months. 
PHA P 
Dissolve 1.69 mg PHA P (phytohemaglutin in P) in 0.1 ml PBS. Dilute 
above stock 1/100 in culture medium immediately before use. Pre­
pare fresh stock solution daily. 
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successfully produced: C57BL/6J C3H/HeJ, C57BL/6J DBA/IJ, 
C3H/HeJ -H. DBA/IJ, C57BL/6J ^  BALB/cJ, SJL/J -M- C3H/HeJ, SJL/J <-+ 
C57BL/6J, C57BL/6J -M- A/JXSJL/J F1 hybrids, C57BL/6J CBA/IJ, C57BL/6J 
-H. CBA/IJ X CBA/H-T6J F1 hybrids, DBA/IJ 4-y A/J x SJL/J F1 hybrids. 
B. Preparation of DNP-conjugates 
1. Preparation of DNP-GLA^  
The synthetic copolymer was prepared as previously described by 
Pinchuck and Maurer (1965a,b). The polymer was the gift of Dr. Paul Maurer, 
Jefferson Medical College, Philadelphia, Pa. It has a molecular weight 
of about 58,000 and contains 57 mole percent glutamic acid (G), 38 mole 
percent lysine (L) and 5 mole percent alanine (A). The polymer was conjuga­
ted in this laboratory with the DNP group as described by Little and Eisen 
(1967). Equal amounts of the polymer GLA^  and potassium carbonate (100 mg 
of each) were dissolved in water such that the polymer concentration was 
2 mg/ml. To obtain a "high conjugation" polymer, an amount of dinitroben-
zene-sulfonic acid (Eastman Chemicals) five times the mole concentration of 
lysine was used in the reaction mixture. To obtain a "low conjugation" 
polymer, an amount of dinitrobenzenesulfonic acid equal to one-tenth the 
mole concentration of lysine was used. The pH of the solution was then 
adjusted to a pH of 10-11 (pH paper) with l.ON NaOH. The reaction mixture 
was covered with parafilm and aluminum foil, to protect the mixture from 
light, and stirred at 37°C for 24 hours. The mixture was then removed and 
dialyzed in the dark at 4°C for 3 days against PBS pH 7.0 (0.14 M NaCl, 0.01 M 
Na^ PO^ ). Three changes of buffer were made. The volume of the solution was 
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measured after dialysis. An amino acid analysis was run on each sample 
to determine the amount of conjugation of DNP to GLA^ . Conjugation was 
determined by the reduction in the number of free lysines for the "high 
conjugation" polymer. However for the "low conjugation" polymer this 
technique was not sensitive enough. The absorption of the "low conjugation" 
polymer at 360 nm was determined. (The molar extinction coefficient for 
e-DNP-lysine at 360 nm is equal to 17,400). The molar concentration of the 
GLA^  was estimated from the original concentration of GLA^ . This value, 
in addition to the value obtained for the molar concentration of DNP-lysine, 
was used to calculate the conjugation of DNP to the GLA^  for the "low con­
jugation" polymer. The above procedure was repeated twice to give Prep I 
and Prep II of both the "high conjugation" and the "low conjugation" 
polymers. 
2. Preparation of DNP-OVA 
DNP-ovalbumin (DNP-OVA) was prepared according to the previously 
described method (Little and Eisen, 1967). Equal amounts of DNBS and OVA 
were used (400 mg of each). After dialyzing for 3 days against PBS pH 7.0 
the DNP-OVA was centrifuged in a desk top clinical centrifuge at speed 
number 6 to remove particulate matter. The amount of protein was then 
determined by the method of Lowry et (1951) using as a standard a known 
concentration of BSA. The number of DNP groups conjugated to the OVA was 
then determined by measuring the absorption at 360 nm. (The molar extinction 
coefficient of e DNP-lysine equals 17,400.) The concentration of DNP-OVA 
was also determined by the method of Eisen (1954). Using this method. 
57 
the dialyzed DNP-OVA was diluted In 0.1 N NaOH and the absorbance read at 
290 and 360 nm. (The extinction coefficient of 1 mg N/ml in 0.1 NaOH for 
DNP-OVA at 290 nm was 13.0; the molar extinction coefficient for DNP-lysine 
equals 17,400.) The molar amount of DNP-OVA were calculated from the value 
at 290 nm and the molar amounts of DNP, from the value at 360 nm. For the 
average number of DNP groups conjugated to each OVA molecule the molar amount 
of DNP was divided by the molar amount of DNP-OVA. A sample calculation is 
provided in the section describing the preparation of DNP BGG. 
3. Preparation of DNP-BSA 
DNP-bovine serum albumin was prepared according to the method pre­
viously described (Little and Eisen, 1967). Equal amounts of DNPS and BSA 
were used (400 mg of each). The DNP-BSA was extensively dialyzed against 
PBS, pH 7.0. Protein was determined by the method of Lowry e_t (1951) 
and the number of DNP groups conjugated to the BSA was determined by 
measuring the absorption at 360 nm. 
4. Preparation of DNP-BGG 
Bovine y  globulins, Cohn fraction II ,  were obtained from Sigma Chemical 
Company. The proteins were conjugated with the DNP group as previously 
described (Little and Eisen 1967). To remove the uncoupled DNP the entire 
reaction mixture (20 ml containing 400 mg of protein) was placed on a 
Sephadex G-25 Column (2.5 cm x 25 cm) and eluted with 0.15 NaCl. 
To determine the degree of conjugation the O.D. at 290 nm and 360 nm was 
determined. (The extinction coefficient of 1 mgN/ml in O.IN NaOH for BGG 
at 290 nm equals 9.7; the molar extinction coefficient for DNP-lysine equals 
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17,400). A 1/101 dilution was made in O.IN NaOH of the DNP-BGG. 
O.D.290 = 0.125 X 101 = 12.6 
O.D.^ gQ = 0.312 X 101 = 31.5 . 
Since the DNP group contributes to the 0'D'2go this value must be corrected 
to determine the amount due to just protein. This contribution of DNP was 
determined previously and found to be 18.2% (Eisen et , 1954). 
12.6 X 0.182 = 2.3 contribution of DNP 
12.6 - 2.3 = 10.3 contribution of BGG 
= 1.06 mgN/ml 
1.06 mg N/ml 
0.16 mg N/ml = 6.64 mg of protein/ml 
1 mg of protein/ml 
6.64 mg of protein/ml 
= 4.16 X 10 ^  M mole/liter 
160,000 (M.W. of BGG) 
O.D. 360 
= 31.5 concentration of DNP 
= 1.81 X 10 ^  moles/liter 
1.81 X 10~^  M DNP 
4.15 X 10~^  M BGG 
= 43.6 or ^  44 average number of 
DNP groups/BGG. 
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5. Preparation of DNP-lyslne-levan 
Native levan (polyfructose) isolated from Bacillus subtilus was a gift 
from Dr. Dexter French. Two fractions were obtained: a more soluble fraction 
(M.W. = 5,500) and a least soluble fraction (M.W. = 74,200). Molecular 
weights were determined by Dr. John Robyt by the analysis of the number of 
reducing ends. Each fraction of the levan was reacted with L-lysine 
according to Fielder et (1970). The 162 mg of levan was dissolved in 
deionized water and cooled to 4°C. While stirring, 9.3 mg of 2, 4, 6 
trichloro—s-triazine in 0.5 ml of dimethyl formamide was added. After 
stirring for 1 hour, 162 mg of L-lysine in 2.0 ml of 0.15 M NaCl was added. 
The mixture was then stirred at 25°C for 1 hour. After diluting with an 
equal volume of deionized water the mixture was held at 4°C for 18 hours. 
The mixture was then dialyzed against deionized water for 2 days. The 
lysine-levan was then treated as GLA^  for coupling to the DNP group, (Little 
and Eisen, 1967) using equal amounts of DNBS and levan (162 mg). The average 
number of moles of DNP per mole of levan was calculated by estimating the 
DNP molarity at 360 nm and the levan molarity from the weight of the poly­
saccharide at the beginning of the reaction using the approximate M.W. of 
each preparation. 
C. Preparation of Adjuvants 
1. A1 (OH)J gel adj uvant 
A modified method of Levine and Vaz was utilized to prepare the A1(0H)2 
gel adjuvant. Equal volumes (500 ml each) of 2N Al2(SO^ )2 (111.0 g/500 ml) 
and 2N NaOH were mixed. The mixture was washed six times with water and 
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centrifuged in a Sorvall centrifuge using the GSA rotor for 2 minutes 
at 1000 RPM. The gel was then washed with 0.15 M NaCl, 0.01 M Tris pH 
7.5 buffer and centrifuged as before. The gel was resuspended in the 
same buffer and put into a Waring Blender for 3 minutes at top speed. 
The gel was stored at room temperature. Separation occurred in the gel 
but re-emulsification restored the gel to its original consistency. 
2. Complete Freund's adjuvant (CFA) 
CFA was obtained from Grand Island Biological Company, Grand Island, 
New York. 
D. Immunization Procedures 
1. Mice 
The mouse strains used for controls in the various immunization 
procedures were virgin females over six weeks old. Groups of at least 5 
mice were immunized. The tetraparental mice were immunized after they 
were eight weeks old. All inbred mouse strains were obtained from Jackson 
Labs, Bar Harbor, Maine. CFl mice were obtained from Carworth Labs, 
Portage, Michigan. 
a. Immunization with DNP-GLA^  The mouse strains used were 
C57BL/6J, C3H/HeJ, DBA/IJ, BALB/cJ, SJL/J, and A/J. The mice were in­
jected with doses varying from 0.07 pg to 82 yg of both the "high" and 
"low" conjugation polymer. The antigen was emulsified in complete Freund's 
adjuvant by pushing the antigen-adjuvant mixture through a T-connection 
made between two syringes or by mixing for 30-60 seconds at high speed in 
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a Virtis 23 mixer. Complete emulslfication was tested by the ability of a 
droplet of emulsion to retain its shape on top of water. The emulsified 
antigen was then injected (26 g needle) into the two rear footpads in a 
total volume of 0.1 ml. The primary injection was given on day 1 and the 
primary bleeding was made on day 10. A secondary injection was given on 
day 21 and the secondary bleeding on day 31. The secondary injection 
contained the same amount of antigen as used in the first injection. It 
was administered in 0.2 ml of water injected i.p. All bleedings were 
made from the orbital venous sinus. The tetraparental mice were immunized 
with either 35 yg or 77 yg of the DNP-GLA^  according to the same immuniza­
tion schedule. 
b. Immunization with DNP-BSA The mouse strains immunized with 
DNP-BSA were the same strains used as those used for DNP-GLA^ . A control 
set of mice of each strain was immunized in a similar manner as with 
DNP-GLA^  with the exceptions that 75 yg of DNP-BSA were used at the primary 
and secondary injections and the secondary injection was given in 0.15 M 
NaCl. Another set of mice which had previously been immunized with either 
"high" or "low" conjugation DNP-GLA^  at doses of 70 yg at the primary in­
jection and 35 yg DNP-GLA^  at the secondary injection, was injected with 
75 yg of DNP-BSA in the same manner as the control mice. The same immuniza­
tion schedule for this set of injections was used as for DNP-GLA^ . 
c. Immunization with DNP-BGG Six mouse strains and two F1 hybrids 
of two of the strains were used. C3H/HeJ, GBA/J, C57BL/6J, BALB/cJ, A/J, 
DBA/IJ, SJL/J, and A/J x SJL/J F1 hybrids were obtained, as usual, from the 
Jackson Labs, Bar Harbor, Maine. GBA/J x CBA/H-T6J F1 hybrids were produced 
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in this laboratory by mating CBA/J females with CBA/H-T6J males. A low 
dose of 1 yg of the DNP-BGG in 1 mg Al(OH)g gel (as determined by dry 
weight) was administered to the mice in a volume of 0.04 ml i.p. at 
each injection. Ten yl of the stock DNP-BGG solution were mixed with 
2.53 ml of the Al(OH)g gel. The high dose of 50 yg DNP-BGG in 10 mg 
Al(OH)g gel was also administered i.p. in a volume of 0.42 ml. 0.16 ml 
of the stock DNP-BGG was thoroughly mixed with 8.48 ml of the Al(OH)^  
gel adjuvant. On day 1 the primary injection was given. The secondary 
injection was on day 29 and the tertiary injection on day 57. On day 36 
and day 64 the secondary and tertiary bleedings were made. A second 
immunization procedure was used in another experiment. The stock DNP-BGG 
was diluted 1:300 and then emulsified 1:1 with CFA. The emulsified mix­
ture was then injected in a total volume of 0.1 ml distributed between 
the two rear footpads. The primary injection was given on day 1 and the 
primary bleeding was made on day 10. A secondary injection was given on 
day 21, and the secondary bleeding on day 31. The secondary injection con­
tained the same amount of antigen as used in the first injection. It was 
administered in 0.1 ml of 0.15 M NaCl, i.p. All bleedings were made from 
the orbital venous sinus. 
The tetraparental mice received 1 yg of the DNP-BGG in 1 mg of 
Al(OH)g gel. The same immunization schedule was used as the one indicated 
for the inbred strains of mice. A fourth and a fifth injection was 
administered to these mice. The fourth injection was given 5 months after 
the 1° injection and the fifth injection was given 6 months after the 1° 
injection. The fourth bleeding was 7 days after the fourth injection and 
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the fifth bleeding was seven days after the fifth Injection. 
d. Immunization with DNP-lys-levan The mouse strains DBA/IJ, 
SJL/J, A/J, BALB/cJ, C3H/HeJ, C57BL/6J, and allophenics of mouse numbers 
3, 3A, 4, 13, 14, 16, 18, 19, 20, 21, 22, 23, 25, 31, 33, and 42 were 
used. (See Results Section). Two doses, 85 yg and 400 yg, of DNP-lys-
levan were administered of the more soluble fraction of the levan. One 
dose 75 yg DNP-lys-levan was administered of the least soluble fraction 
of the levan. The antigen was administered according to the method of Del 
Guercio and Leuchars (1972). The antigen was emulsified in CFA as pre­
viously described and injected in a total volume of 0.1 ml i.p. on day 1. 
The mice were bled on day 8. Two sets of mice were used: 1) those which 
had not been immunized before, and 2) those which had received 35 yg or 
70 yg of DNP-GLA^  in a previous immunization as described previously. 
2. Rabbits 
New Zealand white rabbits were obtained from a local supplier. 
a. Immunization with DNP-BSA DNP-BSA was emulsified as previously 
described with CFA. A total volume of 0.66 ml containing 5 mg of DNP-BSA 
was injected in the two rear foot pads of each rabbit on day 1. The rabbits 
were boosted i.v. with 5 mg of the antigen in 0.15 M NaCl on day 30 and 
45. The rabbits were bled by direct heart puncture on day 50. 
b. Immunization with DNP-BGG The stock DNP-BGG was diluted so that 
after emulsification with CFA the concentration of the emulsion was 0.815 
mg/ml. A total of 1.0 ml was injected into the two rear foot pads of the 
rabbit on day 1. The rabbits were then .boosted on day 27 i. v.. with the 
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same amount of antigen in 0.15 M NaCl. The rabbits were bled on day 41. 
E. Antibody Assays 
1. Amount of DNP-antibody radioactive assay The immune sera were 
assayed for antibody against the DNP group by a modification of the pro­
cedure of Green e_t al. (1969). 50 yl of serum were placed in a 10 x 75 mm 
3 disposable culture tube and mixed with an equal volume of H DNP-lysine 
(1-5 Ci/mM New England Nuclear), ranging in concentration from 1 x 10 ^  M 
to 1 X 10 ^  M, and incubated at 4°C for 1 hour. 200 yl of 66% saturated 
(NH^ )2S0^  pH 5.8 were added to the incubation mixture, mixed and allowed to 
stand for 1/2 hour to 2 hours at 4°C. The tubes were then centrifuged in 
the International PR-2 centrifuge at 2500 rpm (1570 g) for 20 minutes at 
4°C. 100 yl of the supernatant were then counted in 12 ml of Bray's 
solution (4 g PPG, 2.0 g POPOP, 60 g naphthalene, 100 ml methanol, 20 ml 
of ethylene glycol and dioxane to 1 liter) in a liquid scintillation 
counter for 10 minutes. A second set of experiments using the same assay 
procedure was performed. Instead of using 66% saturated (NH^ )^  SO^  pH 5.8 
to precipitate the Igs, 70% or 100% saturated NH^ SO^  was used. Also the pH 
of the (NH^ )2S0^  solution was adjusted to pH 6,8. Serum dilutions for all 
procedures were made in PBS pH 7.0. 
2. Amount of DNP antibody by radial diffusion 
A large pool of CFl mouse sera was accumulated by injecting CFl mice 
with 100 yg of DNP-BGG in CFA according to the immunization schedule 
described previously. This sera was used by T. Berntson in this laboratory 
to do a quantitative precipitin test for DNP-antibody (Eiseji et al., 1954). 
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DNP-BSA was used as a non-cross reacting antigen with DNP-BGG. Each 
tube contained 0.3 ml of mouse serum, 0.15 ml of the DNP-BSA dilution 
and 0.15 ml of streptomycin (100 pg/ml). This was incubated for 1 hour 
at 37°C and for 7 days at 0°C. The tubes were then centrifuged at 2500 
rpm (1510 g) in the International PR-2 centrifuge for 30 minutes at 4°C. 
The precipitates were washed and recentrifuged 2 times with cold 0.15 M 
NaCl (0.3 ml). The precipitate was allowed to drain for 2 minutes and 
then dissolved in 2 ml of 0.1 M NaOH. This was allowed to stand for 1-2 
hours at room temperature. The O.D. at 290 nm and 360 nm was then read 
for each tube. The amount of DNP-antibody was then determined by the 
method of Eisen et aX. (1954). This serum then was used as the control 
known sera for the Mancini technique (Maneini ct al., 1965) as follows. 
3g of Noble Agar (Difco) were melted at 100°C in 100 ml of PBS pH 7.0 made 
0.01% in NaN^  and placed in a 56°C water bath. Dilutions of DNP-OVA and 
DNP-BGG were made such that the concentration of each of these antigens was 
twice that of the final concentration in the diffusion plate. These 
dilutions were warmed to 56°C. The dilutions were made so that the final 
concentration of the antigens was 0.005 mg/ml, 0.01 mg/ml and 0.05 mg/ml. 
After warming to 56°C, the antigen dilutions were mixed 1:1 with the agar. 
The mixtures were poured immediately into diffusion plates. (Miles Labora­
tories, Elkhart, Indiana). Each plate held 10 ml of the mixture. After 
cooling, wells of 3 mm diameters were cut. The agar from the well was then 
aspirated. Care was taken that the plates were poured on a level surface. 
12 pi of the appropriate serum dilution (diluted in PBS pH 7.0) were placed 
in each well. This filled the well completely. The plates were then 
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incubated at 37°C for 3 days in a humid atmosphere. After this time the 
diameter of the ring formed by the antigen antibody precipitate was 
measured with a precision caliper. The diameter squared was plotted vs. 
the Jig per ml of the antibody in the well. Samples of unknown antibody 
concentration were then placed into wells of plates which contained 0.005 
mg/ml of each of the above antigens. The diameter of the sample rings 
were measured in a similar fashion as the controls. The amount of anti­
body in the unknown samples was determined from the plot of the known 
sample. 
3. Antibody affinity assay 
Assays for antibody affinity were performed in the same fashion as 
the previous assay. Sera of the same strain were pooled and dilutions of 
1:5, 1:10, 1:50, 1:100 and 1:200 were made. This set of dilutions was 
used due to the small amount of sera available. The pooled sera were then 
3 tested using five different H-DNP-lysine concentrations. These con-
-6 -7 -7 
centrations were approximately: 1 x 10 M; 5 x 10 M, 1 x 10 M, 
5 X 10 and 1 x 10 ^  M. These concentrations varied slightly depending 
3 
on the concentration of the stock H-DNP-lysine. The antibody affinity 
was then determined by plotting log R vs log K as described by Paul and 
Elfenbein (1975). R is the ratio of the sample antigen binding capacity 
at 33% response divided by the index antigen binding capacity at 33% 
response. 1 x 10 ^  M ^ H-DNP-lysine was used as the index condition. 
Antigen binding capacity at 33% antigen bound (ABC^ )^ equals the reciprocal 
of the dilution at 33% binding of entigen multiplied by one-third of the 
3 total concentration of the H-DNP-lysine in the assay. The association 
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constant is calculated from the following equation 
[(B/F)^  • R • B ] - [(B/F). • B^ ] 
K = 
 ^ (1-R)(B. -B^ ) 
3 in which equals the concentration of one third of the total H-DNP-
lysine concentration at the index condition (1 x 10 ^  M) and B equals the 
3 
concentration of one third of the total H-DNP-lysine concentration at the 
3 test condition. F^  equals the free H-DNP-lysine after 1/2 is bound at 
3 the index condition and F^  equals the free H-DNP-lysine after 1/3 is 
bound at the test conditions. Therefore, it is obvious that the ratio 
B^ /F^  = B^ /F^  = 0.5, and the equation simplifies to: 
K .-fcA . 
 ^ 2(1-R)B^ B^  
Affinity studies were not performed on tetraparental mouse sera. 
4. Amount of anti-DNP IgG 
The amount of anti-DNP IgG present in the sera was determined as 
follows: serial dilutions of the sera 1:2, 1:4, 1:8, 1:16, 1:32 were made. 
Then two 25 yl samples of each dilution were assayed. An equal volume of 
1 X 10 ^  M ^ H DNP-lysine was added to each 10 x 75 mm tube and incubated 
-7 3 for 1 hour at 0°C. The concentration 1 x 10 M H DNP-lysine was chosen 
3 because at this concentration the sera binds the H-DNP-lysine almost as 
_8 3 
well as the 1 x 10 M H-DNP-lysine but gives a greater number of cpm. 
Then to one of the tubes 50 yl of an antimouse IgG prepared in rabbit (Miles 
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Laboratories) were added and to the other tube 100 pi of 90% saturated 
ammonium sulfate were added. After these additions the samples were 
incubated for 3 hours at 37*C and then overnight at 0°C. The samples 
were centrifuged at 2500 rpm (1570 g) for 30 minutes at 4°C in the 
International PR-2 centrifuge and a 50 jjl aliquot of the supernatant of 
each sample was taken and counted as previously described. The anti-DNP 
IgG present in the sera of the tetraparental mice was assayed in the same 
fashion. 
A second method (Schmitt-Verhulst _et , 1974) was used to determine 
the amount of IgG activity in the mouse sera. 2-mercaptcethanol (2-ME) 
was used to Inactivate the IgM present in the mouse sera. Serial dilutions 
of the mouse sera were made (1:2, 1:4, 1:8, 1:16, 1:32, 1:64, 1:128, 
1:256, and 1:512). 
Each of these dilutions was made 0.005 M in 2-ME and allowed to incu­
bate for 1 hour at room temperature. Then iodoacetamide was added so as 
to make a final concentration of 0.1 M. The mixture was allowed to in­
cubate for another 20 minutes at room temperature. Then to each of the 
-8 3 dilutions 50 yl of 5 x 10 M H DNP-lysine were added and the reaction 
mixture was incubated at 4®C for 1 hour. 200 pi of 70% saturated (NH^ )2S0^  
pH 6.8 were added to the mixture. The mixture was then allowed to remain 
in the cold for 1 hour. 100 jil allquots were taken from each tube and 
counted as previously described. Control tubes containing dilutions of 
normal sera were treated similarly. The dilution at which 33% of the 
-^DNP lysine was bound was determined to the nearest logg. 
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F. Preparation and Characterization of Mouse Hemoglobin 
1. Preparation of the hemoglobin 
Mouse hemoglobin was prepared by a modification of the method of 
Clegg and Schroeder (1959). Approximately 0.125 ml of blood was drawn 
from each mouse and mixed with 0.025 ml of cold 3.2% sodium citrate solu­
tion, pH 5.5. The mixture was rapidly cooled to 4°C in an ice bath. For 
the rest of the procedure the samples were kept at 4°C. The blood was 
then centrifuged for 1 minute in a Beckman microfuge to separate the 
plasma from the red blood cells. The red blood cells were then washed 
three times with a volume of 0.15 M NaCl approximately equal to the packed 
volume of cells. The cells were then lysed with a volume of distilled 
water equal to the packed volume of the cells. The lysed cells were then 
centrifuged for 5 minutes to pellet the cellular debris. The supernatant 
which contained the hemoglobin was decanted and made approximately five 
percent in sucrose by the addition of twenty percent sucrose. This solution 
was then recentrifuged for five minutes and the supernatant decanted and 
used as the sample. The protein content of the supernatant was measured 
by the method of Lowry e^  (1951). A standard curve was then made of 
the optical density at 550 nm vs. the concentration of the hemoglobin (see 
Figure 3). Equal amounts (as determined by protein determination) of Hbb 
from different mouse strains gave identical O.D. readings at 550 nm. This 
curve was then used to measure the amount of hemoglobin present in future 
samples. The hemoglobin was then diluted with twenty percent sucrose to 
1.0 pg per yl for immediate application to the polyacrylamide slab gel. 
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Figure 3. The optical density at 550 nra plotted vs. the concentration of 
the Hb. The amount of Hb was determined by a protein 
determination by the method of Lowry 
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2. Characterization of the hemoglobin 
Bisacrylamide and acrylamlde (Eastman Kodak) were recrystallized 
twice according to the procedure of Loening (1967). A modified gel formu­
lation of Gabriel (1971) was used in preparing the slab gel. 14.0 g 
of the twice recrystallized acrylamlde and 0.367 g of the twice re-
crystallized bisacrylamide were dissolved in approximately 150 ml of a 
Tris buffer (46 g/1) pH 8.9. Then 0.2 ml of N,N,N,N^ -tetramethylethylene-
diamine (TMED) Eastman Kodak) were added to the acrylamlde, bisacrylamide 
solution and the final volume of the entire solution was brought to 200 ml. 
This solution could be stored 1 month at 4°C without deterioration. 0.1 g 
ammonium persulfate catalyst was added per 100 ml of the acrylamlde solution 
just before using. It was necessary to warm the solution to room tempera-r 
ture before adding the catalyst to avoid the formation of minute bubbles 
in the polymerized gel. The slab gels were formed in a Bio-Rad Model 220 
Vertical Slab Gel Electrophoresis cell. The electrode chamber buffer was 
made up as a 2Ox stock solution and diluted and cooled to 4°C before 
using. The final concentration was 1.2 g of Tris and 5.8 g of glycine per 
2 liters and the pH was 8.3. Appropriate amounts, between 12.5 pg and 
50 yg, of hemoglobin were applied with a Hamilton syringe into the pre­
formed slots under the electrode chamber buffer. 
The slab gels were pre-electrophoresized for 1/2 hour at constant 
voltage of 200 V (30-50 ma), before the application of the samples. 
After application, the samples were run for 3-1/2 hours at a constant 
voltage of 200 V (approximately 50 ma of current). A standard of 
50 ug of C57BL/6J Hbb was run on each slab gel. After completion of the 
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run, the gels were removed and Immediately stained with a peroxidase 
strain for thirty minutes. The peroxidase stain consisted of 200 mg of 
dimethoxybenzidine dissolved in 5 ml of glacial acetic acid then made 
up to 100 ml with distilled water. 0.1 ml of 30% hydrogen peroxide was 
added immediately before using. This stain is specific for the heme 
group of hemoglobin. The gels were then destained in a solvent made up 
of one part acetic acid five parts methanol and five parts water for 
approximately one to two days. The gels were then cut into strips approxi­
mately 0.8 cm wide and scanned with a gel scanning attachment for a Zeiss 
spectrophotometer at 550 nm with a slit width of 0.02 mm. The scanning 
speed was 20 mm/min and the chart speed was 1 inch/40 seconds. 
The peak heights and the peak widths were then measured. , The peak 
widths were measured by drawing tangents to the curves at 0.15 O.D.^ ^Q and 
measuring the distance between these tangents at the base line of the 
scan. This eliminated the problem of measuring the base width while 
scanning at different O.D. settings on the scanner. The area under the 
peak was measured by an integrator attached to the recorder. The area of 
the peaks and the peak heights were then plotted vs. the amount of Hbb 
applied to the gel. The height (h) of the peak was divided by the width 
(w) of the peak to give a ratio (h/w). The amount applied to the gel slot 
Was then plotted vs. this ratio. 
To correct for small variances in the staining procedure and in the 
amount of time the gels were electrophoresed a standard of 50 yg of 
C57BL/6J Hbb was run with each slab gel. The ratio (h/w) of this standard 
was used to determine the amount of Hbb that was detected on the gel by 
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using the plot of amount of Hbb vs. the ratio (h/w). In addition to 
this standard, the component types of Hbb of the mixed samples were always 
run on the same gel. Again like the standard, the amount of Hbb actually 
detected could be determined. This could be used as a correction factor 
then for the total amount of the mixed samples. The Hbb types (single 
or diffuse) for the mouse strains used in these studies are shown in 
Table 7. 
Samples of mixed hemoglobins were made of the ratios in 10/90, 20/80, 
40/60, 25/75, 50/50, 60/40, 75/25, 80/20, and 90/10 for each of the 
following strain combinations: C57BL/6J with BALB/cJ, C57BL/6J with 
C3H/HeJ, C57BL/6J with A/JxSJL/J F1 hybrids and C57BL/6J with DBA/IJ. 
A total of 50 yg was always applied to the gel. A h/w ratio was calcula­
ted for each sample. The amount of C57BL/6J Hbb in the mixed sample was 
plotted vs. the h/w ratio for the mixed sample. This was plotted on the 
sample plot as the two component Hbbs. 
Two amounts of Hbb, 35 vg and 50 ug, were run for each tetraparental 
mouse. The h/w ratio was calculated for each of those samples and the 
amount of C57BL/6J Hbb was determined from the experimental curves. 
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Table 7. The Hbb type of the Inbred strains of mice 
Mouse Strain Hbb^  type 
A/J d/d^  
SJL/J s/gC 
A/JXSJL/J F1 hybrid d/s 
C3H/HeJ d/d 
BALE/c J d/d 
C57BL/6J s/s 
DBA/IJ d/d 
H^bb Hemoglobin, 
d^ diffuse Hbb. 
single Hbb. 
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III. RESULTS 
A. Tetraparental Mice Produced 
The sex, genotype, and the coat color phenotype of the tetraparental 
mice produced which survived to adulthood are shown in Table 8. It is 
seen that 25 of the 50 tetraparental mice were multicolored. There were 22 
males (9 multicolored) and 28 females (16 multicolored). Table 9 shows 
mice which were born from embryos that were not fused. Also included are 
mice born by natural birth to a mother containing both fused and unfused 
embryos. None of these mice were multicolored, but some may be allophenic 
(IF, 2F, 3F, G, I). Eighty-seven experiments were performed. In these 
experiments 16,000 embryos were collected from % 3,300 mice. Of these 
52% were good embryos. Of these good embryos, 16% were fused and 85% of 
these fused embryos were suitable for transfer to the pseudopregnant CFl 
females. In later experiments the embryos were treated with PHA P prior to 
fusion. This increased the percent of fused embryos to 85%. The percent 
of mice born from fused embryos was 11% and of these 65% survived to 
adulthood. 
B. Characterization of the DNP Conjugates 
Table 10 contains a list of all the polymers used in preparing the DNP-
conjugates as well as the amount of conjugation and concentration. In the 
following sections, the method of calculation for each polymer is described. 
1. DNP-GLA^  
Both the concentration and the degree of conjugation of the stock 
solutions of the "high-conjugation" and the "low-conjugation" polymers were 
Table 8. Complete list of tetraparental mice produced from June 1972 - July 1973 
Mouse # Sex Genotype Coat color phenotype ^  Foster Nursing 
3 (f C57BL/6J4+C3H/HeJ 100% C57BL/6J CFl (CS) b CFl 
4 ? C57BL/6J<+C3H/HeJ 20% C57BL/6J, 80% C3H/HeJ CFl (CS) P® 474 
13 C57BL/6J<+C3H/HeJ 100% C57BL/6J CFl (CS) ps 474 
14 à* C5.7BL/6J-H-c3H/HeJ 95% C57BL/6J, 5% C3H/HeJ CFl (CS) P® 474 
21 ? C57BL/6J-ODBA/1J 80% C57BL/6J, 20% DBA/IJ CFl (CS) P® 474 
22 ? C3H/HeJ4+CFl 100% CFl CEI (NB) c CFl 
23 ? C3H/HeJ<+CFl 20% C3H/HeJ, 80% CFl CFl (NB) CFl 
24 C3H/HeJ-H-CFl 30% C3H/HeJ, 70% CFl CFl (NB) CFl 
25 if C3H/HeJ<+CFl 20% C3H/HeJ, 80% CFl CFl (NB) CFl 
26 $ SJL/J -«•C57BL/6J 20% SJL/J, 80% C57BL/6J CFl (CS) CFl 
27 9 SJL/J^ C57BL/6J 60% SJL/J, 40% C57BL/6J CFl (CS) CFl 
29 ? C57BL/6J<+C3H/HeJ 100% C57BL/6J CFl (CS) CFl 
30 9 C57BL/6J<+C3H/HeJ 100% C57BL/6J CFl (CS) CFl 
31 % C3H/HeJ -h-DBA/U 5% C3H/HeJ, 95% DBA/IJ CFl (CS) CFl 
33 9 C57BL/6J-H-BALB/CJ 60% C57BL/6J, 40% BALB/cJ CFl (NB) CFl 
34 Î C57BL/6J<+BALB/cJ 100% C57BL/6J CFl (NB) CFl 
35 9 C57BL/6J<+BALB/cJ 100% C57BL/6J CFl (NB) CFl 
36 C57BL/6J<+BALB/cJ 100% C57BL/6J CFl (NB) CFl 
37 C57BL/6J-H-BALB/CJ 100% C57BL/6J CFl (NB) CFl 
38 d* C57BL/6J-H-BALB/CJ 100% C57BL/6J CFl (NB) CFl 
39 C57BL/6J -«-BALB/cJ 100% C57BL/6J CFl (CS) CFl 
D^etermined visually by observing the two coat colors at weaning, 
bcs, delivered by Caesarian section. 
N^B, born naturally. 
Table 8. continued 
Mouse # Sex Genotype _ Coat color phenotype ® Foster Nursing 
42 9 C57BL/6J-H-BALB/CJ 70% C57BL/6J, 30% BALB/cJ CFl (CS) CFl 
43 C57BL/6J<»C3H/HeJ 100% C57BL/6J CFl (CS) CFl 
44 <? C57BL/6J<+BALB/cJ 95% C57BL/6J, 5% BALB/cJ CFl (CS) C57BL/6J 
45 DBA/IJ -H-C57BL/6J 70% DBA/IJ, 30% C57BL/6J CFl (CS) CFl 
46 C57BL/6J-«-BALB/cJ 60% C57BL/6J, 40% BALB/cJ CFl (CS) CFl 
47 $ C3H/HeJ<+C57BL/6J 100% C57BL/6J CFl (CS) CFl 
48 9 C3H/HeJ -H-C57BL/6 J 60% C3H/HeJ, 40% C57BL/6J CFl (CS) CFl 
49 9 C57BL/6J-H-A/J X SJL/J 100% A/J X SJL/J CFl (CS) CFl 
50 C57BL/6J<+A/J X SJL/J 100% A/J X SJL/J CFl (CS) CFl 
51 9 C3H/Hej4+C57BL/6J 100% C57BL/6J CFl (CS) CFl 
52 9 DBA/1J<+A/J X SJL/J 100 A/J X SJL/J CFl (NB) CFl 
53 9 DBA/U-H-A/J X SJL/J 90% DBA/IJ, 10% A/J X SJL/J CFl (NB) CFl 
54 DBA/IJ^ A/J X SJL/J 100% DBA/IJ CFl (NB) CFl 
55 DBA/U-H-A/J X SJL/J 80% A/J X SJL/J, 20% DBA/IJ CFl (NB) CFl 
56 9 DBA/lJ-w-A/J X SJL/J 60% A/J X SJL/J, 40% DBA/IJ CFl (CS) CFl 
57 C3H/HeJ -H-C57BL/6J 100% C57BL/6J CFl (CS) CFl 
58 9 C57BL/6J-H.A/J X SJL/J 95% A/J J: SJL/J, 5% C57BL/6J CFl (NB) CFl 
59 9 C57BL/6J<+A/J X SJL/J 100% A/J >: SJL/J CFl (NB) CFl 
60 9 C57BL/6J-wA/J x SJL/J 100% A/J X SJL/J CFl (NB) CFl 
61 9 C57BL/6J-H-A/J X SJL/J 100% C57BL/6J CFl (NB) CFl 
62 9 C57BL/6J-H-A/J X SJL/J 50% A/J X SJL/J, 50% C57BL/6J CFl (NB) CFl 
63 9 C57BL/6J-H-A/J X SJL/J 40% A/J X SJL/J, 50% C57BL/6J CFl (NB) CFl 
64 C57BL/6J-H.A/J X SJL/J 95% A/J X SJL/J, 5% C57BL/6J CFl (NB) CFl 
65 ? C57BL/6J<+A/J X SJL/J 70% C57BL/6J, 30% A/J x SJL/J CFl (CS) CFl 
66 « C57BL/6J<+A/J X SJL/J 70% C57BL/6J, 30% A/J x SJL/J CFl (CS) CFl 
67 C57BL/6J-H-A/J X SJL/J 100% A/J X SJl/J CFl (NB) CFl 
68 d* C57BL/6J-H-A/J X SJL/J 80% C57BL/6J, 20% A/J x SJL/J CFl (NB) CFl 
69 C57BL/6J<+A/J X SJL/J 100% C57BL/6J CFl (NB) CFl 
70 C3H/HeJ •MC57BL/6J 100% C3H/HeJ CFl (CS) CFl 
Table 9. Mice produced from fused or unfused embryos 
Mouse # Sex Genotype Coat color phenotype & Foster Nursing 
IF ? C57BL/6J or C57BL/6J-H-DBA/1J^ 100% C57BL/6J DBA/IJ (NB) c DBA/IJ 
2F 9 C57BL/6J or C57BL/6J-H-DBA/U^ 100% C57BL/6J DBA/IJ (NB) DBA/IJ 
3F ? C57BL/6J or C57BL/6J-h-dbA/U 100% C57BL/6J DBA/IJ (NB) DBA/IJ 
IM <r C57BL/6J 100% C57BL/6J DBA/IJ (NB) DBA/IJ 
2M C57BL/6J 100% C57BL/6J DBA/IJ (NB) DBA/IJ 
3M <r C57BL/6J 100% C57BL/6J DBA/IJ (NB) DBA/IJ 
F <r C3H/HeJ 100% C3H/HeJ CFl (CS) CFl 
G (f A/J-H-C57BL/6J or C57BL/6J 100% C57BL/6J CFl (NB) CFl 
H A/J X SJL/J 100% A/J X SJL/J CFl (CS) CFl 
I C57BL/6J or C57BL/6J<+DBA/1J° 100% C57BL/6J CFl (NB) CFl 
J C57BL/6J X DBA/IJ 100% C57BL/6J DBA/IJ (NB) CFl 
16 9 C3H/HeJ 100% C3H/HeJ CFl (CS) CFl 
18 C57BL/6J 100% C57BL/6J CFl (CS) CFl 
19 C57BL/6J 100% C57BL/6J CFl (CS) BALB/cJ 
20 C57BL/6J 100% C57BL/6J CFl (CS) BALB/cJ 
D^etermined visually by observing the two coat colors at weaning. 
°Born naturally of a mother containing both fused and unfused embryos. 
N^B, born naturally. 
C^S, delivered by Caesarian section. 
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Table 10. The DNP-conjugates prepared with the average number of DNP 
groups conjugated to the carrier molecule and the concentra­
tion of the conjugated molecules 
Average # of Concentration 
DNP-conjugate DNP/carrier in mg/ml 
molecule 
DNP-GLA^  (high conj.) Prep I 165 1.39 
DNP-GLA^  (low conj<) Prep I £.22 1.63 
DNP-GLA^  (high conj.) Prep II 119 1.53 
DNP-GLA^  (low conj.) Prep II 9 1.94 
DNP-OVA 14.4 13.4 
DNP-BSA 28.7 18.3 
DNP-BGG 43.6 6.53 
DNP-lys levan (least sol.) 0.3 ~8.5 
DNP-lys levan (more sol.) 0.1 ~8.5 
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analyzed by amino acid analysis. Prep I "high-conjugation" polymer was 
found to have a concentration of 1.39 mg/ml, while the "low-conjugation 
polymer was found to have a concentration of 1.63 mg/ml. Prep II "high-
conjugation" polymer had a concentration of 1.53 mg/ml, while the "low 
conjugation" polymer had a concentration of 1.94 mg/ml. The data from 
the amino acid analysis of all four polymers are shown in Table 11. The 
degree of conjugation of the "high-conjugation" polymer was simply determined 
by comparing the residual lysine to the original (theoretical) lysine. The 
amount of lysine which had disappeared was presumably that which was 
derivatized as DNP-lysine. For Prep I this value is 2.63 ymoles, which was 
equivalent to 75% substitution of the lysine groups in the original 
polymer. For Prep II, the percentage of substitution of lysine was 54%. 
These values were further checked by taking the ^ •'^ •360nm* Using a molar 
extinction coefficient for e-DNP-lysine of 17,400 at 360 nm, one can calcu­
late the amount of lysine which is substituted with the DNP group. The 
O.D.360njjj gave a value of 75% substitution for Prep I and 46% substitution 
for Prep II. Thus, the two methods, amino acid analysis and absorption 
spectroscopy, show good agreement for the degree of substitution of the 
"high-conjugation" polymers. 
Unfortunately the "low conjugation" polymer was not amenable to this 
exact analysis. The solution was visibly yellow, but the degree of 
substitution (necessarily 10% from the method of preparation) could not be 
determined by amino acid analysis,since the error of the analysis is 
apparently greater than the degree of substitution. Prep I was not sub­
jected to absorption spectroscopy, so it can only be said that the degree of 
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Table 11. Amino acid analysis of high- and low-conjugation DNP-GLA^  
Polymer Amino Acid Experimental Theoretical 
ymoles ymoles 
Prep I 
"High-conj ugation" Lysine 
Glutamic acid 
Alanine 
0.879 
5.51 
0.623 
3.51 
5.51 
0.623 
"Low-conj ugation" Lysine 
Glutamic acid 
Alanine 
4.36 
6.47 
0.642 
4.13 
6.47 
0.642 
Prep II 
"High-conj ugation" Lysine 
Glutamic acid 
Alanine 
1.79 
6.10 
0.619 
3.89 
6.10 
0.619 
"Low-conj ugation" Lysine 
Glutamic acid 
Alanine 
5.17 
7.82 
0.708 
4.99 
7.82 
0.708 
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substitution was > 0% and < 10%. Prep II was subjected to absorption 
spectroscopy and 4% of the lysine residues of this polymer were calcu­
lated to be substituted with the DNP group. Table 10 shows the number of 
DNP groups/GLA^  molecule, calculated from the known M.W. of the polymer, 
the mole percent lysine, and derivatized lysine. 
2. DNP-OVA 
The protein concentration of the DNP-OVA was found to be 13.4 mg/ml 
by the method of Lowry et (1951). By the method of Eisen et (1954) 
the concentration was determined to be 14.4 mg/ml and to have 14.4 DNP 
groups coupled to each ovalbumin molecule. 
3. DNP-BSA 
Since Q.IM NaOH precipitated the DNP-BSA, the DNP-BSA was diluted in 
H^ O and the absorbance read at 360 nm to determine the concentration of 
DNP. The protein concentration was found to be 18.3 mg/ml and the number 
of DNP groups per BSA molecule was determined to be 28.7. 
4. DNP-BGG 
The number of DNP groups coupled to the bovine y globulin was calcu­
lated as described by Eisen £l. (1954). The O.D.^ q^ and O.D.2gQ were 
read in 0.1 M NaOH. The molar extinction coefficient of DNP-lysine (17,400 
at 360 nm) was used to calculate the amount of DNP conjugated to the BGG. 
The extinction coefficient of BGG (9.7 for 1 mg N/ml at 290 nm) was used to 
calculate the amount of BGG. The contribution of DNP to the absorbance at 
290 nm was calculated as previously described (Eisen e^  al., 1954). The 
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average number of DNP groups conjugated to a molecule of BGG was found to 
be 43.6. The concentration of the stock solution of DNP-BGG was 6.53 
mg/ml. 
5. DNP-lys-levan 
The absorbance at 360 nm was observed for the DNP-lys-levan to 
calculate the molarity of the DNP present. The original amount of levan 
to prepare the conjugate was used to determine the molarity of levan. The 
average MW for each fraction was used in determining this molarity. For 
the least soluble fraction the number of DNP groups per levan molecule was 
approximated as 0.3 DNP groups per levan molecule and for the more soluble 
fraction, 0.1 DNP groups per levan molecule. 
Table 10 contains a list of all the polymers used in preparing the DNP-
conjugates as well as the amount of conjugation and concentration. 
C. Percent Response of the Mice to the DNP-Conjugates 
The amount of anti-DNP antibody in a serum sample is defined as the 
3 percentage of H-DNP-lysine bound during the assay procedure as follows: 
3 % H-DNP-lysine bound = % response = 
cpm in normal serum - cpm in ingpune serum  ^
cpm in normal serum 
The error in the assay has been determined to be less than + 5 percent 
(Warner e^  , 1973a). Two different sets of assay conditions were used 
in the experiments described in this thesis. In the earlier part of the 
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work, 66% saturated (NH^ gSO^ , pH 5.8, was used to precipitate the 
3 
H-DNP-lys-antibody complex. In the latter part of this work, 70% satura-
3 
ted pH 6.8, was used to precipitate the H-DNP-lys-antibody 
complex. Figure 4 shows the difference observed between the two assay 
conditions. An increase of the serum dilution (1/512) using 70% sat. 
(NH^ )^ SO^  pH 6.8 from the serum dilution (1/64) using 66% sat. (NH^ )2S0^  
pH 5.8 at 33% response was noted. (The data shown in Figure 4 is un­
published data using rabbit serum against DNP-BGG collected by Robert 
Newton in this laboratory). 
3 The optimal time for incubation of the antibody with H-DNP-lysine-
was found to be 1 hour (Robert Newton, unpublished observations). The 
optimal time for incubation with (NH^ ÏgSO^  was found to be 1 hour (Robert 
Newton, unpublished observations). 
1. The DNP-antibody response of inbred strains to DNP-GLA^ , [66% sat. 
(NH^ )2S0^ ] 
a. Primary response to DNP (Prep I polymers used as antigens) A 
plot of the percent response (defined above) vs. the dose of antigen for the 
"low-conjugation" polymer is shown in Figure 5. A plot of the percent 
response vs. the dose of antigen for the "high-conjugation" polymer is 
shown in Figure 6. The primary response of individual mice is shown. 
b. Secondary response to DNP (Prep 2 polymers used as antigens) A 
plot of the percent response vs. the dose of antigen for the "low conjuga­
tion" polymer is shown in Figure 7. A plot of the percent response vs. the 
dose of antigen for the "high-conjugation" polymer is shown in Figure 8. 
Figure 4. Dilution curves of rabbit anti DNP antibody prepared 
against DNP-BGG. The assay conditions are shown in 
which 66% sat. (M ) SO pH 5.8 (•); 66% sat. (NH,)2S0 
pH 6.8 (•); 100% sat. (NH.i.SO, pH 5.8 (A); and 
100% sat. (NH,)2S0, pH 6.8 (•) was used to precipitate the 
antibody-^ H-DNP lysine complex 
86 
105 
LU 
LU 
0.903 1505 2.107 2.709 
LOG (l/SERUM DILUTION ) 
Figure 5. The analysis of individual (circles) and pooled 
(squares) sera from C3H/HeJ (0,0) and C57BL/6J 
(f, • ) mice at the primary response to varying 
doses of "low-conjugation" DNP-GLA^ . Percent 
response is defined in the text. (I) covers the 
full range of responses for all the C3H/HeJ mice 
tested, while (I) covers the full range of 
responses for all the C57BL/6J mice tested. 
These responses were tested at 1 x 10 M H-DNP-
lysine 
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Figure 6. The analysis of individual (circles) and pooled (squares) 
sera from C3H/H3J (0,0) and C57BL/6J (•»•) mice at 
the primary response to varying doses of "high-
conjugation: DNP-GLA . Percent response is defined 
in the text. (% ) covers the full range of response 
for all the C3H/HeJ mice tested, while (I) covers the 
full range of response for all the C57|L/6^  mice tested. 
These responses were tested at 1 x 10 M H-DNP-lysine 
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Figure 7. The analysis of individual (circles) and pooled (squares) 
sera from C3H/HeJ (0,0) and C57BL/6J (t, •) mice at 
the secondary response to varying doses of "low-conjugation" 
DNP-GLA^ . Percent response is defined in the text. (?) 
covers the full range of response for all the C3H/HeJ mice 
tested, while (I) covers the full range of response for 
all the C57BL/6J mice tested. These responses were tested 
at 1 X 10-8 M 3H-DNP-lysine 
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Figure 8. The analysis of individual (circles) and pooled (squares) 
sera from C3H/HeJ (0,0 ) and C57BL/6J (0, •) mice at 
the secondary response to varying doses of "high-
conjugation" DNPJ^ GLA^ . Percentage of response is de­
fined in the text. (J) covers the full range of response 
for all the C3H/HeJ mice tested, while (I) covers the 
full range of response for all the C57BL/6J mice tested. 
These responses were tested at 1 x 10"^  M ^ H-DNP-lysine 
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The secondary response of Individual mice is shown. It should be noted 
that no data for the 82 yg dose of "low-conjugation" polymer for the 
C57BL/6J mice are included, since these mice died. 
c. Primary response to DNP (Prep II polymers used as antigens) 
A plot of the percent response vs. each respective mouse strain was made. 
Figure 9 shows the data for the response of individual mice to 9.7 yg of 
"low conjugation" DNP-GLA^  (Panel A) and to 97.0 yg of "low conjugation" 
DNP-GLA^  (Panel B). A similar plot is shown for "high conjugation" DNP-
5 GLA for a dose of 7.7 yg in Figure 10 (Panel A) and a dose of 77 yg in 
Panel B. It should be noted that the primary response of the strains 
C57BL/6J and C3H/HeJ was not tested in this experiment. 
d. Secondary response to DNP (Prep II polymers used as antigens) 
The percent response vs. each respective mouse strain was plotted as above 
for the secondary response. The results are shown in Figures 11a and lib 
for "low conjugation" DNP-GLA^  and Figures 12a and 12b for "high conjugation" 
DNP-GLA^ . The low dose (9.7 yg) for "low conjugation" DNP-GLA^  was not 
tested in the strains C57BL/6J and C3H/HeJ at the secondary response. The 
SJL/J mice died before a high dose (97 yg) "low conjugation" DNP-GLA^  
could be obtained. It should be noted that in all immunization procedures, 
at least 5 mice were used at the beginning of the experiment. Fewer data 
points at the end of the experiment mean that some of these mice had died. 
2. The DNP-antibody response of tetraparental mice to "high conjugation" 
DNP-GLA^  fPrep II polymers were used and 66% sat. (NH^ )^ SO^ O 
The response of tetraparental mice is shown in Table 12 and on Table 13 
Figure 9. Primary response of individual mice of different mouse 
strains to low conjugation. DNP-GLA.^  at two doses. 
Panel A shows the individual responses to 9.7 yg of 
the DNP-GLA^  and Panel B shows the responses to 97.0 yg 
of the DNP-GLA^ . (#) represent individual mice and (I) 
represent the range of response of the individual mice. 
These responses were tested at 1 x 10~® M H^-DNP-lysin* 
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Figure 10. Primary response of individual mice of different mouse 
strains to high conjugation DNP-GLA^  at two doses. 
Panel A shows the individual responses to 9.7 pg of the 
DNP-GLA^  and Panel B shows the responses to 97.0 pg 
of the DNP-GLA^ . (#) represents individual mice and (I) 
represent the range of responses of the individual mice. 
These responses were tested at 1 x 10"^  M %-DNP-lysine 
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Figure 11. Secondary response of individual mice of different 
mouse strains to low conjugation DNP-GLA^  at two 
doses. Panel A shows the individual responses to 
7.7 yg of the DNP-GLA^  and Panel B shows the responses 
to 77.0 pg of the DNP-GLA-^ . (•) represents individual 
mice and (I) represents the range of the responses 
of the individual mice. These responses were tested at 
1 X 10"8 M responses of the individual mice. These 
responses were tested at 1 x 10~® M ^ H-DNP-lysine 
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Figure 12. Secondary response of individual mice of different 
mouse strains to high conjugation DNP-GLA^  at two 
doses. Panel A shows the individual responses to 
7.7 jjg of the DNP-GLA^  and Panel B shows the responses 
to 77.0 yg of the DNP-GLA^ . (#) represents individual 
mice and (I) represents the range of the response of 
the individual mice. These responses were tested at 
1 X 10-8 M 3H-DNP-lyslne 
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Table 12. Response of allophenic mice to DNP-GLA^  
Mouse Sex Presumed Genotype 
Coat Color 
Phenotype 
%%-DNP-Lysine Bound ^  
Primary Secondary 
3 C57BL/6J-H-C3H/HeJ 100% C57BL/6J 4.2 1.2 
4 ? C57BL/6J<»C3H/HeJ 20% C57BL/6J, 
80% C3H/HeJ 11.2 22.1 
13 (f C57BL/6J-H-C3H/HeJ 100% C57BL/6J 10.3 3.7 
14 C57BL/6J<+C3H/HeJ 95% C57BL/6J, 
5% C3H/HeJ -2.5 14.2 
21 % C57BL/6J-H-DBA/1J 80% C57BL/6J, 
20% DBA/IJ -6.3 -2.2 
22 9 C3H/HeJ<+CFl 100% CFl 0.2 5.2 
23 ? C3H/HeJ<+CFl 20% C3H/HeJ, 
80% CFl. 0.1 0.7 
24 & C3H/HeJ<+CFl 30% C3H/HeJ, 
70% CFl 4.7 10.5 
25 C3H/HeJ4+CFl 20% C3H/HeJ, 
80% CFl 2.7 -1.0 
31 ? C3H/HeJ -H-DBA/IJ 5% C3H/HeJ, 
95% DBA/IJ ND^  0.2 
33 9 C57BL/6J -H-BALB/cJ 60% C57BL/6J, 
40% BALB/cJ 1.3 42.7 
42 9 C57BL/6J -f^ BALB/cJ 70% C57BL/6J, 
30% BALB/cJ -1.3 -3.0 
A^ll mice were immunized with 35 jig of DNP-GLA^  at each injection, 
except for mice 31, 33, and 42 which received 77 ug of DNP-GLA^  at each 
injection. 
N^D, not done. 
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Table 13. Response of normal mice from embryo transfer experiments to 
DNP-GLA^  
%^ H-DNP-Ly8ine Bound & 
Mouse Sex Genotype Foster Primary Secondary 
16 9 C3H/HeJ CFl 19.7 48.8 
18 C57BL/6J CFl -0.7 4.0 
19 d* C57BL/6J CFl 11.4 23.0 
20 cT C57BL/6J CFl 0.5 -0.6 
®A11 mice were immunized with 35 yg DNP-GLA^  at each injection. 
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is shown the response of normal mice from embryo transfer experiments. 
3. The DNP-antibody response of inbred strains [66% sat. (NH^ )oSO^  to 
DNP-BSA1 
Table 14 shows the primary and secondary response of inbred strains of 
mice which received DNP-BSA alone and those which had been previously 
immunized with "high conjugation" DNP-GLA^ . The dose of the DNP-BSA at 
both injections was 75 yg. The dose of the DNP-GLA^  was 70 pg at the 
primary injection and 35 yg at the secondary injection. 
4. The DNP-antibody response of inbred strains to DNP-BGG 
a. Response using 66% saturated (NH^ )^ SO^  pH 5.8 The secondary 
and tertiary responses of individual mice of the different strains using 
the A1 (OH)2 gel adjuvant and the low dose, 1 yg DNP-BGG, of antigen are 
— 8 O 
shown in Figures 13 and 14 (1 x 10 M H DNP-lys). Figure 15 is a plot of 
percent response versus log (1/serum dilution) for the tertiary response to 
1 yg DNP-BGG in Al(OH)^  get adjuvant (1.62 x 10 ^  M ^ H-DNP-lys). The 
results for the high dose, 50 yg DNP-BGG, in AlCOH)^  get adjuvant are 
-8 
shown in Figures 16 and 17 for the secondary and tertiary responses (1 x 10 
M H DNP-lys). Figure 18 is a plot of percent response versus log (1/serum 
dilution) for the tertiary response to 50 yg DNP-BGG in Al(OH)g gel adjuvant 
(9.36 X 10 M H DNP-lys). Figures 19 and 20 show the primary and secondary 
-8 3 
response using complete Freund's adjuvant and 1 yg DNP-BGG (1 x 10 M H 
DNP-lys). Figure 21 is a plot of percent response versus log (1/serum 
dilution) for the secondary response to 1 yg DNP-BGG in complete Freund's 
-7 3 
adjuvant (9.36 x 10 M H DNP-lys). The average response of the mice of 
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Table 14. Response of Inbred strains to DNP-BSA® 
Mouse Number 1° Response 2° Response 1° Response 2° Response 
and Strain to DNP-GLA^  to DNP-GLA^  to DNP-BSA to DNP-BSA 
1. C3H/HeJ 20.4 35.3 60.8 73.3 
2. C3H/HeJ 21.4 56.0 51.6 69.8 
3. C3H/HeJ 20.9 53.7 60.0 76.0 
4. C3H/HeJ Nib NI 47.2 76.2 
5. C3H/HeJ NI NI 36.7 76.5 
1. A/J 17.2 55.8 61.6 74.8 
2. A/J 33.4 51.8 53.6 75.5 
3. A/J 33.4 50.5 50.4 73.9 
4. A/J NI NI 29.1 80.4 
5. A/J NI NI 24.3 73.2 
1. SJL/J 1.4 -5.0 11.4 6.6 
3. SJL/J -0.4 0.5 7.4 17.2 
4. SJL/J NI NI 33.1 62.5 
1. BALB/cJ 4.0 23.3 23.3 79.5 
2. BALB/cJ 9.3 15.8 27.5 67.5 
4. BALB/cJ NI NI 2.2 74.0 
5. BALB/cJ NI NI 27.7 77.1 
1. DBA/IJ -3.6 -4.4 -9.8 17.5 
4. DBA/IJ 0.1 -1.9 -6.0 4.4 
5. DBA/IJ 4.2 -4.3 -6.0 11.2 
6. DBA/IJ NI NI 14.3 49.5 
7. DBA/IJ NI NI -7.8 23.4 
1. CFl 15.2 -2.4 50.4 75.5 
2. CFl -2.2 0.4 0.4 70.4 
3. CFl 3.0 4.6 50.4 73.4 
4. CFl 27.8 53.4 68.7 82.7 
5. CFl 5.6 16.2 68.7 67.3 
6. CFl NI NI 44.2 68.9 
7. CFl NI NI 38.2 63.8 
T^he dose of the DNP-BSA at both injections was 75 yg. The dose of 
the DNP-GLA was 70 yg at the primary injection and 35 yg at the secondary 
injection. 
N^ot immunized. 
Figure 13. The 2° response of the individual mice (0) and the 
average response (•) of each of the mouse strains 
tested at 1 yg DNP-BGG in Al(OH)o gel adjuvant. 
Percent response is defined in the text. (I) covers 
the range of response for each strain. These responses 
were tested at 1 x 10~8 m ^ H-DNP-lysine 
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Figure 14. The 3° response of the individual mice (0) and the 
average response (•) of each of the mouse strains 
tested at 1 pg DNP-BGG in A1(0H)_ gel adjuvant. 
Percent response is defined in the text. (I) covers 
the range of response for each strain. These responses 
were tested at 1 x 10~® M ^ H-DNP-lysine 
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Figure 15. Dilution curves of pooled 3° response sera from each 
mouse strain challenged with 1 yg DNP-BGG in AlCOH)^  
gel adjuvant. Dilutions and percent response are 
defined in the text. The concentration of H^-DNP-
lysine is 1.62 x 10"^  M 
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Figure 16. The 2° response of the individual mice (•) of each of 
the mouse strains tested at 50 yg DNP-BGG in Al(OH)^  
gel adjuvant. Percent response is defined in the 
text. (I) covers the range of response for each 
strain. These responses were tested at 1 x 10~® M 
% DNP-lysine 
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Figure 17. The 3° response of the individual mice (4) of each of 
the mouse strains tested at 50 yg DNP-BGG in Al(OH)g 
gel adjuvant. Percent response is defined in the 
text. (I) covers the range of response for each strain. 
These responses were tested at 1 x 10~® M H DNP-
lysine 
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Figure 18. Dilution curves of pooled 3° response sera from each 
mouse strain challenged with 1 wg DNP-BGG in AlCOH)^  
gel adjuvant. Dilutions and percent response are 
defined in the text. The concentrations of % DNP-lysine 
is 9.36 X 10-7 M 
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Figure 19. The 1° response of the individual mice (0) and the 
average response (•) of each of the mouse strains 
tested at 1 pg DNP-BGG in CFA. Percent response is 
defined in the text. (I) covers the range of 
response for each strain. These response were tested 
at 1 X 10~® M %-DNP-lysine 
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Figure 20. The 2° response of the individual mice (0) and the 
average response (f) of each of the mouse strains 
tested at 1 pg DNP-BGG in CFA. Percent response 
is defined in the text. (I) covers the range of 
response for each strain. The responses were tested 
at 1 X 10~® M % DNP-lysine 
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Figure 21. Dilution curves of pooled 2° response sera from each 
mouse strain challenged with 1 yg DNP-BGG in CFA. 
Dilutions and percent response are defined in the 
text. The concentration of the % DNP-lysine is 
9.36 X 10-7 M 
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each strain is also shown in Figures 13, 14, 19 and 20. For the 50 yg 
dose of DNP-BGG in Al(OH)g gel adjuvant mice died from every strain during 
the course of immunization. 
Table 15 shows the average response + the standard deviation for 
each mouse strain under the different immunization conditions. There were 
too few data points to calculate the mean and the standard deviation for 
the 50 pg dose in Al(OH)^ . 
b. Response using 70% saturated (NH^ )^ SO^  pH 6.8 The responses 
of pooled sera of the inbred mouse strains tested at the tertiary response 
are shown on Table 16 (1 yg, A1(0H)2), Table 17, (50 ]ig, AlCOH)^ ) and 
Table 18 (1 yg, CFA). The reciprocal of the serum dilution at 33% response 
is also shown for 1 x 10 ^  M DNP lysine and 5 x 10 ^  M DNP lysine. 
5. The DNP-antibody response of tetraparental mice to DNP-BGG [66% satura­
ted (NH4) 2^ 4.1 
Table 16 shows the range of the control data for all the inbred mouse 
strains found in the allophenic mouse combinations. Tables 19 through 24 
show the responses at the secondary, tertiary and pooled fourth and fifth 
—8 3 
responses (1 x 10 M H DNP lysine). In addition, the reciprocal of the 
serum dilution at which 33% of the hapten is bound in the assay at the 
pooled fourth and fifth response is shown. To determine the serum dilution 
for 33% hapten bound of each tetraparental mouse at 1.85 x 10 ^  M ^ H-DNP-
lysine, a plot of percent response vs. log (1/serum dilution) was made. 
(See Table 8 for a full description of the tetraparental mice described in 
Tables 20-24). 
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Table 15. Average response of individual mice of the inbred strains ± 
the standard deviation to DNP-BGG ® 
Average % response ± S.D.^  
Mouse Strain Dose and Adjuvant 
lugAl(0H)3^  1 wg CFA ^  
A/J 69.8 ± 11.9 60.0 ± 4.0 
SJL/J 72.7 ± 6.4 60.7 ± 4.2 
A/J X SJL/J F1 hybrid 76.7 ± 6.1 55.1 ± 5.7 
CBA/J 55.9 ± 25.7 34.8 ± 14.2 
CBA/J X CBA/H-T6J F1 hybrid 39.7 ± 6.7 51.9 ± 13.4 
C3H/HeJ 50.9 ± 18.8 71.2 ± 7.0 
BALB/cJ 52.0 + 13.0 ND e 
C57BL/6J 34.5 ± 20.6 51.0 ± 22.6 
DBA/IJ 41.3 + 14.5 40.7 ± 13.4 
*Too few mice survived to calculate the mean and S.D. for the dose, 
50 yg in AlfOH)]. 
S^tandard deviation. 
*^ 3° response tested at 1 x 10~®M %-DNP-Lysine at 66% sat. (NH^ )2S0^ . 
2^° response tested at 1 x 10~®M %-DNP-Ly8ine at 66% sat. (NH^ )2S0^ . 
®ND, not done. 
Table 16. Response of inbred strains of mice to 1 yg DNP-BGG in AlCOH)^  gel adjuvant at 70% 
(NH^ )2S04 pH 6.8* 
Strain 
5 X 10"^ H-DNP-Lysine 1 X 10"^ M ^ H-DNP-Lysine 
% Response of Pooled Sera 1/serum dilution 
at 33% response 
% Responsè of Pooled Sera 1/serum dilution 
at 33% response undiluted 1:2 dilution undiluted 1:2 dilution 
A/J 52 46 4.2 20 15 ND^  
A/J X SJL 79 74 26 66 48 3.6 
CBA/J 12 6 ND 8 1 ND 
C57BL/6J 2 8 ND 3 1 ND 
DBA/IJ 71 65 14.0 65 35 2.2 
^These responses were from pooled sera. 
^ND, not determined. The response was too low. 
Table 17. Response of inbred strains of mice to 50 yg DNP-BGG in Al(OH)o gel adjuvant at 70% 
(NH^ )2S0^  pH 6.8 3 
Strain 
5 X 10-% 3H-DNP-Lysine 1 X 10~^ M 3H-DNP-Lysine 
% Response of Pooled Sera 1/serum diultion 
at 33% response 
% Response of Pooled Sera 1/serum dilution 
at 33% response undiluted 1:2 dilution undiluted 1:2 dilution 
A/J 68 68 7.8 37 34 2.3 
A/J X SJL/J 75 77 155 75 77 145 
CBA/J 75 73 68 63 60 17.0 
C57BL/6J 21 4 ND^  5 3 ND 
DBA/IJ 35 20 1.2 25 8 ND 
^These responses were from pooled sera. 
^ND, not determined. The response was too low. 
Table 18. Response of inbred strains of mice to 1 yg DNP-BGG in CFA at 70% (NH^ )2S0^  pH 6.8® 
Strain 
5 X 10-% %-DNP-Lysine 1 X 10~^M %-DNP-Lysine 
% Response of Pooled Sera 1/serum dilution 
at 33% response 
% Response of Pooled Sera 1/serum dilution 
at 33% response undiluted 1:2 dilution undiluted 1:2 dilution 
A/J 76 75 34 63 50 3.4 
A/J X SJL/J 79 79 280 75 74 34 
CBA/J 70 73 28 56 38 2.5 
C57BL/6J 59 58 25 51 20 1.5 
DBA/IJ 33 17 1.0 0 -1 
^These responses were from pooled sera. 
^ND, not determined. The response was too low. 
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Table 19. The reciprocal of the serum dilution at ABC33 for individual 
mice of each inbred strain in response to 1 pg DNP-BGG in 
A1(0H)3 gel adjuvant^  
Inbred Strains 
# 
mice 
of 
tested 
Range of 1/serum 
dilution at 
33% Ag bound 
3° Response 
average ± S.D. 
C57BL/6J 5 1.6 to 9.0 50.4 ± 18.1 
BALE/cJ 5 2.75 to 7.5 70.0 ± 4.8 
C3H/HeJ 5 4.0 to 10.5 64.0 ± 6.4 
DBA/IJ 5 UD'^ to 1.8 29.0 ± 17.4 
A/JxSJL/J F1 hybrid 5 11.5 to 56.0 71.9 ± 7.8 
3^H-DNP-Lysine concentration, 1.85 x 10"%, 66% sat. (NH^ )2S0^ . 
S^tandard deviation. 
U^D, undefined. 
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Table 20. The immune response of tetraparental mice of the genotype 
C57BL/6J"^ BALB/cJ to 1 yg DNP-BGG in A1(0H)3 gel adjuvant 
Mouse # Percent Response* 1/serum dilution at 33% antigen bound 
.0 oo ,,coC at pooled 4/5° ^  
34 9.8 41.5 19.2 1.3 
35 54.5 70.5 65.2 10.5 
36 13.6 57.9 58.0 9.0 
37 38.7 60.1 63.4 2.3 
38 6.5 34.3 32.0 3.5 
39 12.3 22.3 17.3 UD 
44 18.8 48.5 62.6 4.5 
46 11.5 6.6 6.6 UD 
*1 X 10-% ^H-DNP-Lysine, 66% (NH^ )2S0^ . 
bl.85 X 10"% VoNP-Lysine, 66% (NH^ )2S0^ . 
Cpooled fourth and fifth response sera. 
U^ndefined. 
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Table 21. The immune response of tetraparental mice of the genotype 
C57BL/6J-^ C3H/HeJ and control mice from unfused embryos of 
these strains to 1 yg DNP-BGG in AlCOH)^  gel adjuvant 
Mouse # 
Percent Response ^  
2" 3 
1/serum dilution at 33% ai^ tigen bound 
o oo 4/5OC at pooled 4/5° 
29 -1.4 4'.5 5.0 
30 11.8 19.3 ND UD ^  
43 2.7 I 0
 
W
 3.0 UD 
47 3.8 16.8 20.9 UD 
48 16.4 34.4 53.2 6.6 
51 11.7 14.4 ND UD 
57 10.8 15.0 ND UD 
70 11.9 17.2 13.9 UD 
F 31.5 52.6 67.2 4.8 
1^ X 10"% ^H-DNP-Lysine, 66% (^ 4)2804. 
1^.85 X 10-8M ^ H-DNP-Lysine, 66% (NH^ lgSO^ . 
cpooled fourth and fifth response sera. 
"^Not done. 
T^ertiary response sera was used to obtain 1/serum dilution at 33% 
antigen bound for mice that were given a fourth and fifth injection. 
U^ndefined. 
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Table 22. The Immune response of tetraparental mice of the genotype 
C57BL/6J +^ A/J X SJL/J F1 hybrid and control mice from unfused 
embryos of these strains 
M jL Percent Response & 1/serum dilution at 33% antigen bound 
' 20 30 4/5OC at pooled 4/50" 
49 71.5 82.3 86.9 13.0 
50 13.7 62.5 55.3 13.0 
58 51.9 68.7 77.2 30.0 
59 59.6 76.0 65.8 13.0 
60 75.8 76.0 70.5 6.0 
61 39.6 60.1 49.4 2.6 
62 53.2 74.3 77.2 12.5 
64 63.4 62.1 46.5 3.6 
65 70.0 71.4 82.0 23.0 
66 69.2 72.6 71.9 6.0 
67 62.0 56.6 72.7 11.0 
68 24.6 77.1 58.2 13.0 
69 -0.7 25.7 died ND ^  
H 51.5 73.9 63.7 5.2 
H X 10~®M 3H-DNP-Lysine, 66% 
1^.85 X 10"% %-DNP-Lysine, 66% (NH^ jgSO^ . 
P^ooled fourth and fifth response sera. 
"^ Not done, died. 
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Table 23. The immune response of tetraparental mice of the genotype 
C57BL/6J-«-DBA/IJ and control mice from unfused embryos of 
these strains 
Percent Response^  1/serum dilution at 33% antigen bound 
• 2° 3" 4/5° <= " P°°led 
IF 13.9 17.2 11.2 UD^  
2F 21.8 54.5 82.7 3.8 
3F -0.1 47.0 83.1 3.3 
IM 3.0 22.0 16.1 UD 
2M 30.6 34.6 19.1 1.8 
3M 25.3 34.2 25.0 UD 
I 30.0 64.2 46.0 1.2 
H X 10-% %-DNP-Lysine, 66% (NH^ )2S0^ . 
bl.85 X 10"®M %-DNP-Lysine, 66% (NH^ jgSO^ . 
'^ Pooled fourth and fifth response sera. 
'^ Undefined. 
136 
Table 24. The immune response of tetraparental mice of the genotype 
DBA/IJ-H-A/J X SJL/J F1 hybrid 
Mouse # Percent Response » 1/serum dilution at 33% aij^ tigen bound 
" 2° 3° 4/5° •= pooled 4/5° 
53 64.8 65.0 58.3 5.2 
55 67.9 died — ND 
56 76.8 74.4 70.3 13.0 
1^ X 10"% ^H-DNP-Lysine, 66% (^ «4)2804. 
1^.85 X 10"% %-DNP-Lysine, 66% (^ 4)2804. 
cpooled fourth and fifth response sera. 
%ot done, died. 
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6. The DNP-antlbody response to DNP-lysine levan 
For both of the levan polymers and for both doses of the more soluble 
fraction the antibody levels produced in the mice were too low to give a 
percent response using the radioactive assay. 
D. Determination of Amounts of DNP-antibody by Radial Diffusion 
To determine the amount of antigen to incorporate into the agar to do 
the radial diffusion the concentrations of 0.005 mg/ml, 0.01 mg/ml and 
0.05 mg/ml of the antigens were used. The antigens used were 
DNP-BGG, DNP-OVA. DNP-OVA acts as a noncross reacting antigen. By using 
this antigen the amount of DNP-antibody can be determined. A sera of a 
known concentration of DNP antibody 60 yg/ml was used as a standard to 
2 determine the amount of DNP-antibody. The diameter vs. the amount in 
yg/ml of this standard DNP-antibody is shown in Figure 22. DNP-OVA was 
mixed in the agar in the above concentrations. All wells were filled with 
the same volume. A quantitative precipitin test was done using DNP-BGG 
to determine the total amount of antibody directed against the antigen DNP-
BGG. The amount of antibody was found to be 160 Mg/ml. The amount was 
2 then used as a standard to make a plot of the diameter vs. amount in pg/ 
ml of DNP-BGG antibody (see Figure 23). DNP-BGG was mixed in the agar in 
the above concentrations. Table 25 shows the amounts of antibody for the 
different inbred strains under the different immunizing conditions. Strains 
which produced low amounts of DNP-antibody did not give rings and as a 
result, amounts could not be calculated. 
2 
Figure 22. A plot of the (diameter of the precipitin ring) 
vs. the amount of antibody applied to the gel. (•) 
0.05 mg/ml (0) 0.01 mg/ml, and (•) 0.005 mg/ml 
of DNP-OVA incorporated into the agar. The points 
were analyzed statistically by the least squares method 
and the lines drawn accordingly 
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Figure 23. A plot of the (diameter of the precipitin ring) 
vs. the amount of antibody to DNP-BGG applied to 
the gel, (•) 0.005 mg/ml, (A) 0.01 mg/ml, and 
(•) 0.005 mg/ml of DNP-BGG incorporated into the 
agar. The points were analyzed statistically by 
the least squares method and the lines drawn 
accordingly 
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E. Affinity of DNP-antibody 
Affinity studies were done only on inbred strains of mice immunized 
with DNP-BGG. The sera used in the affinity studies were pooled sera from 
the secondary ..response using lyg DNP-BGG in CFA, and from the tertiary 
response using 1 yg or 50 yg DNP-BGG in AlCOH)^  adjuvant. In a first set 
of experiments, the ABC^ g values were determined using 66% sat. (NH^ )2S0^  
in the assay. The values for ABC^ ,^ R and are shown in Tables 26-28. 
The values were calculated as described in the chapter. Materials and 
Methods. An example of the calculations is described below for the A/Jx 
SJL/J mice. 
Table 26 shows that the A/JxSJL F1 hybrid mice had their serum tested 
3 
at five different concentrations of H-DNP-lysine. Figure 24 shows a plot 
3 
of % response vs. the serum dilution for each of the H-DNP-lysine con­
centrations. The values for l/serum dilution at 33% response are read 
-6 3 directly from this figure. For instance, at 1.59 x 10 M H DNP lysine, 
l/serum dilution for 33% response is 4.5. The value of ABC^  ^is then 4.5x 
0.33 X 1.59 X 10 ^  = 2.39 x 10 as is shown on Table 26. To calculate 
the values for R, the ABC^  ^for the experimental condition is divided by 
-6 
the value of ABC^  ^at the index condition (1.59 x 10 M). Thus the value 
for R at 3.06 x 10~^  M DNP lysine is 
ABCgg at 3.06 x lO'^ M 1.22 X 10 
,-6 
= 0.513 . 
ABC 33 at 1.59 X 10"^  M 2.39 X 10 
- 6  
Then the value for K is calculated using the equation 
Table 25. Amounts of antibody obtained from inbred strains of mice using radial diffusion^  
yg/ml of Ab 
Mouse Strain 1 yg AKOH)^  50 Mg AKOH)^  1 yg CFA 
DNP-BGG DNP-OVA DNP-BGG DNP-OVA DNP-BGG DNP-OVA 
A/J 20^  1^  39 6 97 55 
A/JxSJL/J F1 88 10 171 68 180 75 
hybrid 
CBA/J 
_d _d 25 3 51 8 
C57BL/6J _d _d _d _d 25 1 
CBA/IJ 25 2 _d _d _d _d 
T^he antigen concentration in the agar for all antigens was 0.005 mg/ml. 
A^ntibody to DNP-BGG. 
A^ntibody to the DNP-group. 
N^o precipitin line formed. 
Table 26. Antibody affinity parameters for 3° response of inbred strains to 1 yg DNP-BGG in AlCOH)^  
gel adjuvant 
H^-DNP-lys 1/serum dilution 
Mouse Strain Concentration at 33% response ABC^ g R K_^  
A/J 1.59 x 0~6M 14.0 7.42 x 10-G __ 
3.06 x 0~7M 17.5 1.79 x 10-G 0.241 3.14 x 10^  
1.60 x O-^ M 25.0 1.33 x 10-6 0.179 9.08 x 10^  
2.93 x 0"% 28.0 2.74 x 10-7 0.037 9.82 x 105 
1.56 x 0~% 21.0 1.09 x 10-7 0.015 4.77 x 10 5 
SJL/J 1.59 x 0"^ M 10.1 5.32 x 10-6 
3.06 x 19.0 1.94 x 10-G 0.364 1.32 x 10^  
1.60 x 0-7% 21.0 1.11 X 10-6 0.209 1.32 X 106 
2.93 x 0-®M 33.0 3.23 x 10-7 0.061 3.22 X 106 
1.56 x 0"% 58.0 3.02 x 10" 7 0.057 4.81 X 10° 
A/J X SJL/J F1 hybrid 1.59 x O-^ M 4.5 2.39 x 10-6 
3.06 x O-^ M 12.0 1.22 x 10" 6 0.513 3.23 X 10^  
1.60 x O-^ M 15.0 7.95 x 10-7 0.333 3.30 X lOf 
2.93 X 0-®M 30.0 2.94 X 10-7 0.123 6.08 X 10° 
1.56 X 0"% 34.0 1.77 x 10-7 0.074 6.67 X 106 
CBA/J 1.59 x O-^ M 2.0 6.24 X 10-7 7 
3.06 X O'^ M 6.6 4.16 X 10:? 0.666 1.10 X 10^  
1.60 X O-^ M 3.6 1.13 X 10 1 0.182 1.57 X 106 
2.93 X 0-% 5.0 3.09 X 10-8 0.049 2.53 X 10® 
1.56 x 0-®M 8.0 2.55 x 10-8 0.041 5.01 X loG 
CBA/J X CBA/H-T6J 1.59 x O-^ M 1.4 4.37 x 10-7 
F1 hybrid 3.06 x O-^ M 1.9 1.20 x 10-7 0.274 7.88 X 10^  
1.60 x 0-7% 2.2 6.93 X 10-8 0.159 1.10 x 106 
Table 26. continued 
%-DNP-lys l/serum dilution 
Mouse Strain Concentration at 33% response ABC33 R 
2.93 X 10~8M 
1.56 X 10-8m 
2.3 
4.0 
1.42 X 10~! 
1.28 X 10 - 8  
0.033 
0.029 
1.06 X 10* 
3.06 X 106 
C3H/HeJ 1.59 X 10~^ M 
3.06 x 10~zM 
1.60 
2.93 
1.56 
10" 
10" 8M 
10"^  
1.4 
3.0 
4.3 
4.6 
4.3 
7.42 X 10 
3.06 X 10 
-7 
-7 
2.28 X 10-7 
4.51 X 
2.24 X 
10 
10 
- 8  
-8  
0.412 
0.307 
0.061 
0.030 
1.83 X 10^  
2.82 X 10( 
2.31 X 10< 
2.00 x 10( 
BALE/cJ 1.59 x 10-% 
3.06 X 10-7M 
1.60 x 10-7m 
2.93 x 10"% 
1.56 X 10-% 
2.4 
3.9 
5.0 
10.0 
7.4 
1.27 X 10-6 
3.97 
2.67 
1.31 
10-7 
10-7 
10 
3.85 X 10 
-7 
—8 
0.312 
0.209 
0.103 
0.030 
8.51 X 105 
1.28 X loG 
4.83 x 10% 
2.00 X 10° 
C57BL/6J 1.59 
3.06 
1.60 
10-&M 
10" 7m 
10" 7m 
-8x 2.93 X 10-»M 
1.56 X 10-% 
undefined 
1.0 
2.7 
3.8 
6.6 
1.02 X 10-7 
1.44 X 10-7 
3.71 X 10-° 
3.4 X 10-8 
DBA/IJ 1.59 x 10-% 
3.06 X 10-7m 
1.60 X 
2.93 X 
1.56 X 
10-7M 
10-% 
10-% 
undefined 
undefined 
1.7 
3.7 
1.6 
9.07 x 10-8 
3.61 X 10-8 
8.32 X 10 -9 
Table 27. Antibody affinity parameters for 3° response of inbred strains to 50 yg DNP-BGG in AlCOH)^  
gel adjuvant 
H^-DNP-lys 1/serum dilution 
Mouse Strain Concentration at 33% response ABCgg R 
A/J 9.36 
1.89 
9.45 
1.85 
9.56 
lO-^ M 
lO-^ M 
10" % 
10" % 
io~9M 
7.2 
8 . 8  
9.4 
12.0 
9.0 
2.25 
5.54 
2.96 
7.40 
10-6 
10-7 
10 
10 
2.87 X 10 
-7 
- 8  
— 8  
0.247 
0.132 
0.033 
0.013 
4.75 X 105 
5.68 X 10^  
1.10 X 10® 
4.09 X 105 
SJL/J 9.36 x 10" 11.0 3.43 x 10-G 
1.89 x 10"7M 12.0 7.56 x 
S: 
0.220 1.83 x 105 
9.45 x 10"% 14.0 4.41 x 0.128 4.92 x 10^  
1.85 x 10-% 16.0 9.87 x 0.029 7.53 x 105 
9.56 x 10-9% 11.5 3.67 x 10-8 0.011 7.54 x 104 
C3H/HeJ 9.36 x 10" 2.0 6.24 x 10-7 
1.89 x 10"'m 2.4 1.51 x 10-7 0.242 4.05 x 10^  
9.45 x 10"% 3.4 1.07 x 10-7 0.172 1.35 x loG 
1.85 x 10"% 3.6 2.22 x 10-8 0.036 1.32 x 10* 
9.56 x lO-^ M 3.0 9.57 x 10-9 0.015 7.79 x 10^  
BALB/cJ 9.36 x 10-7% 4.5 1.40 x 10-6 — 
1.89 x 10-7M 8.0 5.04 x 10-7 0.359 1.94 x 10* 
9.45 x 10"% 9.4 2.96 x 10" 7 0.211 2.20 x 10* 
1.85 x 10-8% 10.0 6.17 x 10" 8 0.044 1.98 x 106 
9.56 x lO-^ M 7.2 2.30 x 10"8 0.016 NC ® 
C57BL/6J 9.36 x 10- 2.5 7.80 X 10 -7 
NC gives a negative number. 
Table 27. continued 
%-DNP-lys 1/serum dilution 
Mouse Strain Concentration at 33% response ABC33 R Kg 
1.89 x lo-^m 
9.45 X 10-8M 
1.85 X 10-% 
9.56 X 10-9m 
5.8 
5.0 
7.0 
6 . 0  
3.65 X 10"7 
1.58 X 10-7 
4.32 X 10"° 
1.91 x lo'g 
0.468 
0.202 
0.055 
0.025 
3.97 X loG 
2.01 X 10* 
3.06 X 10° 
2.29 X 10° 
DBA/IJ 9.36 X lO-^ M 
1.89 X lO-^ M 
9.45 x 10~°M 
1.85 X 10""% 
9.56 x 10"^ M 
undefined 
undefined 
undefined 
undefined 
undefined 
Table 28. Antibody affinity parameters for 2° response of inbred strains to 1 ug in CFA 
%-DNP-lys 1/serum dilution 
Mouse Strain Concentration at 33% response ABC33 R 
A/J 9.36 
1.89 
9.45 
IQ-^ M 
10" Zm 
. __ 10"% 
1.85 X 10"®M 
9.56 X 10-9M 
2 . 2  
4.0 
5.0 
8 . 6  
10.1 
—6 
-7 
6.86 X 10 
2.52 X 10 
1.61 X 10-7 
5.31 X 10 — 8  
3.22 x 10 — 8 
0.367 
0.235 
0.077 
0.045 
2.07 X 10* 
3.27 x 10^  
x 
x 
5.06 
5.88 
SJL/J 9.36 X 10-7%: 
1.89 x 10"7m 
9.45 x 10-8%: 
1.85 X 10"% 
9.56 X lO-^ M 
8 . 2  
10.0 
10.0 
9.0 
14.0 
2.56 X 
6.30 X 
10 - 6  
10-7 
3.15 x 10"' 
10"® 5.55 X 
4.47 X 10-8 
0.246 
0.123 
0.022 
0.018 
4.64 X 10^  
4.00 X 105 
1.59 X 105 
1.16 X 10® 
A/J xSJL/J F1 hybrid 9.36 x 10" 7M 
10" 7m 
8.0 4.24 x 10-6 
1.89 x 19.0 1.98 x 10 G 0.457 2,39 x lof 
9.45 x 10-8% 29.0 4.90 x 10"/ 
10" 8 
0.363 3.92 x 10° 
1.85 x 10-8% 28.0 9.04 x 0.065 2.54 x 10® 
9.56 x 10-9% 23.0 5.15 x 10" 8 0.028 1.80 x 106 
CBA/J 9.36 x 10" 7% 1.4 4.37 x 10"7 
1.89 x 10"7M 
10" 8m 
2.2 1.50 x 10-7 0.342 1.69 x 10® 
9.45 x 4.5 1.42 x 
10-8 
0.325 5.27 x 106 
1.84 x 10"% 
IO"9M 
4.7 2.90 x 0.066 4.05 x 10® 
9.56 x 8.2 2.62 x 0.056 7.60 x 10® 
CBA/J x CBA/H-T6J 
F1 hybrid 
9.36 x 10~^ M 
1.98 X 10"7M 
9.45 X 10"8M 
1.7 
3.5 
5.8 
-7 
2.21 X 10"7 
1.83 X 10"7 
0.417 
0.345 
2.93 X 10° 
5.91 X 106 
Table 28. continued 
H^-DNP-lys 1/serum dilution 
Mouse Strain Concentration at 33% response ABC33 R Kg 
1.85 X 10~% 
9.56 X 10" M 
10.1 
10.0 
6.23 x 10 G 
3.22 x 10-8 
0.118 
0.061 
8.98 X 10° 
8.44 x 106 
C3H/HeJ 9.36 X 10-7M 
1.89 X 10"7M 
9.45 X lO'^ M 
1.85 x lo-gM 
9.56 x 10"^ M 
3.0 
7.0 
8.0 
8 . 6  
7.4 
9.36 X 10-7 
1.41 x 10-7 
2.52 X 10 
5.30 
2.36 
-7 
10-8 
10-8 
0.471 
0.269 
0.057 
0.025 
4.04 X 106 
3.65 X 10° 
3.20 x 106 
2.41 X 106 
C57BL/6J 9.36 X 10-7M 
1.89 x 10-7M 
9.45 X 10-8M 
1.85 X 10-8M 
9.56 X 10"^ M 
2 . 2  
4.0 
6 . 0  
5.0 
5.0 
6.71 x 10-7 
2.52 x 10-7 
1.89 X 10-7 
3.09 X 10-8 
1.60 X 10~8 
0.376 
0 .282  
0.046 
0.024 
2.21 X 10® 
4.00 X 10* 
2.23 X 10° 
2.21 x 106 
DBA/IJ 9.36 X 10-7M 
1.89 x 10"7M 
9.45 X 10-8M 
1.85 X 10-^  
9.56 x 10"^ M 
1.2 
2 . 2  
3.0 
4.6 
6 . 2  
3.74 X 10-7 
1.39 x 10-7 
9.45 
2.84 
1.98 
10 
10 
10 
— 8  
- 8  
- 8  
0.371 
0.253 
0.076 
0.053 
2.13 X 106 
3.23 x 106 
4.92 x 10G 
7.06 X 106 
Figure 24. Dilution curves of pooled 3° response sera of 
A/JxSJL F1 hybrid mice at different % DNP-lysine ^  
concentrations: (•) 1.59 x 10"^  M; (#) 3.06 x 10"' M; 
(V) 1.60 X 10-7 M; (A) 2.93 x lO'S M; and (X) 
1.56 X 10"° M. The log of the serum dilution at 
33% response is also shown for 1.59 x 10"^  M 3h DNP 
lysine. Percent response and dilutions are defined 
in the text 
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0.699 1.000 1.699 2.000 
LOG (1/SERUM DILUTION) 
2.301 
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2(1-R)B^ B^  
as described in the chapter entitled Materials and Methods. 
0.513 (0.53 X 10~^ ) - (1.02 x 10~^ ) 
K = 7 7 = 3.23 X 10 . 
 ^ 2(1 - 0.513)(0.53 X 10 )(1.02 x lO" ) 
All the values contained in Tables 26, 27 and 28 were obtained in a similar 
fashion. Next, a plot of log R vs. log K was made. The resulting plots 
for each strain are shown in Figure 25 [Al(OH)g gel adjuvant, 1 pg DNP-BGG], 
in Figure 26 [A1(0H)2 gel adjuvant, 50 yg DNP-BGG] and Figure 27 [CFA, 1 pg 
DNP-BGG], 
In a second set of experiments, the ABC^ g values were determined using 
70% sat. (NH^ ÏgSO^  in the assay (see Tables 16-18). For these experiments, 
3 -6 -8 
only two concentrations of H DNP-lysine were used: 10 M and 5 x 10 M. 
Table 29 shows the one K calculated for each of the strains of mice tested. 
a 
This value is compared with the value obtained from the previous set of 
experiments. 
F. Determination of Anti-DNP IgG of the Total DNP-antibody 
The percent IgG was calculated by dividing the dilution of the highest 
percent response of anti-DNP antibody precipitated with the anti-IgG serum 
(Miles Laboratories) by the percent response of the same dilution pre­
cipitated with the 90% saturated (NH^ )2S0^ . An example of how this was 
accomplished is shown in Figure 28 (mouse strain C3H/HeJ) and in Figure 29 
(mouse strain C57BL/6J). The data shows that the C3H/H3J mice show 100% IgG 
Figure 25. Relative affinities of pooled serum antibodies produced 
by the different mouse strains at 3° response to 1 pg 
DNP-BGG in A1(0H)„ gel adjuvant. The mouse strains 
represented are in Panel A: C3H/HeJ (•), CBA/J (#), 
CBA/J X CBA/H-T6J F1 hybrid ( A ) ,  BALB/cJ (A); in Panel B: 
SJL/J (•), A/J (o), and A/J x SJL/J F1 hybrid (•). Log 
K and log R are defined in the text 
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Figure 26. Relative affinities of pooled serum antibodies produced 
by the different mouse strains at 3° response to 50 yg 
DNP-BGG in A1(0H)_ gel adjuvant. The mouse strains 
represented are SJL/J (•), A/J (D), C3H/HeJ (•), 
BALB/c J ( A ) ,  and C57BL/6J (0). Log K and log R are 
defined in the text 
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Figure 27. Relative affinities of pooled serum antibodies produced 
by the different mouse strains at 3° response to 1 yg 
DNP-BGG in CFA. The mouse strains represented are in 
Panel A; C3H/HeJ (V), CBA/J (0), CBA/J x CBA/H-T6J F1 
hybrid (•); in Panel B: C57BL/6J (0), DBA/IJ (A); in 
Panel C: A/J (O), SJL/J (0), and A/J x SJL/J F1 
hybrid (•). Log K and log R are defined in the text 
133 
7.0 
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Table 29. Affinity of mouse sera tested with 70% sat. (NH^ )2S0^  under various immunization conditions 
1 yg DNP-BGG 50 yg DNP-BGG 1 jjg DNP-BGG 
Mouse Strain in AlCOH)^  in AlCOH)^  in CFA 
Kai^  Ka2^  Kai Ka2 Kal Ka2 
A/J 9.82 X 105 NC c 1.10 X 10^  4.37 X loG 5.06 X 10^  2.76 X 10? 
A/J X SJL F1 hybrid 6.08 X 10G 1.49 X 10^  ND d 1.10 X 10^  2.54 X 10^  1.88 x 10? 
CBA/J 2.53 X 106 NC ND 5.70 X 10^  4.05 X 106 3.56 X 107 
C57BL/6J NC NC 3.06 X 10^  NC 2.23 X loG 1.51 x 108 
DBA/IJ NC 1.20 x 107 NC NC 4.92 x loG NC 
E^xperiment with 66% sat. (NH^ )2S0^  pH 5.8. 
E^xperiment with 70% sat. (NH^ )2S0^  pH 6.8. 
N^C, noncalculable. 
N^D, not done. 
Figure 28. Percent response of dilutions of pooled sera from C3H/HeJ 
mice at the 3° response to 50 Pg DNP-BGG in Al(OH)g gel 
adjuvant. One series of dilutions is precipitated with 
90% saturated ammonium sulfate (•) and the other with 
rabbit antimouse IgG (•). Percent response is defined 
in the text. The concentration of % DNP-lysine used 
is 9.45 X 10-8 M 
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Figure 29. Percent response of dilutions of pooled sera from 
C57BL/6J mice at the 3° response LO 50 pg DITF-BGG 
in Al(OH)- gel adjuvant. One series of dilutions 
is precipitated with 90% saturated ammonium sulfate 
(#) and the other with rabbit antimouse IgG (•). 
Percent response is defined in the text. The concen­
tration of % DNP-lysine used is 9.45 x 10~8 m 
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at a serum dilution of 1:2, whereas the C57BL/6J mice show 60% IgG at a 
serum dilution of 1:4. The complete results of these calculations for 
all the inbred strains at the different doses and in the different adjuvants 
is shown in Table 30. On Table 26 is also shown the log^  at 33% response 
of sera of the various mouse strains from the different immunizing con­
ditions. The sera were treated in two different manners. In one case the 
sera were not treated with 0.005 M mercaptoethanol and 0.1 M iodoacetamide 
and in the other case they were. A reduction greater than 2 indicates the 
presence of IgM antibody and a low amount of IgG antibody. 
Table 31 shows the % IgG of tetraparental mice. The sera of these 
mice was treated with antimouse IgG to calculate the % IgG. 
G. Response of Rabbits to DNP-BSA and DNP-BGG 
The response to DNP-BSA of the rabbits was very low. High titer 
antibody was not obtained even after several boosts with the antigen. 
Immunization with DNP-BGG, however, produced high titer-DNP-antibody. As 
determined by a quantitative precipitin test the amount of DNP-antibody was 
found to be 3.5 mg/ml. 
H. Hemoglobin Results 
1. Hemoglobin characterization 
A scan of 50 yg of hemoglobin for each mouse strain is shown in 
Figures 30-34. Figure 30 shows C57BL/6J Hbb; Figure 31, C3H/HeJ Hbb; 
Figure 32, BALB/cJ Hbb; Figure 33, A/JxSJL/J F1 hybrid Hbb; and Figure 34, 
DBA/IJ Hbb. A plot is also shown of the area under the curve vs. the amount 
of Hbb applied to the gel for each strain (Figures 35-39). On the same 
Table 30. Percent IgG of total anti-DNP antibody for inbred strains 
1 pg DNP-BGG in Al(OH)g gel 50 yg DNP-BGG in AlCOH)] gel 1 yg DNP-BGG in CFA 
Mouse Strain log2 log2 log2 
% IgG* Dilution^  1 
1 
M
 
g
 
+ME 
+I % IgG Dilution 
-ME 
-I 
+ME 
+I % IgG Dilution 
-ME 
-I 
+ME 
+I 
A/J 75.2 1:8 2 1 72.6 1:8 3 3 84.6 1:8 5 5 
SJL/J 101.5 1:8 ND® ND 100.0 1:8 ND ND 107.5 1:8 ND ND 
A/J X SJL/J 
F1 hybrid 104.2 1:16 5 4 ND - 7 7 94.0 1:8 8 7 
CBA/J ND - f^ ND - 6 6 92.4 1:4 5 4 
T^he percent error is ±7%. 
T^he serum dilution at which maximum precipitation of IgG by the anti-IgG serum was observed. 
2^ mercaptQethanol. 
l^odoacetamide. 
®ND, not done. 
T^he amount of antibody was too low to accurately determine the % IgG using our assay procedure. 
Table 30. continued 
1 yg DNP-BGG in AKOH)^  gel 50 yg DNP-BGG in AKOH)^  gel 1 Ug DNP-BGG in CFA 
Mouse Strain log2 log2 log2 
% IgG* Dilution^  
-MRC 
-I d 
+ME 
+I % IgG Dilution 
-ME 
-I 
+ME 
+I % IgG Dilution 
-ME +ME 
-I +I 
CBA/J X 
CBA/H-T6J 
F1 hybrid 87.4 1:2 ND ND ND ND ND 84.1 1:2 ND ND 
C3H/HeJ 101.1 1:4 ND ND 98.0 1:2 ND ND 86.0 1:4 ND ND 
BALE/cJ 110.0 1:8 ND ND 85.8 1:4 ND iro ND - ND ND 
DBA/IJ 
_f _f 4 1 _f _f _£ _f 66.3 1:4 _f __f 
C57BL/6J 59.4 1:2 
_f _f 62.3 1:4 f 65.8 1:2 5 2 
Table 31. Percent IgG of total anti-DNP antibody for the tetraparental mice and control mice from 
unfiised embryos 
Genotype of tetraparental mice 
or control mice from unfused Mouse # Coat color phenotype % IgG* Dilution ^ 
embryos of these strains 
C57BL/6<fBALB/cJ 34 100% C57BL/6J 38.0 1:2 
35 100% C57BL/6J 102.0 1:4 
36 100% C57BL/6J 72.8 1:4 
37 100% C57BL/6J 19.3 1:2 
38 100% C57BL/6J TL c —— 
39 100% C57BL/6J TL — — 
44 95% C57BL/6J 5% BALB/cJ 33.2 1:2 
C57BL/6J-H-c3H/HeJ 43 100% C57BL/6J TL 
47 100% C57BL/6J 24.5 1:4 
48 40% C57BL/6J 60% C3H/HeJ 56.7 1:2 
51 100% C57BL/6J TL ~ 
70 100% C3H/HeJ 45.3 1 
F 100% C3H/HeJ 97.8 1:8 
C57BL/6J+»A/J X SJL/J F1 hybrid 49 100% A/J x SJL/J 88.4 1:8 
58 95% A/J x SJL/J /5% C57BL/6J 83.4 1:8 
59 100% A/J x SJL/J 71.1 1:8 
60 100% A/J x SJL/J 112.4 1:16 
61 100% C57BL/6J 97.7 1:2 
62 50% A/J x SJL/J /50% C57BL/6J 81.3 1:8 
T^he error for this assay has been determined to be ±7%. 
D^ilution at which maximum precipitation of the IgG occurred. 
'^ Too low to test. 
Table 31. continued 
Genotype of tetraparental mice 
or control mice from unfused Mouse // Coat color phenotype % IgG^  Dilution 
embryos of these strains 
64 95% A/J X SJL/J /50% C57BL/6J 34.3 1:2 
65 70% C57BL/6J/30% A/J x SJL/J 88.5 1:8 
66 70% C57BL/6J/30% A/J x SJL/J 40.3 1:8 
67 100% A/J X SJL 48.6 1:2 
68 80% C57BL/6J/20% A/J x SJL/J 103.2 1:8 
H 100% A/J X SJL 89.9 1:8 
C57BL/6J-H.DBA/1J IF 100% C57BL/6J 30.3 1:4 
2F 100% C57BL/6J 26.3 1 
3F 100% C57BL/6J 57.6 1:2 
IM 100% C57BL/6J 32.1 1 
2M 100% C57BL/6J TL 
3M 100% C57BL/6J TL 
I 100% C57BL/6J 17.6 1 
J 100% C57BL/6J 42.1 1:2 
DBA/IJ-H-A/J X SJL/J F1 hybrid 53 90% DBA/lJ/10% A/J X SJL/J 67.8 1:4 
56 60% A/J X SJL/J /50% DBA/IJ 84.2 1:4 
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Figure 30. A scan at 550 nm of 50 yg of C57BL/6J hemoglogin 
after staining with the peroxidase stain. The scan 
is shown from the top of gel to the bottom 
170 
C3H/HeJ 
. 0  
. 0  
. 0  
. 0  
TOP OF GEL BOTTOM 
Figure 31. A scan at 550 nm of 50 ug of C3H/HeJ hemoglobin after 
staining with the peroxidase stain. The scan is shown 
from the top of the gel to the bottom 
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Figure 32. A scan at 500 nm of 50 yg of BALB/c hemoglobin after 
staining with the peroxidase stain. A scan is shown 
from the top of the gel to the bottom 
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Figure 33. A scan at 550 nm of 50 pg of A/JxSJL/J F1 hybrid 
hemoglobin after staining with the peroxidase stain. 
The stain is shown from the top of the gel to the 
bottom 
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Figure 34. A scan at 500 nm of 50 yg of DBA/IJ hemoglobin after 
staining with the peroxidase stain. The scan is 
shown from the top of the gel to the bottom 
Figure 35. The area (•) under the curve and the peak heights (0) 
for the mouse strain C57BL/6J plotted vs. the amount 
applied to the gel. The points were analyzed statistically 
by the least squares method and the lines drawn accordingly 
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Figure 36. The area (m) under the curve and the peak heights (0) 
for the mouse strain C3H/HeJ plotted vs. the amount 
applied to the gel. The points were analyzed 
statistically by the least squares method and the 
lines drawn accordingly 
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Figure 37. The area (•) under the curve and the peak heights (0) 
for the mouse strain BALB/cJ plotted vs. the amount 
applied to the gel. The points were analyzed 
statistically by the least squares method and the 
lines drawn accordingly 
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Figure 38. The area (•) under the curve and the peak heights (0) 
for the F1 hybrid of mouse strains A/JxSJL/J F1 
plotted vs. the amount applied to the gel. The points 
were analyzed statistically by the least squares method 
and the lines drawn accordingly 
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Figure 39. The area (•) under the curve and the peak heights (0) 
for the mouse strain DBA/IJ plotted vs. the amount 
applied to the gel. The points were analyzed 
statistically by the least squares method and the 
lines drawn accordingly 
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figure, the peak height Is also plotted vs. amount of Hbb applied to the 
gel for each strain. The intersection of these lines on the a^-axis indi­
cates the minimum amount of hemoglobin that can be detected for each strain. 
These values are shown on Table 32. 
2. Calculation of the amount of hemoglobin in mixtures of single and 
diffuse hemoglobins 
A method was devised to analyze the amount of single and diffuse 
hemoglobin in a mixed sample of hemoglobin. It is seen in Figures 30-34 
that the diffuse types of hemoglobin (C3H/HeJ, BALB/cJ, A/JxSJL/J F1 hybrid 
and DBA/IJ) show a significant broadening and shortening of the peaks 
compared to the single type of hemoglobin (C57BL/6J). This observation was 
utilized to experimentally separate the single from the diffuse components 
in any given mixture. For each individual sample, and for each mixture, the 
ratio of the maximum peak height to the width (width measured as described 
in Materials and Methods) was determined. A plot of this h/w ratio vs. 
the amount of Hbb applied to the gel is shown in Figures 40-43. Figure 40 
shows the data for C57BL/6J and C3H/HeJ; Figure 41, for C57BL/6J, and 
BALB/cJ; Figure 42, for C57BL/6J and A/JxSJL/J F1 hybrids; and Figure 43, 
for C57BL/6J and DBA/IJ. In each plot, the left y-axis shows the different 
amounts of Hbb applied to the gels of each of the two individual strains, 
and the right y-axis shows the total amount of C57BL/6J Hbb present in a 
mixed sample. The same amount (50 pg) of the mixed Hbb was always applied 
to the gel. It is seen that for all these plots, (Figures 40-43) a linear 
relationship is shown between the amount of Hbb applied to the gel and the 
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Table 32. The minimum amount of hemoglobin detectable by gel electro­
phoresis for each mouse strain 
Mouse Strain Minimum amount of detectable Hbb (yg) 
C57BL/6J 6 
C3H/HeJ 12 
BALB/cJ 10 
A/J X SJL F1 hybrid 7 
DBA/IJ 3 
Figure 40. A plot of the amount of Hb applied to the gel vs. the 
h/w ratio; C57BL/6J (•) and C3H/HeJ (0). Mixed 
samples (•) of C57BL/6J and C3H/HeJ were plotted as 
amount of C57BL/6J present in the 50 yg sample vs. 
the h/w ratio of the sample. The slanted dotted line 
represents the theoretical line of the amount of 
C57BL/6J vs. the h/w ratio of the samples. All the 
experimental lines were statistically determined by 
the least squares method 
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Figure 41. A plot of the amount of Hb applied to the gel vs. 
the h/w ratio; C57BL/6J (•) and BALB/cJ (0). 
Mixed samples (•) of C57BL/6J and BALB/cJ were plotted 
as amount of C57BL/6J present in the 50 ng sample vs. 
the h/w of the sample. The slanted dotted line 
represents the theoretical line of the amount of 
C57BL/6J vs. the h/w ratio of the samples. All the 
experimental lines were statistically determined by 
the least squares method 
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Figure 42. A plot of the amount of the Hb applied to the gel 
vs. the h/w ratio; C57BL/6J (•) and A/JxSJL F1 hybrid 
(0). Mixed samples (•) of C57BL/6J and A/JxSJL/J F1 
hybrid were plotted as amount of C57BL/6J present in 
the 50 yg sample vs. the h/w of the sample. The 
slanted dotted line represents the theoretical line of 
the amount of C57BL/6J vs. the h/w ratio of the 
samples. All the experimental lines were statistically 
determined by the least squares method 
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Figure 43. A plot of the amount of Hb applied to the gel vs. the 
h/w ratio; C57BL/6J (•) and DBA/IJ (0). Mixed samples 
(•) of C57BL/6J and DBA/IJ were plotted as amount of 
C57BL/6J present in the 50 ng sample vs. the h/w of 
the sample. The slanted dotted line represents the 
theoretical line of the amount of C57BL/6J as the h/w 
ratio of the samples. All the experimental lines were 
statistically determined by the least squares method 
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h/w ratio. Also it was observed that the slopes of the diffuse Hbbs were 
significantly greater than that of the single Hbb. Thus in a mixed sample 
of single and diffuse Hbbs the amount of single Hbb present can be 
determined from the ratio of h/w of the mixed sample. If a constant 
amount (50 pg) of a mixed sample is placed on the gel it can be empirically 
seen that a sample, containing 100% C57BL/6J Hbb (50 pg), will have the 
same h/w ratio as 50 pg of C57BL/6J Hbb. If the sample is 100% C3H/HeJ 
(diffuse, see Figure 40) then the h/w ratio will be the same as 50 ug of 
C3H/HeJ Hbb. Assuming then that both the h/w ratios and the amounts of 
Hbb are additive in a mixed sample, the mixtures which contain both types 
of Hbb in a total of 50 pg should have h/w ratios between the h/w ratio 
of 50 Mg (3H/HeJ Hbb) and the h/w ratio of 50 yg C3H/HeJ Hbb. At 50 ug 
C3H/HeJ Hbb there is no C57BL/6J Hbb present. However since only 6 pg of 
C57BL/6J Hbb is detectable, this was used as the point of no C57BL/6J Hbb 
and the 50 pg point, (see Figure 40, the slashed lines represent this 
relationship). If this relationship holds, then experimentally determined 
h/w ratios of mixed samples of known amounts of C57BL/6J Hbb and 
C3H/HeJ Hbb should be on this line which shows the amount of C57BL/6J 
Hbb vs. h/w ratio. This, in fact, is the case for all the samples tested 
(see Figures 40-43). These figures were then used to determine the amount 
of C57BL/6J Hbb present in any given allophenic mouse. These results as 
well as the amounts applied to the gel to determine these values are 
shown in Table 33. 
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Table 33. Amount of C57BL/6J Hbb found in tetraparental and control mice 
from unfused embryos 
Mouse # Genotype Amount applied to gel % C57 Hbb 
(UE) 
36 C57BL/6J-H-BALB/CJ 35 49 
37 C57BL/6J-H.BALB/CJ 35 57 
38 C57BL/6J-H-BALB/CJ 35 91 
39 C57BL/6J-«-BALB/cJ 35 100 
44 C57BL/6J<+BAiB/cJ 35 86 
46 C57BL/6J-H-BALB/CJ 50 17 
51 C57BL/6J<+C3H/HeJ 35 63 
70 C57BL/6J -H-C3H/HeJ 35 106 
58 C57BL/6J<+A/J X SJL/J 50 0 
59 C57BL/6J4+A/J X SJL/J 35 0 
60 C57BL/6J-H-A/J X SJL/J 50 0 
61 C57BL/6J<+A/J X SJL/J 35 0 
62 C57BL/6J^A/J X SJL/J 50 48 
64 C57BL/6J^A/J X SJL/J 50 19 
67 C57BL/6J.WA/J x SJL/J 50 34 
68 C57BL/6J-H-A/J X SJL/J 50 0 
I C57BL/6J<+DBA/1J 50 34 
IF C57BL/6J or C57BL/6J<+DBA/1J 50 44 
2F C57BL/6J or C57BL/6J<+DBA/1J 50 58 
2M C57BL/6J 50 103 
F C3H/HeJ 50 0 
H A/J X SJL/J 50 0 
J C57BL/6J X DBA/IJ 50 46 
IZ C57BL/6J X DBA/IJ 50 57 
2Z C57BL/6J X DBA/IJ 50 57 
3Z C57BL/6J X DBA/IJ 50 60 
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The threshold of detection for the different Hbbs is shown on 
Table 32. Since 35 or 50 yg of Hbb were always applied in sample which 
contained two Hbb types, the samples were well above this threshold 
However when a sample contained a small amount of one component compared 
to the other component, an increase in error occurred. As observed in 
the known mixed samples, the difference in h/w ratios between a mixture of 
10% single and one 20% single can be observed (see Figure 40). However, 
the difference between 40% single and 50% single is more obvious. Thus 
the values obtained between 20-80% are more accurate than those outside 
these values. Thus for the allophenic mice more significance is attached 
to the numbers which fall in this range (20-80%). The total amount 
applied to the gel slightly affects this value, increasing the error at 
the 35 yg application. 
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IV. DISCUSSION 
The purpose of this study was to investigate the immune response of 
tetraparental mice to two H-2-linked antigens DNP-GLA^ and low dose DNP-BGG. 
The production of the tetraparental mice was centered on fusing two strains— 
one which would respond and one which would not respond to the particular 
H-2 linked antigen. 
A. Response of Mice to DNP-conjugates 
5 
1. Response of Mice to DNP-GLA 
a. Response of inbred strains Before tetraparental mice could be 
tested for their response to the respective H-2 linked antigen it was 
necessary to define and characterize the response of the control strains. 
The mice immunized with the DNP-GLA^ were tested for both primary and 
secondary responses. In this system, a small but significant primary re­
sponse is given to both the low and high conjugation polymers. This can be 
seen in Figures 5,6,9 and 10. For the secondary response, there is some 
difference between the effects of the "low conjugation" polymer and the 
"high conjugation" polymer in eliciting the antibody response. In Figures 
7 and 8 where the doses for the strains C57BL/6J and C3H/HeJ are shown, it 
is clear that the response to the "low conjugation" polymers continues to 
increase until the highest dose (82 yg) was reached. However, the "high 
conjugation" polymers reached the highest antibody effectiveness at 7 yg of 
DNP-GLA^ and leveled out after this dose is reached. Although the response 
is similar with respect to "response or nonresponse" for both the "low and 
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high" conjugation polymers, the range of response for the "responder" 
mice seems to be greater with the "low conjugation" polymer than with the 
"high conjugation polymers (see Figures 7 and 11). 
Thus, the mouse strains C3H/HeJ, BALB/cJ and A/J are characterized as 
responders and the strains C57BL/6J, SJL/J and DBA/IJ are nonresponders at 
the secondary response. Random bred CFl mice were also tested for their 
response to DNP-GLA^. CFl mice would have a heterogeneous population of 
H-2 types and genes and would therefore be expected to give a hetero­
geneous type of response to the DNP group. As shown on Table 14, only two 
of the five CFl mice tested gave a significant secondary response. 
b. Response of the tetraparental mice After characterization of 
the response of the parental strains of the tetraparental mice, the re­
sponse of the tetraparental mice was examined. The results of the immuniza­
tion of the tetraparental mice immunized with DNP-GLA^ are shown on Table 
12. Nine of the twelve tetraparental mice described were phenotypically 
allophenic, as shown by coat color. The response or nonresponse of these 
mice is independent of the sex of the mouse as can be seen on Table 12. 
Mice which had a C57BL/6J coat color phenotype showed immune responses 
corresponding to a C57BL/6J response. Of the multicolored allophenic mice 
which responded, each will be considered individually. Mouse 4 consists 
phenotypically of 80% responder (C3H/HeJ) and 20% nonresponder (C57BL/6J) 
cells. Mouse 4 did give a response of 22.1%. However, this response is 
somewhat lower than the response of the control C3H/HeJ mice. Mouse 14, which 
shows a very small population (5%) of responder cells, also gave a small but 
significant response. Mouse 21, the result of the combination of two 
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nonresponder types of cells (C57BL/6J and DBA/IJ), is a definite non-
responder (-2.2%). This is indirect evidence that the defect leading to 
nonresponse in both the C57BL/6J and DBA/IJ may be possibly the same defect 
since ^  vivo complementation did not lead to response. 
Mice 23, 24, and 25 show no significant secondary response although 
each of these mice definitely contains significant numbers of responder 
(C3H/HeJ) cells. Mouse 31 also does not show a significant response. 
Mouse 33 is the only one of the nine multicolored allophenic mice which 
shows a response that correlates well with the responder parental strain 
(BALB/C). Mouse 42, however, showed no secondary response even though it 
contained slightly fewer responder cells than mouse 33. From these results 
it is indicated that coat color phenotype may not be a good reflection of 
the lymphocyte population. There already is evidence (Moustafa and 
Brinster, 1972) that mice of a single coat color are actually tetraparental 
when examined for the other strain specific markers such as isozyme patterns, 
hemoglobin type or immunoglobulin type. 
Unfused or single embryos (see Table 13) provided control mice for the 
immunization with DNP-GLA^. All of these mice responded as predicted from 
their genotypes. Mice 18, 19, and 20 of C57BL/'''J phenotype acted as non-
responders and mouse 16 of C3H/HeJ phenotype acted as a responder. This 
also shows that Jji utero or "milk effects" from foster mothers were 
negligible. 
2. Response of mice to DNP-BSA and DNP-lysine levan 
Mice that had been immunized with DNP-GLA^ in the usual immunization 
pattern were challenged with DNP-BSA. BSA as a carrier molecule for the DNP 
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group is recognized by most mouse strains as immunogenic. This antigen, 
DNP-BSA should then induce DNP antibody in the mouse strains produced. 
As can be seen in Table 14, mice which received only DNP-BSA as an 
immunogen did give significantly high primary and secondary responses. 
However, if the mice had been previously immunized with DNP-GLA^, a 
significant difference was noted in the response of mice which had been 
nonresponders to the DNP-GLA^. These mice did not make significant amounts 
of DNP antibody to the DNP-BSA. As can be seen in Table 14, they, in 
fact, acted as nonresponders to the DNP-BSA just like their response to 
the DNP-GLA^. However, the responder mice to DNP-GLA^ had their response 
enhanced by the stimulation with the DNP-BSA. This seems to indicate that 
a nonresponder-type animal which does not recognize the carrier portion of 
an H-2-linked antigen then suppresses any further response to that hapten, 
even if it is linked to another immunogenic carrier. 
Using a different approach, Hraba et al. (1970) did an experiment in 
which mice were injected several times with a DNP-mouse serum albumin, a 
weak immunogen, and then challenged with DNP-keyhole limpet hemocyanin as 
strong immunogen. It was found that the response to the strong immunogen 
DNP-KLH was partially suppressed by the previous injections of the DNP-MSA. 
The mice thus immunized did not produce high affinity but did produce low 
affinity antibody. Golan and Borel (1971) extended these experiments and 
found that by using the tolerizing immunogen, DNP-MSA, mice could be in­
duced to have a specific ability not to respond to the DNP-KLH. The 
tolerization is probably due to two phenomena: T-cell suppression of B-cell 
antibody production to hapten conjugated to an unrecognizable carrier and/or 
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a defect in the antibody producing cells. The first seems more probable, 
in that B cells produced low affinity antibody but not high affinity anti­
body which would require T cell cooperation (Hraba e^ al. (1970). 
In another experiment done by Gershon ^  (1973), mice immunized 
with another synthetic polymer GAT^^ (synthetic copolymer of glutamic acid 
alanine and tyrosine) similar results were found. In this experiment 
mice were immunized with the H-2 linked antigen GAT^^. The strain DBA/1 
(H-2^) does not make antibody to this polymer. Other mouse strains with 
different H-2 types, however, do make antibody to this polymer. The 
thymocytes of the nonresponder strain DBA/1 did show some evidence of 
recognizing this antigen since they did synthesize DNA when stimulated by 
the GAT^^. However, this recognition event did not lead to memory produc­
tion as with the responder mice. These nonresponder mice did make anti­
body to the GAT^^ when it was complexed to an immunogenic carrier (methy­
lated BSA). If the mice were challenged with GAT^^ prior to the challenge 
with the GAT^^ coupled to methylated BSA the antibody response to the GAT^^ 
determinant was abolished at least temporarily. The study with the DNP-GLA^ 
and DNP-BSA previously discussed showed a permanent suppression of the re­
sponse to DNP. However, this could be a function of the difference between 
the experiments. In the case of GAT^^, (Gershon et ^ ., 1973) the GAT^^ 
is the immunizing agent. After coupling the MBSA, the GAT^^ acts as a 
hapten. For the DNP-GLA^ and DNP-BSA experiment, the DNP is the hapten in 
both cases. 
Levan is a thymus independent antigen which is capable of direct stimu­
lation of B cells. This antigen, however, will produce only IgM type 
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antibody even after repeated injections (Del Guercio £t £l., 1974). DNP 
antibody production to a conjugate of DNP-lys-levan is lower than produc­
tion of DNP antibody against DNP-protein conjugate. As a result, the radio­
active assay used in previous assays for DNP-antibody is not sensitive 
enough to detect the DNP-antibody produced. Another assay, that of the 
plaque assay of DNP-T4 phage (Del Guercio and Leuchars, 19^72) was used to 
detect DNP antibody. This assay is approximately 100 times more sensitive 
than the radioactive assay. Some preliminary results indicate that DNP-lys-
levan does induce DNP-antibody production. These assays were performed in 
this laboratory by Sandra Nelson Walters. The DNP-antibody produced is 
approximately 20 times less than the antibody production of a DNP-protein 
conjugate. Also it was noted that DNP-lys-levan does not act as "boosting" 
agent to the antibody produced against a DNP-protein conjugate when ad­
ministered in a secondary injection. This is an indication of the specifi­
city of B cell recognition of haptens. In this case T cells have recognized 
a carrier and in turn have triggered the B cell antibody production. How­
ever, an antigen which is capable of acting without T cell triggering cannot 
act on B cells which have been specifically triggered by another antigen and 
boost antibody production. 
3. Response to DNP-BGG 
a. Response of inbred strains 
of mice to low dose (1 yg) DNP-BGG administered in Al(OH)g adjuvant was first 
investigated by Vaz and Levine (1970). The immune response of these mice to 
the antigen is genetically controlled by an H-2 linked gene. If a larger 
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dose (100 pg) was administered in the Al(OH)g gel adjuvant, the mice re­
sponded with no correlation to their H-2 type. Vaz and Levine (1970) used 
a passive hemagglutination test to detect the titer of the hapten specific 
antibody in the mouse sera. The amount of IgGl antibody was determined 
by passive cutaneous anaphylaxis at two hours. Reagenic antibody was de­
termined using the same test but read at 48 hours. At the primary response 
after challenge with 100 yg the response was similar for all the strains. 
However, repeated doses of the low dose 1 pg DNP-BGG induced a difference 
in the types of response. Mice of H-2 types b, d, and q were low responders, 
whereas mice of H-2 types a, k, and s were high responders. The low re­
sponder strains were also found not to produce IgGl nor reagenic antibodies, 
whereas the high responder strains produced both. 
This immunization procedure was then used for the repeated low doses 
of 1 yg of DNP-BGG in AlOOH)^ adjuvant for the following strains of mice: 
A/JxSJL/J F1 hybrids (H-2^^^), A/J (H-2*/*), SJL/J (H-2^/^), BALB/cJ 
(H-2^/^). C3H/H3J (H-2k/k)^ CBA/J (H-2'^/^), CBA/Jx CBA/H-T6J F1 hybrids 
(^k/k^, C57BL/6J (H-2^/^), and DBA/IJ (H-2^/^). The undiluted sera of 
these mice was tested at the secondary response (see Figure 13) and at the 
tertiary response (see Figure 14). The DNP-antibody was detected using a 
radioimmunoassay procedure. Inspection of Figures 13 and 14 reveals that 
the differences between low responder and high responder strains are not 
obvious using the assay procedure. However, when serial dilutions of this 
antisera were made, the differences between high responder and low re­
sponder strains became more apparent. Figure 15 shows a plot of percent 
response vs. log (1/serum dilution) for each of the strains tested at the 
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tertiary response. A distinct division among the strains is seen in the 
manner which the sera dilutes out. The sera of the low responding strains 
and H-2^^^ dilutes out very quickly. The sera of H-2^^^ and 
mice falls in an intermediate range. The sera of ^ and 
mice dilutes out slowly indicating a high response. 
Vaz and Levine (1970) examined the primary response of various strains 
after one injection of 100 yg DNP-BGG. However, the secondary or tertiary 
responses of the mice were not investigated. The investigation of these 
responses was then undertaken for the amount of 50 yg of DNP-BGG in 10 mg 
AlCOH)^ gel adjuvant. The mouse strains used were A/J, SJL/J, C3H/HeJ, 
BALB/cJ, C57BL/6J and DBA/IJ. As shown in the secondary and tertiary 
responses in Figures 16 and 17, respectively, the differences among the 
responder and nonresponder strains are less pronounced than with the low 
dose of antigen. However, some significant differences still persist. 
Most striking are the DBA/IJ mice which continue to be low responders and 
the SJL/J and A/J mice which continue to be high responders. 
The purpose of the next set of experiments was to determine the effect 
of a different adjuvant other than Al(OH)g on the immune response of the 
mice to repeated low doses of DNP-BGG. Complete Freund's adjuvant was 
chosen since many antigens under H-2 linked genetic control have been tested 
using the adjuvant. Some examples are; (T,G)-A—L (McDevitt and Chinitz, 
1969), GAT^^ (Martin e^ aJL., 1971; Merryman and Maurer, 1972), GL0 
(Merryman et al., 1972) and GLA^ (Warner et al., 1973). With respect to 
the amount of antibody, the differences between the responses of the strains 
to DNP-BGG in CFA level out considerably as can be seen for the primary and 
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secondary responses in Figures 19 and 20. This becomes even more clear in 
the diluted sera as can be seen in Figure 21. 
The explanation of these results depends partially on an explanation 
of the effect of adjuvants on the three cell types involved in the inmiune 
response: T cells, B cells, and macrophages. Hamaoka and Katz (1973) 
have shown that adjuvants do not replace the requirement for T cells in 
eliciting a response to T dependent antigens. The response to DNP-protein 
conjugates in the presence of adjuvants was completely abrogated by treat­
ment with anti-0 serum and complement before challenge with antigen. The 
adjuvant actions investigated were concanavalin A, LPS, beryllium sulfate, 
and Bordetella pertussis. 
Dresser (1968) has suggested that the effect of adjuvants may be to 
reduce the doses of antigen required for the initiation of cell activation. 
Later, Dresser (1972) found that as the antigen concentration increased, 
the effect of adjuvant on B cells also increased. He also found that some 
B cells can produce IgM without T cell triggering. It.'was. suggested that, the 
mechanism of adjuvant action is similar to that of T cell triggering of B 
cells to produce antibody. This was supported by the fact that the adjuvant 
Bordetella pertussis can partially replace absent T cells and stimulate B 
cells toward antibody production. 
The effect of adjuvant in reducing the amount of antigen required for 
antibody production can be a partial explanation for the observation that 
complete Freund's adjuvant levels out the response of the mice compared to 
the A1(0H)2 gel adjuvant. This could be acting in effect as a "better" 
adjuvant in this case. 
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In the second set of experiments that were performed using 70% 
saturated (NH^)2S0^ pH 6.8 (Tables 16-18), the percent response of the 
pooled sera of these inbred strains was similar to that of the average 
percent response using 66% saturated (NH^)2S0^ pH 6.8 (Table 15). The 
DBA/IJ mice, however, gave a higher response in the second set of experi­
ments. There appears to be some variation in the response of the DBA/IJ 
mice. 
b. Response of tetraparental mice After characterization of the 
inbred strains of mice to DNP-BGG, the study of the response of the tetra­
parental mice was undertaken. The undiluted serum of each mouse was tested 
for its ability to respond at the secondary and tertiary bleeding. Since 
the original difference between high and low responders was not clearly 
apparent for the control strains, this data is difficult to interpret. 
In order to better elucidate the contribution of each parental strain, the 
sera of individual mice from each strain were diluted and the range of the 
reciprocal of the serum dilution was determined (Table 19). However, for 
two of the strains, BALB/cJ and C3H/HeJ, which were combined with C57BL/6J, 
an overlap of the ranges occurred making it somewhat difficult to inter­
pret the data from the tetraparental mice made from these strains. However, 
for a third strain, A/JXSJL/J F1 hybrid combined with the C57BL/6J, a gap 
exists between the two ranges and makes it possible to interpret the data 
meaningfully. As can be seen on Table 22, it appears that mice 49, 50, 58, 
59, 62, 65, 67, and 68 are responding as A/JxSJL F1 hybrids. Mice 60, 61, 
64, 66 and H fall in the range of the C57BL/6J type of response. For the 
genotype C57BL/6J DBA/IJ no in vivo complementation test occurs making 
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any of these mice into responders. For the genotype DBAIJ JxSJL/J 
F1 hybrid mouse 53 falls in between the range of both parental strains 
and mouse 56 acts as a A/JxSJL/J F1 hybrid. 
B. Amounts of DNP-antibody as Determined by Radial Diffusion 
This method was used to determine the amount present of DNP-antibody 
as well as the amount of antibody present against DNP-BGG. The sera used 
were for the second set of experiments performed. As can be seen on Table 
25, the amounts of DNP antibody are higher for the high responding mice. 
The amount for the low responding strains is not detectable or very low. 
There is a correlation of this test then, with the percent response given 
in the radioimmuneassay. 
When the amount of antibody produced against the immunizing agent, 
DNP-BGG, was determined for the inbred strains, the amount of antibody was 
found to be significantly higher than the antibody to just the DNP group. 
This phenomenon was also observed by Eisen et al. (1954) in rabbits. In 
the case in which an inbred strain produced a high amount of DNP-antibody, 
the ratio of the amount of DNP-antibody to the amount of antibody to DNP-BGG 
increased. However, the accuracy in detecting small amounts of DNP-antibody 
is significantly less than for larger amounts. 
C. Affinity of DNP-antibody 
The affinity of the DNP-antibody produced against DNP-BGG was studied. 
A method devised by Paul and Elfenbein (1975) was used because the amount 
of antibody was limited. This made conventional methods of calculating 
the average intrinsic association constants impossible to do. By usiqg the 
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method of Paul and Elfenbein, the relative average affinity of the anti­
body could be calculated. In using this method there is a selection for 
high affinity antibody that is produced by the nature of the concentration 
of the radioactive ^H-DNP-lysine. Using too high a concentration (10 ^ M) 
would mean diluting the radioactivity with cold DNP-lysine and using too 
-9 3 low a concentration (10 ) would mean that there would be too little H-DNP-
lysine to count accurately. However, when companion studies were done 
using inhibition of plaque formation with DNP-lysine in the SRBC assay, 
this method has been shown to correlate well in studies of higher affinity 
antibodies (Paul et al., 1971; Elfenbein et al., 1973; Davie et al., 1972). 
Using this method, then, the serum dilution at which 33% of the hapten is 
bound is shown on Tables 26-28 [66% sat. (NH^)2S0^ pH 6.8]. The two 
low responding strains (C57BL/6J and DBA/lJ) did not bind 33% of the 
hapten for the highest concentration of hapten and as a result, the affini­
ties could not be calculated for 1 yg in ^ (OH)^ and 50 yg in Al(OH)g for 
the DBA/IJ. As can be seen from Figures 25-27, log K falls between 5.3 
and 7.0 for all three studies. As can be seen in Figure 25, the affinity 
of the artibody produced against 1 iig DNP-BGG in Al(OH)g gel adjuvant shows 
no correlation with the amount of antibody for high and intermediate 
responders. The affinity of the low responders could not be tested. Fig­
ure 26 shows that the range of affinity of the antibody at the tertiary 
response to 50 yg DNP-BGG is within the same order of magnitude as for the 
low dose of antigen. Again, no correlation of amount of antibody was found 
with the affinity of the antibody. In this study, insufficient antibody 
was produced by the DBA/IJ and CBA/J strains for affinity studies. It is 
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Interesting to note that the low responder strain C57BL/6J did produce 
sufficient antibody for the affinity study, and the affinity is in the same 
range as that of all the other strains. Finally, the 1 yg dose in CFA 
(Figure 27) shows the same range of affinities as the other two studies. 
All strains produced sufficient antibody for this study, and again there 
was no correlation of amount of antibody produced with the affinity of the 
antibody from any one particular strain. 
In the second set of experiments, (70% sat. (NH^)2S0^ pH 6.8) the 
affinity of the DNP antibody was tested for one condition (5 x 10 ^  M 
3 -6 3 
H DNP-lysine). 10 M H DNP-lysine was used as the index condition. 
Table 29 compares the values obtained in this set of experiments with 
those obtained in the previous experiments. Although within the same 
order of magnitude as the first calculated, the 50 yg dose administered 
in Al(OH)g gel adjuvant appears to have slightly lowered antibody affinity 
compared to the low dose in the Al(OH)g gel adjuvant. In contrast, the 
low dose administered in CFA has significantly increased the antibody 
affinity over that of the low dose in Al(OH)g gel adjuvant, especially for 
the low responding strains C57BL/6J and DBA/IJ. 
D. Determination of the Percent IgG of Total Antibody 
1. Percent IgG antibody of inbred strains 
The determination of the percent IgG of the total was also studied 
for the various strains of mice at the tertiary response for 1 yg DNP-BGG 
and 50 yg DNP-BGG in Al(OH)g gel adjuvant and at the secondary response 
for 1 yg DNP-BGG in CFA, Table 30 shows the percent IgG of total anti-
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DNP antibody for the various strains of mice. The percent IgG seems to be 
independent of the dose of antigen or the type of adjuvant used for immuni­
zation. The two low responder strains, C57BL/6J and DBA/IJ, show signifi­
cantly less IgG than the other strains. In fact, except for the A/J mice 
which appear anomalous, all the intermediate and high responder strains 
show 85-100% IgG, whereas the low responder strains show less than 66% IgG. 
Even though differences in the amount of antibody produced by the "low" and 
"high" responder strains disappears somewhat with the high dose of antigen 
and disappears completely with the complete Freund's adjuvant, the type 
of antibody produced remains different for "high" and "low" responder 
mice. In Figures 28 and 29 are shown plots of C3H/HeJ and C57BL/6J, 
antibody precipitation curves, respectively. As can be seen on these 
figures, the maximum precipitation of IgG by anti-IgG antibody is an approxi­
mation. Since serial dilutions were done, the points between these dilu­
tions were not obtained, due to the small amount of sera. At 1:3 or 1:6 
dilutions there is a possibility that the precipitation may be higher. 
Another set of experiments was performed using 2-mercaptoethanol to 
confirm the results with the anti-IgG antibody. The low responding and 
nonresponding strains did show a significant reduction in total DNP-anti-
body after treatment with 2-ME (see Table 29). This is an indication that 
part of the total antibody is not IgG, since IgG activity is insensitive 
to 2-ME treatment. (IgM activity is sensitive to 2-ME.) This evidence 
then supports the anti-IgG antibody data. 
Vaz and Levine (1970) originally showed that the low responding mice 
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did not produce IgGl. This class of antibody is present in the responder 
strains. This could account for the lower production of IgG in the low 
responding mice. Of the different IgG classes produced, IgGl is the most 
dependent on T cells for its production. Thus, if T cell receptors were de­
fective for determinants on the DNP-BGG, it would then be expected that the 
antibody response requiring this T-cell interaction would be missing. 
Using a different antigen, Torrigiani (1972) has shown this requirement for 
T cells for the production of IgGl antibody to a low dose of keyhole 
limpet hemocyanin. 
2. Percent IgG of tetraparental mice 
The percent IgG of tetraparental mice was determined by the use of 
anti-IgG antibody. The results are shown on Table 31. Mice which re­
sponded as their 100% C57BL/6J coat color indicates and gave less than 
60% IgG are mice 34, 37, 38, 39, 43, 47, 51. Also mice which were multi­
colored, 44, 46, 48, 64, 66, and 67, gave less than 60% IgG. The amount 
of C57BL/6J ranged from 5 - 95% by coat color in these mice. Some of the 
interesting mice are those which were phenotypically by coat color a 
responder or low responder and immunologically^ by percent IgG, were the 
reverse. Mouse 35 is 100% C57BL/6J by coat color and produced 102.0% IgG. 
Mouse 36, again 100% C57BL/6J by coat color,-produced 72.8% IgG. Mouse 61, 
100% C57BL/6J by coat color', produced 97.7% IgG. Mouse 67, 100% A/JxSJL/J 
F1 hybrid, produced 48.6% IgG and mouse 70, 100% C3H/HeJ, produced only 45.3% 
IgG. This indicates another marker, in addition to coat color, is needed 
to characterize these mice. 
Mouse 53 and 56, a combination of DBA/1 -<->• AJxSJL/J, responded with 
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67.8% IgG and 84.2% IgG, respectively. Mouse 53 was 90% DBA/lJ by coat 
color and mouse 56 was 40% DBA/IJ. These mice responded as predicted 
from their coat color. 
E. Hemoglobin Analysis 
Heterogeneity of hemoglobins within animal species has been reported 
(Kitchen, 1974). It is not surprising, then, that 3 types of hemoglobin 
have been found in mice (Oilman, 1974). Thus, when tetraparental mice are 
produced, this information can be used to mark the contribution of each 
parental strain to the tetraparental mouse by the amount of each type of 
hemoglobin present. Thus, a method was devised to analyze the amount of 
single and diffuse hemoglobin in a mixed sample of hemoglobin. In order 
to determine the linearity of area under the curve or peak height vs. 
the amount applied to the gel, and plots were made of these parameters. 
As can be seen in Figures 35-39, for each mouse strain a linear relation­
ship was found for both the area and peak height vs. the amount applied to 
the gel. After measuring the peak width, another linear relationship was 
found. If the amount applied to the gel was plotted vs. the ratio of the 
peak height to the peak width, a straight line was obtained for each strain. 
(See Figures 40-43). Also, it was noticed that the slopes of the diffuse 
hemoglobin were significantly greater than that of the single hemoglobin. 
As discussed in the Results chapter, if a constant amount (50 yg) of a 
mixed sample is placed on the gel, it can be empirically seen that if the 
sample is 100% C57BL/6J, no diffuse Hbb is present and the sample will have 
the same h/w ratio as 50 yg C57BL/6J. If the sample is 100% C3H/HeJ 
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(diffuse, see Figure 40), then the h/w will be the same as 50 pg of 
C3H/HeJ Hbb. Assuming then that both the h/w ratios and the amounts of 
Hbb are additive in a mixed sample, the mixtures which contain both types 
of Hbb in a total of 50 yg should have h/w ratio between the h/w ratios of 
50 yg C3H/HeJ Hbb and 50 pg C57BL/6J Hbb. The use of actual mixed samples 
of single and diffuse Hbb showed a good correlation with this empirical re­
lationship. The experimental lines showing the amount of C57BL/6J Hbb in 
a mixed sample and its coincidence with the theoretical line (dotted line) 
can be seen in Figures 40-43. One of the difficulties involved in assess­
ing the amounts of each component Hbb in a mixed sample is the sensitivity 
of detection. Table 32 shows the minimum amount detectable of each type 
of Hbb. Although both hemoglobins contribute to detection in a mixed 
sample this problem must still be considered as the outside points of the 
sample, i.e., those in which there are small amounts (^ 20% of the total) 
of either component. However, from 20-80% of either component, the tech­
nique works. A good example is in mice which are F1 hybrids of diffuse 
Hbb and single Hbb types. Hemoglobin expression is allelic and these mice 
should contain a 50/50 mixture of single/diffuse. Mice J, LZ, 2Z and 3Z 
are such mice. They were found to contain 46, 57, 57 and 60% single Hbb, 
respectively. Taking these factors into consideration, the amount of 
C57BL/6J Hbb present in tetraparental mice was calculated. 
Mice which showed a high tertiary response (Tables 20-21) or a high 
dilution at 33% response, a high percent of IgG (Table 31) responder type 
coat color, and little C57BL/6J hemoglobin (Table 33) are 58, 59, 60, 61, 
62, 68, F, and H. These mice responded as predicted. Mice which showed 
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a low tertiary response at a low dilution at 33% response, a low percent 
IgG, nonresponder type coat color, and C57BL/6J Hbb are 37, 38, 39, 44, 51, 
IF, 2F, 2M and J. Again these mice responded as predicted. Mice I, IF, 
and 2F were a fusion of two low responders, strains (C57BL/6J and DBA/IJ). 
As a result, these mice acted as low responders. The presence of both types 
of Hbb indicates that by Hbb composition these mice were really tetra-
parental. The anomalies included mice 36, 46, 64, 67 and 70. Mouse 36 was 
100% C57BL/6J by coat color; however, it gave a high % IgG and a high ter­
tiary response. Only 49% of the Hbb present in this mouse was characterized 
as C57BL/6J Hbb indicating the presence of responder cells in this mouse. 
Mouse 46 gave low immunological responses and showed 60% C57BL/6J by coat 
color. However, mouse 46 only showed 17% C57BL/6J Hbb. Mouse 64 also gave 
low immunological responses but was almost all (95% A/J x SJL/J) responder 
cells by coat color. In addition, this mouse showed only 19% C57BL/6J Hbb. 
Mouse 67 acted in the same manner as mouse 64. However, the amount of 
C57BL/6J Hbb was higher (34%). Mouse 70 showed low immunological responses 
but showed 100% (C3H/HeJ) responder coat color. However, mouse 70 showed 
106% C57BL/6J Hbb. Three of these mice, 35, 46, and 70 show partial or 
complete reversals of the coat color with the Hbb. However, in mice 64 
and 67 there is some agreement with the coat color and Hbb. In the mice 
36 and 70, the immunological data agree with the Hbb characterization as 
to which strain predominates in the allophenic mouse. In the case of 
mouse 46, the coat color evaluation correlates best wtih the immunological 
data. However, for the other two mice, 64 and 67, the immunological 
data do not agree with the Hbb characterization or coat color 
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evaluation. In these mice, the small amount of nonresponder cells present 
may be contributing to the suppression of response in these mice. 
From the work of Kennedy et , (1975), it is already known that non­
responder thymus cells from mice do bind the antigen GAT^^, but suppress B 
cell antibody production. This binding of GAT^^ by nonresponder mice was 
found to be inhibited by anti- H-2 sera but not by anti-Ig sera. This 
binding also increased significantly at 37°C compared to 4°C. HSmmerling 
and McDevitt (1974) also found increased numbers of antigen-binding T cells 
at 37°C when they incubated the cells with (T,G)-A—L. The inhibition of 
this binding by anti H-2 sera strongly suggests that the H-2 antigen is 
in close proximity of the gene product or might exist as a molecular 
complex with the H-2 antigen. Shevach e^ (1974) have evidence to 
this effect with regard to guinea pig ^  genes. In (2x13)F1 guinea pigs 
it was found that antisera to each of the parental strains blocked the 
specific immune responsiveness related to that strain but not the other, 
thus suggesting a complex or close proximity of the ^  gene and the H-2 
antigen. 
McDevitt e^ al. (1974) and Freed et al. (1973) found when they 
immunized tetraparental mice with (T,G)-A—L both allotypes of the parental 
strains were produced. It was then suggested that this was evidence that 
the defect of gene expression and regulation was in the T cells. How­
ever, this has been contended by Shearer £t al. (1972) who reports that 
with certain antigens the defect may lie with the B cell. Other studies 
indicate that the Ir-gene product function may be quite complex and re­
quire both T and B cell expression of the ^  gene (Katz, e^ 1973; 
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Katz et al., 1975). 
In vitro studies (Katz et , 1975) have shown that in order for 
optimal antigen-specific T-B cell interactions to occur, the interacting 
cells must share genes located in the K end of the H-2 complex. Dorf e£ al. 
(1975) have done studies using F1 hybrid mice iii vivo and have demonstrated 
conclusively that gene identities must exist in the K and/or I regions in 
order for optimal effective cooperative lymphocyte interactions to occur 
in vivo. These cell interaction molecules are probably present in varying 
quantities on T and B lymphocytes and macrophages and interact by homology 
in cooperative type interactions (Benacerraf and Katz, 1975). 
Thus» in tetraparental mice, identity in the K end of the H-2 locus 
would be required to stimulate the low responder B cells to produce IgG 
antibody in significant amounts. However, there may be a possibility that 
this requirement for identity may be circumvented in a tetraparental 
mouse since the cells of the mouse have been together since the eight-cell 
stage and some "blocking" factor may prevent this recognition from oc­
curring, allowing T and B cells of different H-2 types to interact. 
In the tetraparental mice produced in this study, none of the strains 
combined was identical in the K end of the H-2 locus. If the work of 
Katz and his colleagues is true for tetraparental mice, little cellular 
interaction should have occurred between the T and B lymphocytes from the 
two parental strains. In fact, the tetraparental mice do not give a mixed 
response (one in between the two parental strains) but acted as one of the 
parental strains. This can be seen in the percent IgG produced by these 
mice. Even though the mice showed phenotypically both coat colors and both 
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hemoglobin types they acted as one of the parental strains. One explana­
tion for this phenomenon is that each antigen.system affects the response 
a.n a different way. For (T,G)-A—L there may be a crossing of the histo­
compatibility barrier. For the antigens, DNP-GLA^ and low DNP-BGG, this 
appears not to be the case. 
Study of the H-2 linked immune response genes has provided insights 
into the mechanism of the immune response. Tetraparental mice have pro­
vided an vivo model through which to study this mechanism and contribute 
to the information elucidating the mechanism of the immune system. 
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V. CONCLUSION 
The first purpose of the work reported in this thesis was to define 
the immune response of inbred strains of mice to two gene controlled 
antigens, DNP-GLA^ and low dose DNP-BGG. The second purpose was to 
produce allophenic mice from various combinations of inbred strains and 
to test their response to DNP-GLA^ and low dose DNP-BGG. 
The immune response of mice to DNP-GLA^ was as expected. The mouse 
strains which gave a significant immune response to this antigen were 
C3H/HeJ, A/J, and BALB/cJ. C57BL/6J, DBA/IJ and SJL/J mouse strains were 
nonresponders to this antigen. Of the allophenic mice tested, only two 
mice responded. A possible explanation for the nonresponse of the rest 
of the allophenic mice was that suppressor T cells had suppressed anti­
body synthesis by the B cells, resulting in low or nonresponse. 
Most of the experiments described herein used the antigen DNP-BGG. 
An attempt was made to determine the amount of antibody, the affinity of 
the antibody, and the type of antibody produced against DNP-BGG. Three 
different immunization schedules were used: 1 ng DNP-BGG in Al(OH)^ gel 
adjuvant; 50 yg DNP-BGG in Al(OH)g gel adjuvant; and 1 yg DNP-BGG in CFA. 
The inbred strains of mice responded to low dose (1 yg) DNP-BGG in 
Al(OH)g gel adjuvant in a manner similar to that described by Vaz and 
Levine (1970). However, a few exceptions were noted. Vaz and Levine 
(1970) found the SJL/J mice to be low responders and the C3H/HeJ and 
CBA/J mice to be high responders. In this work the SJL/J mice were high 
responders and the C3H/HeJ and CBA/J mice were medium responders. 
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When the undiluted sera from the inbred strains of mice were tested 
for DNP-antibody, the difference between responders and low responders 
was not obvious. However, dilution of the sera from the inbred strains 
of mice showed differences among the high responders, the medium re­
sponders, and the low responders. The antigen binding capacity at thirty-
three percent response (ABC^^) was lower for the low responders than the 
high responders. This suggested a smaller amount of antibody was present 
in the sera from low responders. This was confirmed by the Mancini 
technique. At least a ten-fold difference in the amount of antibody was 
found between low responder and high responder strains of mice. 
The affinity of the DNP-antibody produced by mice immunized with 
DNP-BGG was tested. When the assay conditions utilized 66% (NH^)2S0^ 
pH 5.8, the affinities of the DNP-antibody of the high and low responding 
strains were within the same order of magnitude. When the assay con­
ditions utilized 70% (NH^)2S0^, pH 6.8, the affinities of the high and 
low responding strains were the same as those estimated with the assay 
system using 66% (NH^)2S0.^ pH 5.8 when the mice were immunized with 1 yg 
DNP-BGG in Al(OH)g gel adjuvant. However, using these conditions, [70% 
(NH^)2S0^ pH 6.8), the affinity for the DNP antibody was noticed to de­
crease when the inbred strains of mice were Immunized with 50 (Jg DNP-BGG, 
and when the mice were immunized with 1 yg DNP-BGG in CFA, the affinity 
of the antibody increased. These results were as expected. It is well 
known that a decrease in affinity often occurs with a higher dose of 
antigen and that an increase in affinity often occurs when CFA is used. 
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The type of antibody produced in the mice immunized with DNP-BGG was 
also studied using anti-mouse IgG anti-sera and 2-ME. When the anti-mouse 
IgG anti-sera was used, the mice of the low responding type showed IgG 
production. However, the IgG DNP-antibody was at most 60% of the total 
DNP-antibody. The responding strains showed 80 - 100% IgG DNP-antibody 
of the total DNP-antibody. This work with the anti-mouse IgG antibody 
then indicated that low responding strains may produce lower amounts of 
IgG. This work was partially confirmed when the C57BL/6J mice showed a 
reduction in antibody activity with 2-ME. Levine and Vaz (1970) found 
that low responding strains to low dose DNP-BGG did not produce IgGl 
type antibody. The lowering of IgG antibody in the low responding strains 
may be due to the fact that the low responding strains are missing this 
class of antibody, IgGl. 
The allophenic mice, immunized with low dose DNP-BGG, were tested 
for the amounts and type of DNP-antibody produced. These mice were 
characterized as to coat color and hemoglobin type. Further characteriza­
tion of the hemoglobin is needed to draw definitive conclusions as to the 
composition of these mice. Interestingly, many of these mice responded 
to DNP-BGG. 
One of the hypotheses that has been proposed for the mechanism of 
nonresponse of mice to H-2-linked Ir gene controlled antigens has been 
that of cross tolerance (Benacerraf and McDevitt, 1972). The fact that 
tetraparental mice which expressed both coat colors showed a response to 
DNP-BGG suggests this is probably not an adequate explanation. Cross 
tolerance means that the immunizing antigen that is injected is cross 
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reactive with the animal's own antigens. Allophenic mice are tolerant 
of each of the strains from which they are made, since they have been 
fused from the embryonic state. One of these strains in each allophenic 
mouse was a low responding strain. If cross tolerance were the mechanism 
of nonresponse, then these mice should not respond. However, they did 
respond, indicating that cross tolerance is not a likely explanation for 
the mechanism of nonresponse to %r gene controlled antigens. 
Another mechanism explaining nonresponse to H-2-linked Ir gene 
controlled antigens is a defect in one or both of the immunocompetent 
cells (T or B cell). The T cell defect hypothesis (Benacerraf and 
McDevitt, 1972; Mitchell et al., 1972; Bechtol ^  al., 1972; Freed et al., 
1973; McDevitt et al., 1974; McDevitt and Landy, 1972) suggests that the 
Ir gene product is expressed on T cells and is defective. This makes T 
cells unable to stimulate B cell IgG antibody synthesis. The B cell de­
fect hypothesis (Shearer et , 1972; Benacerraf et , 1974; Mozes, 
1974) suggests that the gene product is expressed in the B cell which 
then makes B cells incapable of producing IgG antibody in spite of T cell 
stimulation. Although almost all available data seem to point to the T 
cell defect hypothesis and expression of the Ir gene product on T cells 
as the explanation for nonresponse, there is no direct proof of this 
hypothesis and the controversy continues. To date, the ^  gene product 
has not been Isolated and immediate resolution of this problem is not 
likely. However, isolation of this product should show which cell(s), T 
or B express(es) this product. When this is accomplished, the mechanism 
of j[r gene control of immune responsiveness will be finally resolved. 
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